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The socio-demographic characteristics of diabetes, hypertension, 
and cardiovascular disease risk in India 
Abstract 
Background:  
Cardiovascular disease (CVD) is the leading cause of mortality in India. Yet, the 
evidence is sparse on how diabetes, hypertension, and predicted CVD risk vary between 
population groups in the country. This dissertation aimed to determine how the prevalence of 
diabetes, hypertension, and predicted CVD risk in India varies by state, rural-urban location, and 
individual-level socio-demographic characteristics. 
Methods:  
Data were pooled from the Annual Health Survey (2012-2013) and the District-Level 
Household Survey-4 (2012-2014). Diabetes was defined as a plasma glucose !126 mg/dl if 
fasted or !200 mg/dl if non-fasted, and hypertension as a systolic blood pressure (BP) 
!140mmHg or a diastolic BP !90mmHg. Predicted 10-year CVD risk was calculated for each 
participant aged 30 to 74 years using the Framingham risk score, and dichotomized into high 
(!30%) or low risk (<30%).  
Results:  
1,320,555 adults aged !18 years were included in the diabetes and hypertension analysis, and 
797,932 adults aged 30 to 74 years in the CVD risk analysis. The crude prevalence of diabetes, 
hypertension, and high CVD risk was 7.3% (7.1 - 7.4), 23.6% (23.4 – 23.7), and 14.6% (14.4 – 
14.8) among females, respectively, and 7.8% (7.6 - 8.0), 27.3% (27.1 – 27.5), and 31.7% (31.4 – 
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32.0) among males, respectively. There was substantial variation in the prevalence of each 
outcome among states. Being in the richest compared to the poorest household wealth quintile 
was associated with only a modestly higher probability of diabetes (rural: 2.8 [2.5 - 3.1] 
percentage points; and urban: 3.5 [3.0 - 3.9] percentage points) and hypertension (rural: 4.2 [3.7 - 
4.6] percentage points; and urban: 3.0 [2.4 - 3.7] percentage points). The differences in the 
probability of all conditions by educational category were generally small. 
Conclusion:  
The prevalence of diabetes and hypertension in India is high, and predicted CVD risk was 
approximately twice as high as has been estimated for the United States. The important variation 
in the prevalence of each outcome by state and socio-demographic characteristics can inform 
planning and resource allocation as well as effective targeting of CVD programs to reach those 
most in need.   
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Introduction 
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, including in low- and 
middle-income countries (LMICs).1 India is estimated to contribute almost one fifth (18.9%) of 
the world’s CVD burden as measured by disability-adjusted life years (DALYs).2 Importantly, 
extant evidence suggests that South Asians are predisposed to developing CVD.3-9 South Asian 
migrants have 1.5-2.0 times the prevalence of coronary artery disease compared to age- and sex-
matched white Europeans,3-5 and are estimated to develop coronary artery disease six to ten years 
earlier than white Europeans.6 Further, South Asian immigrants in Western populations have a 
higher prevalence of type 2 diabetes, and tend to develop type 2 diabetes at a younger age and 
lower body mass index (BMI), than their white European counterparts.7-9 Given the Indian 
population’s predisposition to developing CVD and diabetes, India’s huge population size,10 and 
the country’s rising living standards,11 CVD and its risk factors in India are critically important 
to not just India, but also for global health.  
 
In addition to its large burden on health, CVD is also a major cause of impoverishing household 
healthcare expenditures in LMICs.12 In India, which has the highest proportion of total health 
expenditures from out-of-pocket payments of any ‘BRICS’ (Brazil, Russia, India, China, and 
South Africa) country and where only 15% of the population has health insurance,13,14 Jan et al. 
found that 59% of uninsured and 20% of insured individuals who had been hospitalized for acute 
coronary syndrome experienced catastrophic healthcare expenditure (defined as treatment costs 
greater than"30% of annual household income).15 By diverting savings from capital investments 
to healthcare consumption and by reducing labor supply, CVD also has a large negative impact 
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on economic growth. For example, Bloom et al. estimated that CVD will reduce India’s 
economic output by $2.17 trillion between 2012 and 2030.16  
 
Although the cardiovascular consequences of hypertension and diabetes – such as myocardial 
infarction and stroke – are costly to treat, the management of hypertension and diabetes are less 
costly and less complex, providing an opportunity to effectively address these conditions and 
mitigate adverse outcomes in India and similar settings. For instance, many effective anti-
hypertensive and anti-diabetic medications, as well as insulin, are generic and have relatively 
low production costs.17 However, the existing evidence suggests that less than half of Indian 
adults with diabetes or hypertension have been diagnosed.18,19 There is, therefore, a clear need 
for expansion of CVD prevention, screening, and treatment services in India.  
 
Understanding how CVD risk and the prevalence of CVD risk factors vary among population 
groups is essential for health system planning, and to target resources for prevention, screening, 
and treatment interventions most effectively and efficiently. However, oftentimes evidence on 
CVD risk in India is restricted to healthcare facility-based samples or small population-based 
cohorts in specific locales. Hence, there is an important knowledge gap and need for evidence 
underpinned by analyses, which utilize large-scale nationally representative surveys. In pooling 
data from two large household surveys in India, which are jointly representative for the entire 
country, and using rigorous methods of analysis, I aim to address critical knowledge gaps in 
relation to CVD risk in India. These analyses are important empirical contributions to the 
evidence base to help inform policy and practice in India to more effectively address CVD. 
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Specifically, my aims for each of the three dissertation papers and the contributions I will make 
are outlined below.   
 
Paper 1 aims to provide a new diabetes prevalence estimate for India, and to determine how 
diabetes prevalence in the country varies by state, rural versus urban residence, and individual-
level socio-demographic characteristics. A particular focus of this analysis is the relationship 
between diabetes and household wealth in India with a view towards examining empirically the 
frequently held assumption that diabetes is mainly restricted to wealthier urban strata of Indian 
society. This paper uses capillary glucose measurements in non-pregnant adults aged 18 years 
and older. While the recently published ICMR-INDIAB study addresses some of these aims,19 
there is still no empirical diabetes prevalence estimate for India that relies on nationally 
representative data. This study will fill this important knowledge gap by using data from a much 
larger set of states (and a larger sample size within each state) than INDIAB. Methodologically, 
this study will extend the INDIAB study by disaggregating socioeconomic status into household 
wealth quintile and educational attainment (unlike the composite indices used in INDIAB), and 
employing district-level fixed effects regressions, thereby ‘filtering out’ observed and 
unobserved confounders at the district level.  
 
To date, there has not been a study of hypertension in India, and its variation among population 
groups, that uses nationally representative data. Paper 2 aims to fill this important knowledge gap 
by determining the prevalence of hypertension nationally as well as by state. Methodologically, 
this study also relies on district-level fixed effects regressions but, in addition, examines how 
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rural-urban differences in hypertension prevalence vary with a district’s standard of living. This 
paper uses blood pressure measurements in non-pregnant adults aged 18 years and older.  
 
Paper 3 aims to fill the acute knowledge gap that despite existing analyses of CVD risk factors in 
India, no population-based study in the country has examined the predicted risk of a CVD event 
as an outcome. Such an analysis is crucial as CVD is an important endpoint of interest to policy 
makers, and its variation among population groups is unclear given that CVD risk factors likely 
vary differently along socio-economic and demographic gradients. Specifically, this study aims 
to determine the proportion of India’s population, which has a 10-year predicted risk of a CVD 
event of 30% or more. I chose this threshold because it is used by the World Health Organization 
(WHO) in its Global NCD targets to define who is eligible for counselling and/or medication to 
reduce CVD risk.20 This risk was calculated using four different commonly used CVD risk 
calculators that do not require blood lipid measurements: the Framingham Risk Score,21 
Globorisk,22 the Harvard-NHANES score,23 and WHO-ISH.24 The natural logarithm of CVD risk 
was regressed onto rural-urban residence and individual-level socio-demographic characteristics. 
This analysis was restricted to adults aged 30 to 74 years, which is the age range for which 
commonly used CVD risk calculators have generally been validated.  
 
Jointly, these three papers will provide a comprehensive assessment of the socio-demographic 
pattern of CVD risk in India. Specifically, as explained above, papers 1 and 2 fill important 
knowledge gaps with regards to the prevalence and socio-demographic variation of diabetes and 
hypertension in India. In contrast, the socio-demographic patterns of smoking and Body Mass 
Index (BMI) in India are well studied.25,26 By creating a composite CVD risk estimate using 
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participants’ age, sex, smoking status, BMI, diabetes status, and systolic blood pressure, paper 3 
can thus be viewed as combining evidence from papers 1 and 2 with evidence on these 
comparatively better-studied CVD risk factors to yield a full picture of CVD risk in India.  
 
The major contributions of these three papers to existing studies of cardiovascular risk factors in 
India are that i) the dataset is nationally representative having collected data in virtually all 29 
states and seven Union Territories of India (as compared to the INDIAB study,19 which has thus 
far published diabetes estimates for only 15 states); ii) unlike the INDIAB study, which sampled 
only around 4,000 participants per state, both AHS and DLHS-4 have aimed to achieve a 
representative sample of participants from each district in India (sampling a mean of 
approximately 3,000 individuals per district); iii) it examines hypertension and diabetes as well 
as composite cardiovascular disease risk in the same dataset (as compared to the INDIAB study, 
for example, which focused on diabetes); and iv) throughout this dissertation, I use regressions 
with fixed effects at the level of the primary sampling unit, which filters out area-level effects 
(e.g., the local socio-economic environment) on the outcome, rather than using pooled 
regressions (as the INDIAB study has done), which is less suited for identifying individual-level 
(as opposed to area-level) effects on the outcome. 
 
The main aim of all three papers in this study is to examine how the outcome (diabetes, 
hypertension, and predicted CVD risk) varies within India. In Figure 0.1, I have laid out the 
different levels at which variation in the outcome was examined in this dissertation. Papers 1 and 
2 of this dissertation are in press at JAMA Internal Medicine.27  
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Figure 0.1 Socio-demographic variables examined in this dissertation.     
  
Individual: Age, 
sex, education, 
marital status
Household: 
Household wealth 
quintile
District: Mean 
household wealth 
quintile
State: Prevalence by 
state, mean 
household wealth 
quintile
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PAPER 1 
The socio-demographic characteristics of diabetes in India: 
Evidence from a nationally representative sample of 1.3 million 
adults 
 
 
Abstract  
Importance: The prevalence of diabetes in India is increasing. Yet, there has not been a 
nationally representative study to ascertain how prevalence varies among population groups in 
the country.  
Objective: To determine how diabetes prevalence varies by state and adults’ socio-demographic 
characteristics.    
Design: Cross-sectional nationally representative study carried out between 2012 and 2014. 
Setting: Population-based. 
Participants: 1,320,555 adults with a capillary glucose measurement  
Exposures: State, district, rural versus urban location, age, sex, household wealth, educational 
attainment, and marital status.  
Main measure: Diabetes (plasma glucose !126 mg/dl if fasted or !200 mg/dl if non-fasted) 
Results: The crude prevalence of diabetes was 7.5% (95% CI, 7.3 - 7.7) ranging from 2.3% 
(95% CI, 2.0 - 2.8) among females in Madhya Pradesh to 17.9% (95% CI, 15.4 - 20.7) among 
males in Goa. Being in the richest compared to the poorest household wealth quintile was 
associated with only a modestly higher probability of diabetes (rural: 2.81 percentage points; 
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95% CI, 2.53 - 3.08 and urban: 3.47; 95% CI, 3.03 - 3.91). While household wealth quintile and 
living in an urban area were both positively associated with diabetes, the prevalence among those 
in the poorest quintile in rural areas aged 40 years and older was nonetheless high (5.9% [95% 
CI, 5.5 - 6.2]). The differences in the probability of diabetes by educational category were 
generally small ("1 percentage point).   
Conclusions: Diabetes prevalence in India was lower than previously estimated. Nonetheless, 
diabetes is common in middle and older age groups across all geographies and socio-
demographic groups. Knowledge of variations in prevalence will help inform resource allocation 
to more effectively and efficiently target diabetes programs in India to those most in need. 
!
!
Introduction 
As with other low and middle income countries (LMICs), India is in the midst of a rapid 
epidemiological transition: the estimated proportion of disability-adjusted life years (DALYs) 
attributable to non-communicable diseases (NCDs) in India has risen from 31% of total DALYs 
in 1990 to 53% in 2015.28 An increasing prevalence of diabetes – a NCD in itself and a major 
risk factor for other NCDs as well as cardiovascular mortality29 – is both an important driver and 
consequence of this transition. The NCD Risk Factor Collaboration estimates suggest that 
between 1980 and 2014, the age-standardized diabetes prevalence among adults in India has 
grown from 3.7% to 9.1% in men and 4.6% to 8.3% in women.30  
 
In 2015 India had 1.3 billion people,31 accounting for more than one sixth of the world’s 
population.31 In addition, India is projected to be the greatest contributor to global population 
growth until at least 2050.31 Given that its huge and growing population is also rapidly aging and 
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urbanizing,31,32 the country’s performance in stemming its diabetes epidemic is crucial to 
achieving the Sustainable Development Goal 3 (SDG) target of reducing premature mortality 
from NCDs by one third by 2030 globally.33 Further, as out-of-pocket spending for diabetes and 
cardiovascular disease is a major cause of impoverishing healthcare expenditures in LMIC,12,34 
the course of India’s diabetes epidemic will also impact on its ability to reduce poverty and 
achieve universal health coverage.33   
 
Despite being an increasingly important public health problem, there has not been a nationally 
representative analysis of diabetes prevalence in India. Instead, to date prevalence estimates for 
India have relied on sub-national studies. The largest of these studies (the INDIAB study) 
measured capillary blood glucose in 57,000 adults across 14 states and one Union Territory,19 
which jointly account for 47% of India’s population.35 This study differentiates itself from the 
INDIAB study by including participants from all states of India (except Gujarat, and Jammu and 
Kashmir) and achieving a sample that is representative at the level of the district (rather than the 
state). There have only been six other studies that were carried out across more than one state, 
two of which were conducted before 2003 (one only sampled urban populations),36,37 two were 
restricted to rural areas,38,39 and two were limited to select cities.40,41 All other studies sampled 
participants in specific locales or communities within a single state,42-53 or relied on self-report to 
define diabetes.54 Even less is known about how diabetes prevalence varies across states, 
geography, and individual-level socio-demographic characteristics. Yet, it is precisely this 
information that is needed most urgently for health system planning and targeting of prevention, 
screening, and treatment programs, and to address social inequities. 
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As far as we are aware, this is the first nationally representative analysis of biomarker-defined 
diabetes across India. Our aim was to provide a new diabetes prevalence estimate for India, and 
to determine how diabetes prevalence in the country varies by state, rural versus urban location, 
and individual-level socio-demographic characteristics. 
 
Methods 
Data sources 
This study combines data from the most recent rounds of two large-scale population-based 
surveys in India: (i) the second update of the Annual Health Survey (AHS) and (ii) the fourth 
round of the District-Level Household Survey (DLHS-4). The states and Union Territories 
covered by each survey are shown in eFigure1. Jointly, these surveys cover 620 districts across 
all 29 states of India, except Jammu and Kashmir (where data were not collected due to violent 
conflicts) and Gujarat (for which data are not available in the public domain). In addition, the 
DLHS-4 covered five (Andaman and Nicobar Islands, Chandigarh, Daman and Diu, Delhi, and 
Puducherry) of the seven Union Territories of India. States and Union Territories for which data 
were unavailable constituted 6% of India’s population according to the most recent population 
census (2011).35  
 
The AHS was carried out between 2012 and 2013 and covered 284 districts in the nine states of 
India with the highest rates of infant and child mortality in the country in 2010: Assam, Bihar, 
Chhattisgarh, Jharkhand, Madhya Pradesh, Odisha, Rajasthan, Uttar Pradesh, and Uttarakhand.55 
These states accounted for 48% of the country’s population in 2011.35 The AHS used self-
weighting two-stage cluster random sampling in each district, stratified by rural or urban 
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location. In the first stage, 12 primary sampling units (PSU; villages in rural areas and census 
enumeration blocks in urban areas) per district were selected through simple random sampling 
with probability proportional to population size (using projections from the 2001 India Census). 
In the second stage, households were selected through systematic random sampling whereby all 
non-pregnant household members aged 18 years and older were eligible for blood glucose and 
body mass index (BMI) assessment. Height, weight, and fasting blood glucose measurements 
were taken 12-18 months after interviewer administration of a questionnaire that asked 
participants detailed socio-demographic information and whether they were receiving regular 
diabetes treatment. Response rates for the AHS have not been published. We matched AHS 
biomarker data to AHS respondents’ socio-demographic data as detailed in eMethods2 before 
merging AHS with DLHS-4 data.  
 
The DLHS-4 was conducted between 2012 and 2014 and covered 336 districts in 18 states and 
five Union Territories (henceforth referred to as ‘states’) of India that jointly accounted for 46% 
of India’s population in 2011.35,55 The DLHS-4 used two-stage cluster random sampling for each 
district stratified by rural versus urban location. In the first stage, rural PSUs (villages) were 
selected with probability proportional to population size (using projections from the 2001 India 
Census) and urban PSUs (an ‘urban frame survey block’) through simple random sampling. In 
the second stage, households were selected through systematic random sampling whereby all 
non-pregnant household members aged 18 years and older were eligible for a blood glucose and 
BMI measurement. The household response rate varied from 87.1% in Meghalaya to 96.5% in 
Punjab,56 with the mean response rate across all DLHS-4 households being 92.9%. The response 
rate for ever-married women within the interviewed households varied from 83.3% in Kerala to 
!! 12 
98.4% in Mizoram with the mean being 92.7%. Response rates for men and unmarried women 
have not been published.  
 
Ascertainment of diabetes  
Both AHS and DLHS-4 measured blood glucose in men and non-pregnant women aged 18 years 
and older. A capillary blood sample (using a finger prick) was taken and blood glucose measured 
using the SD CodeFree handheld glucometer, which multiplies capillary blood glucose readings 
by 1.11 to display their plasma equivalent.57  
 
Diabetes was defined as having a high plasma reading (!126 mg/dl if reporting to be fasted or 
!200 mg/dl if reporting to be non-fasted). All participants were asked to fast overnight until the 
time of the glucose measurement in the morning. Fasting status was verified by self-report in the 
DLHS-4 but not recorded in the AHS. 58.4% of participants in the DLHS-4 reported to have 
fasted. The prevalence and regression results in this paper assume all AHS respondents to be 
fasted. However, we also show prevalence estimates for the nine AHS states assuming all 
participants were non-fasted.  
 
Because the states covered by the AHS are poorer than those covered by the DLHS-4, the 
relative differences in diabetes prevalence by household wealth quintile are affected by the 
choice of plasma glucose cut-off (fasted versus non-fasted) used to define diabetes in the AHS. 
We therefore conducted a sensitivity analysis re-running all regressions that included household 
wealth quintile among only those respondents in whom fasting status was verified by self-report 
(i.e., DLHS-4 participants only).   
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Ascertainment of socio-demographic characteristics 
Independent variables for this study were age, sex, marital status, household wealth quintile, 
education, and rural or urban location. We created a household wealth index using five key 
housing characteristics (water supply, type of toilet and whether it is shared, cooking fuel, 
housing material, and source of lighting) and ownership of 12 assets (radio, TV, computer, 
phone, fridge, bike, scooter, car, washing machine, sewing machine, house, and land). These 
variables were combined into a single measure, separately for urban and rural areas, using the 
first component in a principal component analysis (as per the methodology developed by Filmer 
and Pritchett58,59). This index was then categorised into quintiles (separately for rural and urban 
areas) based on the distribution in the aggregate dataset. More detail on the computation of the 
household wealth index is provided in eMethods3.  
 
Statistical analysis  
We calculated the prevalence of diabetes by state, rural versus urban residence, sex, age group, 
and household wealth quintile. These prevalence estimates were weighted to account for both the 
complex survey design and the pooling of AHS with DLHS-4 data. More detail on the 
computation of the sampling weights is provided in eMethods4. National diabetes prevalence 
was also standardized to the age distribution of the WHO’s standard population.60 In addition, we 
fit multivariable linear probability models (LPMs) - run separately for rural and urban areas - to 
further investigate the association of diabetes and hypertension with individual-level socio-
demographic characteristics. Our regressions included a binary indicator (‘fixed effect’) for each 
of 18,126 primary sampling units (PSUs) to filter out area-level effects on diabetes and 
hypertension. As there are relatively few observations in each PSU, we fit LPMs rather than 
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logistic or probit models to avoid the incidental parameter problem.61 An added advantage of the 
LPM is the interpretability of the regression coefficients as simple absolute differences in the 
probability of the outcome. To avoid the possibility of fitted probabilities above one and below 
zero, we use logistic regression (with district-level fixed effects to sidestep the incidental 
parameter problem) for predicted probability plots. In addition, we fit a multilevel linear 
probability model (random intercepts at the level of the district and random slopes for household 
wealth quintile) with district-level mean household wealth quintile (as an indicator of a district’s 
standard of living) as level 2 variable to investigate the (possible) interaction between an area’s 
standard of living and (individual-level) household wealth. The standard errors in all regression 
models were adjusted for clustering at the PSU level. Statistical analyses were run in R version 
3.3.2 (2016, Vienna, Austria),62 and all figures were created with the ggplot2 package.63 
 
This study received a determination of “Not Human Subjects Research” by the institutional 
review board of the Harvard T.H. Chan School of Public Health on 23 November 2016 (protocol 
number: IRB16-1915).  
 
Results 
Sample characteristics:  
1,618,359 non-pregnant adults were interviewed. 297,804 (18.4%) had a missing value for the 
plasma glucose measurement, yielding a sample size for analysis of 1,320,555 adults. Table 1.1 
shows the (unweighted) characteristics of the participants. 7.6% of participants had diabetes. 
46.9% were male and 43.0% were aged 18 to 35 years. More than a third (38.5%) reported not to 
have completed primary school. 14.6% of participants were overweight (25 kg/m2 " BMI <30 
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kg/m2) and 4.3% obese (BMI !30.0 kg/m2). Less than a third (32.6%) were residing in an urban 
area. The percentage of observations missing was less than one percent for all variables except 
wealth quintile (4.4% missing) and BMI (1.8% missing). eTable1 disaggregates the sample 
characteristics by whether the blood glucose measurement was missing or not.   
 
Table 1.1. Sample characteristics 
Characteristic Total 
By sex By diabetes status 
Females Males With diabetes 
Without 
diabetes 
n 1,320,555 701,408 619,147 100,242 1,220,313 
Diabetes (%) 100,242 (7.6) 52,019 (7.4) 48,223 (7.8) 100.0 0.0 
Male (%) 46.9 0.0 100.0 48.5 46.8 
Missing (%) 0.0 NA NA 0.0 0.0 
Age group (%)      
18-25 years 19.0 18.6 19.5 5.7 20.2 
26-35 years 24.0 25.2 22.6 12.6 25.1 
36-45 years 21.3 21.8 20.7 20.0 21.4 
46-55 years 16.2 16.4 16.0 24.1 15.5 
56-65 years 11.6 11.0 12.3 21.8 10.7 
>65 years 7.9 7.0 8.9 15.8 7.2 
Missing (%) 0.0 0.0 0.0 0.0 0.0 
Currently married (%) 75.0 75.9 73.9 80.4 74.5 
Missing (%) 0.2 0.1 0.2 0.1 0.2 
Wealth quintile (%)      
1 (poorest) 20.1 20.2 20.1 12.1 20.9 
2 19.6 19.5 19.8 16.0 20.0 
3 19.5 19.5 19.5 20.0 19.5 
4 20.1 20.1 20.1 23.8 19.8 
5 (richest) 20.6 20.8 20.4 28.2 19.9 
Missing (%) 4.4 4.3 4.5 2.2 4.6 
Educational attainment (%)      
<Primary School 38.5 47.2 28.7 38.2 38.5 
Primary School 12.4 11.9 13.1 12.7 12.4 
Middle School 15.4 13.8 17.3 14.4 15.5 
Secondary School 13.9 11.6 16.4 15.7 13.7 
High School 9.7 8.0 11.7 7.8 9.9 
>High School 10.0 7.6 12.8 11.2 9.9 
Missing (%) 0.4 0.4 0.5 0.2 0.4 
BMI (%)      
<18.5 kg/m2 19.0 20.2 17.7 11.7 19.7 
18.5-22.9 kg/m2 47.3 45.8 49.0 34.6 48.4 
23.0-24.9 kg/m2 14.8 13.9 15.9 17.3 14.6 
25.0-29.9 kg/m2 14.6 15.0 14.1 25.7 13.5 
!30.0 kg/m2 4.3 5.2 3.3 10.7 3.7 
Missing (%) 1.8 1.8 1.8 1.7 1.8 
Urban area (%) 32.6 32.7 32.5 45.9 31.4 
Missing (%) 0.0 0.0 0.0 0.0 0.0 
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Abbreviations: %=Percentage; BMI=Body Mass Index; kg=kilogram; m=meter  
 
National prevalence of diabetes: 
The crude weighted prevalence of diabetes among adults (!18 years) in India was 7.3% (7.1 - 
7.4) among women and 7.8% (7.6 - 8.0) among men (eTable2), ranging from 2.4% (95% CI, 2.2 
- 2.5) among men aged 18-25 years to 14.0% (95% CI, 13.5 - 14.5) among men above 65 years. 
The age-standardized prevalence was 6.1% (6.0 - 6.3) and 6.5% (6.4 - 6.7) among women and 
men, respectively. If all AHS respondents are assumed to be unfasted, the crude prevalence was 
5.9% (5.7 - 6.1) among women and 6.1% (5.9 - 6.2) among men (eTable3). 
 
Prevalence of diabetes by individual-level socio-demographic characteristics:  
Urban areas had higher crude diabetes prevalence than rural areas (Figure 1.1). Diabetes 
prevalence rose with increasing household wealth quintile in all age groups and both sexes in 
rural areas, and among older age groups (>45 years) in urban areas. In urban areas, the greatest 
absolute increase in diabetes prevalence occurred between the fourth and the fifth wealth 
quintile, while in rural areas the increase in diabetes with rising wealth quintile tended to be 
more gradual. Females and males generally had similar diabetes prevalence across age groups 
and wealth quintiles.     
 
!! 17 
 
Figure 1.1. Crude prevalence of diabetes by rural versus urban residence, sex, age group, and 
household wealth quintile. 
 
Regressing diabetes separately for rural and urban areas onto individuals’ socio-demographic 
characteristics and PSU-level fixed effects shows that age group is the strongest correlate of 
diabetes (Table 1.2). Those in the highest household wealth quintile only had a moderately 
higher probability of diabetes than those in the poorest quintile (rural areas: 2.81 percentage 
points [2.53 - 3.08]; urban areas: 3.47 percentage points [3.03 - 3.91]). The absolute differences 
in the probability of diabetes between education groups were generally small (all less than one 
percentage point). Males had a statistically significantly higher probability of diabetes but the 
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difference between the sexes was only 0.31 percentage points (0.21 - 0.42) in rural areas and 0.56 
(0.37 - 0.74) percentage points in urban areas. The regression results were qualitatively similar 
when restricting the sample to participants in whom fasting status was ascertained through self-
report (eTable5). 
 
 
  
!! 19 
Table 1.2. Multivariable linear regressions of diabetes on socio-demographic characteristics 
and PSU-level fixed effectsa,b,c 
Characteristic 
Rural Urban 
Difference in probabilityc  
(95% CI) P 
Difference in probabilityc 
(95% CI) P 
Age group     
18-25 years Ref.  Ref.  
26-35 years 1.42 (1.28 - 1.57) <0.001 2.57 (2.33 - 2.81) <0.001 
36-45 years 3.76 (3.57 - 3.95) <0.001 7.04 (6.71 - 7.36) <0.001 
46-55 years 6.60 (6.36 - 6.83) <0.001 12.11 (11.70 - 12.52) <0.001 
56-65 years 8.82 (8.53 - 9.10) <0.001 15.86 (15.36 - 16.36) <0.001 
>65 years 9.96 (9.63 - 10.29) <0.001 17.09 (16.51 - 17.67) <0.001 
Wealth quintile     
1 (poorest) Ref.  Ref.  
2 0.27 (0.11 - 0.44) <0.001 1.04 (0.72 - 1.36) <0.001 
3 0.59 (0.40 - 0.79) <0.001 2.10 (1.73 - 2.46) <0.001 
4 1.12 (0.90 - 1.34) <0.001 2.92 (2.53 - 3.32) <0.001 
5 (richest) 2.81 (2.53 - 3.08) <0.001 3.47 (3.03 - 3.91) <0.001 
Education      
<Primary School Ref.  Ref.  
Primary School 0.63 (0.46 - 0.81) <0.001 0.77 (0.39 - 1.14) 0.522 
Middle School 0.51 (0.35 - 0.68) <0.001 0.66 (0.31 - 1.00) 0.864 
Secondary School 0.57 (0.37 - 0.77) <0.001 0.57 (0.22 - 0.91) 0.001 
High Schoold -0.24 (-0.46 - -0.01) 0.039 -0.16 (-0.53 - 0.20) 0.383 
>High Schoold -0.40 (-0.68 - -0.12) 0.005 -0.90 (-1.28 - -0.52) <0.001 
Currently married  -0.02 (-0.16 - 0.13) 0.831 0.21 (-0.04 - 0.46) 0.094 
Male  0.31 (0.21 - 0.42) <0.001 0.56 (0.37 - 0.74) <0.001 
Abbreviations: PSU=Primary Sampling Unit; CI=Confidence Interval; Ref.=Reference category.  
a These linear probability models included all socio-demographic variables listed in the table (age group, wealth 
quintile, education, marital status, and sex) and a binary indicator for each PSU (PSU-level fixed effects). Standard 
errors were adjusted for clustering at the PSU level.  
b These regressions assumed all AHS participants to be fasted at the time of the blood glucose measurement. 
Regression results assuming that all AHS participants were unfasted are shown in eTable4. eTable5 shows the 
regression results when restricting the sample to those in whom fasting status was verified through self-report (i.e., 
DLHS-4 participants only).  
c The regression coefficients (denoted as “Difference in probability”) should be interpreted as the average absolute 
difference (in percentage points) in the probability of having diabetes compared to the reference category. 
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Figure 1.2 demonstrates that (i) the absolute differences in the probability of diabetes between 
wealth quintiles were higher in older than younger age groups, (ii) among all wealth quintiles, 
the probability of diabetes increased more steeply with age in urban than in rural areas, and (iii) 
the largest absolute difference in the probability of diabetes between subsequent wealth quintiles 
in urban areas was between the first (the poorest) and the second quintile.  
 
 
Figure 1.2. The predicted probability of diabetes and hypertension by age group, rural-urban 
location, and household wealth quintilea,b  
a Predicted probabilities were obtained from multivariable logistic regressions of diabetes and hypertension on 
individuals’ socio-demographic characteristics (age group, household wealth quintile, education, marital status, sex, 
and rural-urban location), district-level fixed effects, and an interaction term between age group and household 
wealth quintile.  
b Predicted probabilities assuming that all AHS respondents were unfasted are shown in eFigure6. 
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Prevalence of diabetes by state:  
The age-standardized prevalence of diabetes varied from 2.33% (95% CI, 1.98 - 2.75) among 
females in Madhya Pradesh to 17.90% (95% CI, 15.37 - 20.74) among males in Goa (Figure 1.3 
and eTable6). In general, there was a higher diabetes prevalence in South India than in other 
regions. eTable6, eTable7, and eTable8 show state-level prevalence estimates and CIs by sex, 
rural versus urban residence, and age group. We also detail these estimates when we assumed 
AHS participants were non-fasted rather than fasted (eTable9, eTable10, and eTable11). State- 
and district-level prevalence was positively associated with the standard of living in a 
state/district as measured by the mean household wealth quintile in a state/district (eFigure8). 
Interacting district-level mean household wealth quintile with (individual-level) household 
wealth quintile in a multilevel model shows that this positive association between a district’s 
standard of living and diabetes did not exist in the richest household wealth quintile (eFigure9).    
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Figure 1.3. Age-standardized prevalence of diabetes by state1 
1 The Union Territories Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small 
area.  
 
Discussion 
Our study is the first to analyze nationally representative, individual-level biomarker-based data 
on diabetes in India, which has over a sixth of the world’s population and 22% of the population 
in LMICs.31 Our analysis found that diabetes is common in middle and older age across all 
geographic settings and population groups in the country. While household wealth and living in 
an urban area were positively associated with diabetes, the prevalence of diabetes in middle and 
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old age among the lowest wealth quintile in rural areas was still high. For instance, among those 
older than 40 years in the poorest wealth quintile in rural areas, 5.9% (95% CI, 5.5 - 6.2) had 
diabetes. Diabetes was also common across education groups in the country. These findings are 
unlikely to be a result of applying a fasting blood glucose threshold to non-fasted AHS 
participants. In fact, the prevalence of diabetes in the lowest national wealth quintile in DLHS-4 
participants (for whom fasting status was verified through self-report) was considerably higher 
than among AHS respondents.  
 
With this cross-sectional survey data, we could not ascertain to what degree the impact of 
diabetes on mortality, morbidity, and impoverishing healthcare expenditures differs between 
wealth and education groups. However, studies in India and other LMIC strongly suggest that the 
poor are more likely to be undiagnosed and untreated,64-67 and more likely to experience 
impoverishing healthcare expenditures from NCD care than the wealthy.12,66,68 This 
consideration, along with the high diabetes prevalence observed throughout wealth quintiles 
(particularly in older age groups, urban areas, and districts with a high diabetes prevalence and/or 
mean household wealth) and education groups in this study, implies that health system efforts to 
stem the diabetes epidemic in India should not be limited to wealthier or more educated strata of 
society. Instead, investments into far-reaching and comprehensive diabetes prevention, 
screening, and treatment programs are needed. The return of these investments on health, 
economic growth,16,69,70 and financial risk protection will substantially influence the country’s 
performance in achieving the SDG targets of ending poverty, reducing premature mortality from 
NCDs by one third, and attaining universal health coverage.33  
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Currently, however, India’s investment in the health system, and the prevention and care of 
NCDs is insufficient. The country has one of the lowest total health expenditures as a proportion 
of gross domestic product (GDP) in the world (3.9% in 2013),13 and the highest proportion of 
total health expenditures from out-of-pocket payments of any ‘BRICS’ (Brazil, Russia, India, 
China, and South Africa) country (with governmental health spending at only 1.4% of GDP).13 
Further, despite the rapid epidemiological transition, which has brought a large burden of NCDs, 
India’s national health policy – like that of most other LMIC71 – has a continued focus on 
communicable diseases.72 
 
Our finding of a relatively high diabetes prevalence among the poor and less educated, along 
with the observation that the relative differences in diabetes prevalence between wealth quintiles 
might be decreasing, lends support to those who have argued that NCDs are not merely a 
problem of aging, affluence, and lifestyle choices.73-75 With diabetes being a major risk factor for 
other NCDs, our results suggest that the type of NCDs suffered by the world’s poorest billion – 
58% of whom are estimated to be living in India76 - may overlap to a large degree with those 
affecting wealthier groups. While more research is needed, this provides some evidence against 
the hypothesis put forward by some groups, including the Lancet Commission for Reframing 
NCDs and Injuries for the Poorest Billion,73 that the world’s poorest suffer mostly from different 
types of NCDs than wealthier groups.  
 
We were only able to study the prevalence of one disease (diabetes) among different socio-
demographic groups rather than the proportion of each group’s total disease burden that is caused 
by diabetes. Specifically, India still faces a large burden of infectious diseases and has poor 
!! 25 
maternal and child health indicators in many states.77 Because these diseases disproportionately 
affect the poor, it is plausible that despite a relatively high prevalence, diabetes only accounts for 
a small proportion of the total disease burden among the poor and less educated. Hence, in order 
to inform Indian policy makers on the degree to which diabetes prevention and care should be 
prioritized to improve the health and economic well-being of the indigent, more research is 
needed on the relative disease burden caused by diabetes and related NCDs compared to other 
diseases among the poor. Ideally, such research should also take into account the interaction 
between non-communicable and communicable diseases, including the higher risk of active 
tuberculosis in individuals with diabetes.78  
 
Our study has several limitations, which we tried to address where possible. First, a one-time 
capillary blood glucose measurement is not recommended for the diagnosis of diabetes in 
clinical settings.79 It has, however, been shown to have an acceptable sensitivity and specificity 
for defining diabetes in population-based research, and is the recommended method for 
monitoring diabetes prevalence in the WHO’s STEPwise Approach to Non-communicable 
Disease Risk-Factor Surveillance.80-82 Second, the study was unable to distinguish between type 
1 and type 2 diabetes. However, the International Diabetes Federation estimates that 72,000 
children with type 1 diabetes aged zero to 14 years lived in India in 2015, which was merely 
0.02% of the country’s population in this age range.31,83 Extrapolating this percentage to adults 
would suggest that the proportion of adults with type 1 diabetes in our sample is likely very 
small. Third, a substantial proportion (18.4%) of blood glucose measurements were missing. 
Fourth, fasting status was not ascertained in the AHS. We addressed this limitation by 
additionally providing prevalence estimates assuming that all AHS respondents were non-fasted 
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instead of fasted, and by showing regression results after restricting the sample to DLHS-4 
respondents. Last, and maybe most importantly, only participants with a high blood glucose 
measurement were considered to have diabetes because no information on diabetes treatment 
was available in the data. Thus, participants on diabetes medications who achieved a normal 
blood glucose will not have been counted as diabetic in this analysis – our prevalence estimate is 
therefore likely an underestimate. In addition, given that wealthier individuals are more likely to 
be on treatment for diabetes, the wealth gradients observed in this analysis are likely more 
shallow than they would have been had full information on treatment been available.  
 
While the key strength of this study is its ability to disaggregate prevalence by state and 
individual-level socio-demographic characteristics, we also provide a new diabetes prevalence 
estimate for India that does not extrapolate from sub-national studies. eFigure12 shows our age-
standardized prevalence estimate and confidence interval in comparison to that of existing 
national prevalence estimates for adults in India. We observed an age-standardized diabetes 
prevalence of 6.3% (6.2-6.5). This figure is lower than the age-standardized estimates provided 
by the International Diabetes Federation (which has estimated an adult prevalence of 9.3% [7.6 
to 11.4] for 2015),83 the NCD Risk Factor Collaboration (estimating an adult prevalence of 9.1% 
[5.2 to 14.2] for 2014),30 and the Global Burden of Disease Project (estimating an age-
standardized prevalence among the entire population of 6.5% [uncertainty range: 6.0-7.1] in 
2015).84 While our prevalence figures are lower than these modelled estimates, our state-level 
prevalence estimates are very similar to those obtained in the largest sub-national study to date, 
mentioned in the introduction. Regardless, the prevalence of diabetes in the country will likely 
continue to rise rapidly with urbanising and aging of the Indian population; the urban population 
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is projected to increase from 30.9% in 2010 to 50.3% in 2050 (adding the largest absolute 
number of urban dwellers globally of any country),32 and the share of the country’s population 
aged 60 years and older is estimated to rise from 8.9% in 2015 to 19.4% in 2050.31  
 
In conclusion, while we found a lower national prevalence of diabetes than has been estimated 
thus far, India’s diabetes epidemic is evident across different wealth and education groups in 
middle and old age, and the differences in diabetes prevalence between wealth groups may be 
narrowing in younger generations and as standards of living in India are rising. The implication 
of our finding is that a major investment in diabetes prevention, detection, and treatment 
programs aimed at improving health access, consistent care, and financial risk protection is likely 
needed across the country if India is to avert catastrophic health, social, and economic 
consequences of diabetes. Given the size, growth, rapid urbanization, and aging of India’s 
population,31,32 as well as the high levels of impoverishing healthcare expenditures caused by 
NCDs,12 the country’s success in tackling its diabetes epidemic will be crucial to achieving the 
SDGs not just in India, but globally.  
 
 
 
  
!! 28 
PAPER 2 
Hypertension in India: A nationally representative study of 1.3 
million adults  
 
Abstract  
Importance: Understanding how the prevalence of hypertension varies within a country as large 
as India is essential for the targeting and planning of relevant healthcare services. However, there 
has been no previous nationally representative study of hypertension in India to guide policy 
makers.  
Objective: To determine the prevalence of hypertension in India and its variation between states, 
rural versus urban location, and by individual-level socio-demographic characteristics.  
Design: Cross-sectional nationally representative study carried out between 2012 and 2014. 
Setting: Population-based. 
Participants: 1,320,555 adults with a blood pressure (BP) measurement.  
Exposures: State, district, rural versus urban location, age, sex, household wealth, educational 
attainment, and marital status.  
Main measure: Hypertension (systolic BP !140mmHg or diastolic BP !90mmHg).  
Results: The crude prevalence of hypertension was 23.6% (95% CI: 23.4 – 23.7) among females 
and 27.3% (95% CI: 27.1 – 27.5) among males. Prevalence ranged from 12.1% (95% CI: 11.8 - 
12.5) in those aged 18-25 years to 45.6% (95% CI: 45.0 - 46.2) in those aged 65 years and older. 
Prevalence was highest in the Northern states of Punjab and Himachal Pradesh, the Northeastern 
states of Sikkim and Nagaland, and the Southern state of Kerala. Hypertension was not 
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associated with education and weakly associated with household wealth quintile (OR for the 
richest versus the poorest quintile: 1.13 [95% CI: 1.10 – 1.16] in rural and 1.10 [95% CI: 1.06-
1.14] in urban areas).  
Conclusions and relevance: We found the national prevalence of hypertension to be lower than 
previously estimated by the WHO. Importantly, however, we identified a substantially higher 
prevalence among young adults than the WHO estimated for South Asia and any other region in 
the world, which will – if untreated – likely translate to a rise in CVD in India in the future. The 
substantial variation in hypertension prevalence between states, rural versus urban areas, sex, and 
age groups identified by this study should guide the targeting of hypertension screening and 
treatment efforts across the country. In addition, given that we found a high prevalence in nearly 
all population subgroups, there is an urgent need in India for public health approaches to reduce 
blood pressure at the population level.   
 
Introduction 
Hypertension is the leading risk factor for mortality from CVD and chronic kidney disease in all 
regions of the world.85 Given that CVD is the top cause of death globally,1 the health 
consequences of hypertension are therefore immense. In 2011, WHO member states signed the 
Global Action Plan for the Prevention and Control of Non-Communicable Diseases (the ‘25x25 
initiative’),20 which aims to reduce the prevalence of hypertension by 25% between 2010 and 
2025. In addition, the target of SDG 3.4 is to reduce by one third premature mortality from non-
communicable diseases by 2030. India will play a crucial role in achieving these targets, given 
that the country is thought to have contributed 19% of the global CVD burden (as measured by 
disability-adjusted life years) in 2015.2 Importantly, this proportion is likely to increase in the 
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future given that i) India will add the highest number of people to global population growth of 
any country until at least 2050,31 ii) India’s population is aging and urbanizing rapidly,31,32 and 
iii) the country is experiencing rapid economic growth,11 which is frequently accompanied by an 
increase in obesity and its associated cardiovascular risk factors, including hypertension.86 The 
latter is particularly worrying given that adults of Asian Indian ethnicity are thought to be 
predisposed to developing CVD when exposed to obesogenic environments and lifestyles.87    
 
Although the cardiovascular consequences of hypertension – such as myocardial infarction, 
angina, and stroke - are costly to treat, the management of hypertension is relatively less costly 
and less complex, providing the opportunity to effectively and efficiently address this condition 
and mitigate adverse outcomes in low-resource settings. Diagnosing hypertension does not 
require laboratory services nor a high level of training.88 Similarly, many effective hypertensive 
medications are generic and should be available at low cost.17 However, it has been estimated 
that less than half of hypertensive adults in LMICs have been diagnosed and only around a third 
are on treatment.89 While evidence is sparse, the situation appears to be similar, or even worse, in 
India.18 In order to inform planning, and more efficient and effective targeting of resources in 
India’s health system, it is essential to understand how the prevalence of hypertension varies 
among population groups across the country. Yet, to date, there has not been a nationally 
representative study of hypertension in India to guide policy makers.18 Pooling data from a 
nationally representative sample of 1.4 million adults, this study aims to determine how the 
prevalence of hypertension in India varies between states, rural versus urban location, and by 
individual-level socio-demographic characteristics. 
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Methods 
Data sources: 
We pooled data from two large household surveys in India: The District-Level Household 
Survey-4 (DLHS-4) and the second update of the Annual Health Survey (AHS). eFigure1 shows 
the states and Union Territories covered by each survey. Both surveys are representative at the 
district-level. They jointly cover all 29 states of India except Jammu and Kashmir (data were not 
collected due to violent conflicts) and Gujarat (data were not available in the public domain), and 
five of India’s seven Union Territories (data were not available for Dadra and Nagar Haveli, and 
Lakshadweep). The two states and two Union Territories not included in this analysis only 
accounted for 6% of India’s population in 2011 (the time of the last census).35 Both surveys 
administered a questionnaire to the household head to ascertain socio-demographic information 
for each household member (regardless of whether the individual was present or absent at the 
time of the interviewer’s visit), and measured blood pressure (BP) twice in each household 
member aged 18 years and older using an electronic BP monitor (Rossmax AW150). 
 
Annual Health Survey: 
Data for the AHS were collected between 2012 and 2013 in all 284 districts of nine states of 
India, which were selected because they had the highest rate of infant and child mortality in the 
country in 2010.55 The two-stage cluster random sampling design of the AHS was self-weighting 
at the district level. In the first stage, villages in rural areas and census enumeration blocks in 
urban areas were selected through simple random sampling with probability proportional to 
population size (using projections from the 2001 India Census). In the second stage, households 
were selected through systematic random sampling (sampling the first household randomly, and 
!! 32 
then selecting every alternate household). The AHS dataset containing participants’ socio-
demographic information was merged with the dataset containing BP measurements as outlined 
in eMethods2.  
 
District-Level Household Survey-4: 
Data for the DLHS-4 were collected between 2012 and 2014 in all 336 districts of 18 states and 
five Union Territories (henceforth also referred to as ‘states’) of India.55 In the first stage, census 
villages in rural areas were selected through probability proportional to population size (again, 
using projections from the 2001 India Census), and urban frame survey blocks in urban areas 
through simple random sampling. In the second stage, households were selected through 
systematic random sampling.90 
 
Definition of outcome and explanatory variables: 
A binary indicator for hypertension was the outcome variable in this analysis. Using the average 
of the two BP measurements, we defined hypertension as mean systolic BP !140 mmHg or mean 
diastolic BP !90 mmHg.91 The explanatory variables for this study were state, household wealth 
quintile, education, marital status, and whether the household was located in a rural or urban 
area. We used household ownership of 12 assets (radio, TV, computer, phone, fridge, bike, 
scooter, car, washing machine, sewing machine, house, and land) and five key housing 
characteristics (water supply, type of toilet and whether it is shared, cooking fuel, housing 
material, and source of lighting) to generate the household wealth index in a principal component 
analysis (PCA). Following the methodology developed by Filmer and Pritchett,58,59 we extracted 
the first component in the PCA separately for urban and rural areas, and divided this variable 
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into quintiles (again, separately for rural and urban areas) based on the distribution in the 
national dataset. More detail on the computation of the household wealth quintiles is provided in 
eMethods3.  
 
Statistical analysis: 
Hypertension prevalence was calculated by state, rural versus urban residence, sex, age group, 
and household wealth quintile using sampling weights to account for both the survey design and 
the pooling of AHS with DLHS-4 data. More detail on the computation of the sampling weights 
is provided in eMethods4. Age-standardized prevalence estimates were weighted to the age 
distribution of the WHO’s standard population.60 To investigate how district-level hypertension 
prevalence and the difference in prevalence between urban and rural areas in a district was 
associated with the population’s standard of living, we plotted these outcomes against the 
district-level mean household wealth quintile. These were the only analyses for which we used a 
household wealth index that was not created separately for rural and urban areas to avoid 
possible bias from the fact that the degree of urbanization varied between districts.  
 
We fit multivariable linear probability models (LPMs) - run separately for rural and urban areas - 
to further investigate the association of hypertension with individual-level socio-demographic 
characteristics. Our regressions included a binary indicator (‘fixed effect’) for each of 18,126 
primary sampling units (PSUs) to filter out area-level effects on hypertension. As there are 
relatively few observations in each PSU, we fit LPMs rather than logistic or probit models to 
avoid the incidental parameter problem.61 An added advantage of the LPM is the interpretability 
of the regression coefficients as simple absolute differences in the probability of the outcome. 
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The standard errors in all regression models were adjusted for clustering at the PSU level. 
Statistical analyses were implemented in R version 3.3.2 (2016, Vienna, Austria),62 and all 
figures were created with the ggplot2 package.63 
 
This study received a determination of “Not Human Subjects Research” by the institutional 
review board of the Harvard T.H. Chan School of Public Health on 23 November 2016 (protocol 
number: IRB16-1915).  
 
Results  
Sample characteristics: 
1,618,359 non-pregnant adults were interviewed. 297,804 (18.4%) had a missing value for at 
least one of the two BP readings, yielding a sample size for analysis of 1,320,555 adults. Table 
2.1 shows the (unweighted) characteristics of the participants. 26.5% of participants had 
hypertension. 43.4% of participants were aged 18 to 35 years. 47.0% of women and 28.6% of 
men had not completed primary school. Three quarters of participants were married and a third 
(32.5%) were living in urban areas.  
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Table 2.1. Sample characteristicsa,b,c 
 Total Female Male 
n 1,320,555 701,408 619,147 
    
Hypertension, no. (%) 350,273 (26.5) 170,145 (24.3) 180,128 (29.1) 
    
Age group, no. (%)    
18-25 years 253154 (19.2) 131,388 (18.7) 121,766 (19.7) 
26-35 years 320,018 (24.2) 178,779 (25.5) 141,239 (22.8) 
36-45 years 281,706 (21.3) 153,249 (21.8) 128,457 (20.7) 
46-55 years 212,465 (16.1) 114,018 (16.3) 98,447 (15.9) 
56-65 years 150,940 (11.4) 75,911 (10.8) 75,029 (12.1) 
>65 years 102,253 (7.7) 48,056 (6.9) 54,197 (8.8) 
    
Education, no. (%)    
<Primary School 504,829 (38.4) 328,296 (47.0) 176,533 (28.6) 
Primary School 163,953 (12.5) 83,338 (11.9) 80,615 (13.1) 
Middle School 203,128 (15.4) 96,659 (13.8) 106,469 (17.3) 
Secondary School 182,391 (13.9) 81,380 (11.6) 101,011 (16.4) 
High Schoold 128,270 (9.8) 55,876 (8.0) 72,394 (11.7) 
>High Schoold 132,544 (10.1) 53,329 (7.6) 79,215 (12.9) 
Household wealth quintile, no. (%)    
1 (poorest) 254,652 (20.2) 135,454 (20.2) 119,198 (20.2) 
2 248,101 (19.7) 130,896 (19.5) 117,205 (19.8) 
3 245,748 (19.5) 130,413 (19.4) 115,335 (19.5) 
4 253,905 (20.1) 134,977 (20.1) 118,928 (20.1) 
5 (richest) 259,491 (20.6) 139,077 (20.7) 120,414 (20.4) 
Currently married, no. (%) 988,456 (75.0) 532,786 (76.0) 455,670 (73.7) 
Urban area, no. (%) 429,330 (32.5) 228,954 (32.6) 200,376 (32.4) 
Abbreviations: no.=number; %=Percentage. 
a These figures were not weighted using sampling weights.  
b These sample characteristics are for all participants who had a non-missing blood glucose and blood pressure 
measurement. Sample characteristics stratified by whether the blood pressure measurement was missing are shown 
in eTable1.  
c The percentage missing for all socio-demographic variables (i.e., age, education, household wealth, marital status, 
and urban-rural location) was less than 0.5% except for household wealth quintile (4.4% of observations were 
missing).  
d Generally referred to as ‘higher secondary school’ in the Indian school system.  
 
National prevalence of hypertension: 
The crude prevalence of hypertension was 25.3% (95% confidence interval [CI]: 25.2 – 25.4). 
While, overall, hypertension prevalence was higher among males (27.3% [27.1 – 27.5]) than 
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females (23.6% [23.4 – 23.7]), females had a higher prevalence in older age groups (56-65 years 
and >65 years) than males (Table 2.2). Age-standardized to the WHO standard population, 
hypertension prevalence was 22.1% (22.0 – 22.2); 24.5% (24.3 – 24.6) among males and 20.0% 
(19.9 – 20.1) among females.  
 
Table 2.2. Crude hypertension prevalence by age group and sex 
Age group 
Female 
Percent (95% CI) 
Male 
Percent (95% CI) 
18-25 years 9.5 (9.2 - 9.8) 15.0 (14.5 - 15.4) 
26-35 years 14.3 (13.9 - 14.7) 21.0 (20.6 - 21.5) 
36-45 years 23.1 (22.6 - 23.5) 27.6 (27.1 - 28.1) 
46-55 years 32.6 (32.2 - 33.1) 33.7 (33.1 - 34.3) 
56-65 years 41.1 (40.5 - 41.7) 39.0 (38.3 - 39.6) 
>65 years 48.3 (47.6 - 49.0) 43.2 (42.5 - 43.9) 
Total 23.6 (23.4 – 23.7) 27.3 (27.1 – 27.5) 
Abbreviations: CI=Confidence Interval.  
 
Prevalence of hypertension by individuals’ socio-demographic characteristics: 
Prevalence of hypertension tended to be higher among older adults, those in urban areas, and 
wealthier individuals (Figure 2.1). In the youngest age group (ages 18-25 years), hypertension 
prevalence ranged from 8.4% among rural females in the fourth wealth quintile to 19.4% among 
urban males in the highest wealth quintile. The positive gradient by household wealth quintile 
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was less strong in urban than in rural areas. eFigure4 shows that hypertension was less strongly 
associated with education than with household wealth. 
 
Figure 2.1. Crude prevalence of hypertension by rural versus urban residence, sex, and 
household wealth quintile 
 
Regressing hypertension on individuals’ socio-demographic characteristics (age, household 
wealth quintile, education, marital status, and sex) and PSU-level fixed effects shows that the 
absolute differences in the probability of hypertension between household wealth quintiles were 
relatively small (e.g., rural areas: 4.15 percentage points [3.68 - 4.61] for the richest versus the 
poorest quintile; urban areas: 3.01 percentage points [2.38 - 3.65] for the richest versus the 
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poorest quintile) (Table 2.3). The absolute differences in the probability of hypertension between 
education groups were less than two percentage points for all education groups (compared ot 
those not completing primary school). On average, males had a 3.64 (3.23 - 3.70) percentage 
points higher probability of hypertension in rural areas and 5.99 (5.67 - 6.31) percentage points 
in urban areas.  
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Table 2.3 Multivariable linear regressions of hypertension on socio-demographic characteristics 
and PSU-level fixed effectsa,b,c 
Characteristic 
Rural Urban 
Difference in probabilityc  
(95% CI) P 
Difference in probabilityc  
(95% CI) P 
Age group     
18-25 years Ref.  Ref.  
26-35 years 6.68 (6.39 - 6.96) <0.001 8.12 (7.71 - 8.52) <0.001 
36-45 years 14.33 (13.98 - 14.68) <0.001 17.84 (17.34 - 18.34) <0.001 
46-55 years 21.84 (21.41 - 22.27) <0.001 27.49 (26.89 - 28.08) <0.001 
56-65 years 28.76 (28.26 - 29.26) <0.001 34.52 (33.84 - 35.19) <0.001 
>65 years 34.77 (34.19 - 35.35) <0.001 39.78 (39.00 - 40.56) <0.001 
Wealth quintile     
1 (poorest) Ref.  Ref.  
2 0.14 (-0.18 - 0.46) 0.402 1.35 (0.87 - 1.83) <0.001 
3 0.84 (0.47 - 1.20) <0.001 2.43 (1.90 - 2.96) <0.001 
4 1.95 (1.55 - 2.35) <0.001 2.77 (2.21 - 3.34) <0.001 
5 (richest) 4.15 (3.68 - 4.61) <0.001 3.01 (2.38 - 3.65) <0.001 
Education      
<Primary School Ref.  Ref.  
Primary School 0.57 (0.27 - 0.88) <0.001 -0.04 (-0.57 - 0.48) 0.867 
Middle School 0.36 (0.06 - 0.67) 0.018 -0.30 (-0.81 - 0.20) 0.239 
Secondary School 0.47 (0.13 - 0.80) 0.007 -0.29 (-0.79 - 0.21) 0.259 
High Schoold -0.26 (-0.67 - 0.14) 0.200 -1.61 (-2.16 - -1.06) <0.001 
>High Schoold 0.15 (-0.35 - 0.64) 0.562 -1.72 (-2.28 - -1.17) <0.001 
Currently married  -2.62 (-2.88 - -2.35) <0.001 -2.14 (-2.51 - -1.78) <0.001 
Male  3.46 (3.23 - 3.70) <0.001 5.99 (5.67 - 6.31) <0.001 
Abbreviations: PSU=Primary Sampling Unit; CI=Confidence Interval; Ref.=Reference category.  
a These linear probability models included all socio-demographic variables listed in the table (age group, wealth 
quintile, education, marital status, and sex) and a binary indicator for each PSU (PSU-level fixed effects). Standard 
errors were adjusted for clustering at the PSU level.  
b These regressions assumed all AHS participants to be fasted at the time of the blood glucose measurement. 
Regression results assuming that all AHS participants were unfasted are shown in eTable4. eTable5 shows the 
regression results when restricting the sample to those in whom fasting status was verified through self-report (i.e., 
DLHS-4 participants only).  
c The regression coefficients (denoted as “Difference in probability”) should be interpreted as the average absolute 
difference (in percentage points) in the probability of having diabetes/hypertension compared to the reference 
category. 
d Generally referred to as ‘higher secondary school’ in the Indian school system.  
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State- and district-level prevalence of hypertension: 
The age-standardized prevalence of hypertension varied from 13.6% (12.2 – 15.0) among 
females in Chattisgarh to 43.4% (38.3 – 48.7) among males in Daman and Diu. Excluding Union 
Territories, hypertension prevalence tended to be highest in the Northern states of Punjab and 
Himachal Pradesh, the Southern state of Kerala, and the Northeastern states of Sikkim and 
Nagaland (Figure 2.2). The state- and district-level prevalence of hypertension was positively 
correlated with standard of living (as measured by the state- or district-level mean household 
wealth quintile) (eFigure10). eFigure11 shows that there was no substantial interaction between 
household wealth quintile and a district’s standard of living (as measured by district-level mean 
household wealth quintile).    
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Figure 2.2. Age-standardized state-level prevalence of hypertension by sex and rural versus 
urban residence within each state1,2 
1 The map does not show Jammu and Kashmir, and Gujarat (no data available in the public domain). 
2 The Union Territories, Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small 
area.  
3 Point estimates and 95% confidence intervals for each state are shown in eTable6, eTable7, and eTable8.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; 
GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, 
Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, Meghalaya; MZ, Mizoram; 
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NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; 
TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal 
 
While hypertension prevalence tended to be higher in urban compared to rural areas, the opposite 
was the case in Andaman and Nicobar, Arunachal Pradesh, Goa, Kerala, Nagaland, and Punjab. 
Both the absolute and relative difference in hypertension prevalence between urban and rural 
areas within each district was negatively associated with the standard of living in a district as 
measured by the district-level mean household wealth quintile (Figure 2.3). State-level age-
standardized prevalence estimates (with 95% CIs) by sex and rural versus urban location are 
detailed in eTable6, eTable7, and eTable8.  
 
 
Figure 2.3. Association of the district-level mean household wealth quintile with the 
difference in the age-standardized prevalence of hypertension between urban and rural 
areas in a district1,2,3,4,5  
1 ‘Absolute difference’ refers to the hypertension prevalence in urban areas in a district minus the hypertension 
prevalence in rural areas in a district. 
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2 ‘Relative difference’ refers to the hypertension prevalence in urban areas in a district minus the hypertension 
prevalence in rural areas in a district.  
3 p-values refer to the statistical significance of the linear (ordinary least squares) regression line (shown in black).  
4 Districts were divided into regions as per their allocation to Zonal Councils by the Government of India.92   
5 The dashed grey line indicates the absence of a difference in hypertension prevalence between urban and rural 
areas (absolute difference of zero percentage points and a relative difference of one).  
 
Discussion 
This first nationally representative study of hypertension in India found an age-standardized 
prevalence of 24.5% (24.3 – 24.6) among males and 20.0% (19.9 – 20.1) among females. While 
still within the uncertainty intervals, these figures are lower (particularly among women) than the 
modeled estimates by the WHO/Non-Communicable Disease Risk Factor Collaboration (NCD-
RisC) for India for 2015 (26.5% [21.2 – 32.4] among males and 24.7% [19.9 – 29.9] among 
females), which used the same definition of hypertension as was used in this study.93,94 More 
strikingly, as plotted in eFigure2, we found a substantially higher prevalence of hypertension 
among age groups below 45 years and a lower prevalence in older age groups than estimated by 
WHO/NCD-RisC for South Asia (India contributed 76% of the population of South Asia, as 
defined by WHO/NCD-RisC).31,93 In fact, in younger age groups, our prevalence estimates for 
India were higher than those for Central and Eastern Europe - a region that WHO/NCD-RisC 
identified as having the highest hypertension prevalence globally.93,94 An important finding of 
this study, therefore, is the unexpectedly high prevalence of hypertension among young adults in 
India, which – if untreated – may result in longer lifetime exposure to this risk factor and higher 
CVD rates in the future. Additionally, the discrepancy between our empirical findings and the 
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modeled estimates by WHO/NCD-RisC highlights that sophisticated modeling cannot replace 
investments into large-scale population-based surveys.  
 
We found that hypertension was common across different states and population groups in India. 
Refuting the hypothesis that the condition is mainly concentrated among wealthier and more 
educated groups in the country, hypertension was not substantially associated with education and 
only weakly associated with household wealth, especially among females. Importantly, the 
prevalence of hypertension is expected to increase over the coming years among all population 
groups,93,95 largely because India’s population is aging and urbanizing,10 and standards of living 
in the country are increasing.11 Our findings, therefore, provide much needed new evidence to 
support a public health approach in India to reduce BP at the population level throughout socio-
demographic groups. Nonetheless, such efforts must also be accompanied by screening and 
treatment programs for hypertension. This study reveals substantial variation in hypertension 
prevalence between states and rural versus urban location – findings which could be used to 
inform the planning and targeting of such hypertension-focused primary care efforts.   
 
While, overall, hypertension prevalence in urban areas in India was higher than in rural areas, we 
found that the difference between urban and rural areas tended to decrease as the standard of 
living in a district increased. This finding suggests that as districts become wealthier, rural-urban 
differences in hypertension prevalence disappear. In this respect, our findings are similar to those 
of a study among adults from a total of 628 communities in 17 countries,89 in which the 
investigators found hypertension prevalence to be higher in urban than in rural areas in the four 
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low-income countries in the study, whereas the reverse tended to be true in the other 13 
countries, all of which were middle- or high-income.89  
 
Equity concerns have been raised about investing limited financial and human resources for 
health into CVD screening and treatment in LMICs, as CVD is generally thought to occur more 
frequently in wealthier than poorer strata of society in these countries.73,96 For instance, an 
international effort has been initiated to examine to what degree the world’s poorest billion - 
58% of whom are estimated to be living in India76 – suffer from the same NCDs as wealthier 
billions.73 The hypothesis of this initiative is that the world’s most indigent suffer from different 
NCDs and that the NCD community’s focus on CVD will, therefore, exacerbate inequalities in 
health between wealth groups.73,74 However, in this study, we show that the wealth and education 
gradients in hypertension prevalence are minor, especially when compared to age gradients. 
Although the evidence base is limited because of a lack of large nationally representative 
studies,97 our finding is broadly similar to the socio-demographic variation in hypertension 
prevalence that has been reported in other LMICs.98 Prevalence of CVD risk factors by wealth 
groups, however, can only partially inform these equity-focused policy decisions because of two 
main limitations. The first is that prevalence estimates do not take into account that CVD events 
are likely to have more detrimental effects among the poor than the wealthy because poorer 
individuals tend to have lower access to good quality healthcare services and less financial risk 
protection.12,64-68 The second limitation is that examining a single risk factor or disease at a time 
does not provide information on the relative contribution of the disease to the wealth group’s 
total disease burden. In particular, many areas of India are still facing a substantial infectious 
disease burden and poor maternal and child health indicators77 – health problems that 
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disproportionately affect the poor. Despite these limitations, our finding of a high hypertension 
prevalence throughout wealth and education groups strongly suggests that the world’s poorest 
billion also have an important CVD burden.    
 
Our study has several limitations, which we tried to address where possible. First, a substantial 
proportion (18.4%) of adults had a missing value for at least one of the two systolic or diastolic 
BP measurements. Of these, 91% had a missing value for all four BP values and 87% had a 
missing consent variable (basic socio-demographic information on these participants was still 
collected from the household head), suggesting that missing BP measurements were mostly due 
to some adults being absent at the time of the household visit (rather than refusal to consent or 
data entry errors). Second, while clinical guidelines generally recommend to confirm high BP 
measurements at a second patient visit before diagnosing hypertension,91 this study used BP 
measurements from only one household visit, which is the standard in population-based surveys, 
including the WHO STEPwise approaches to surveillance (WHO STEPS) surveys.99 It is 
important to note that this study used a ‘population-based’ rather than a clinical definition of 
hypertension whereby hypertension was defined purely based on BP measurements and not 
treatment status (i.e., normotensive adults on hypertensive medication were not counted as 
hypertensive). This definition of hypertension was chosen because it is the definition used by the 
WHO for Target 6 of its Global Action Plan for NCDs and by the NCD-RisC group for 
monitoring hypertension prevalence around the world.20,93   
 
In conclusion, the unexpectedly high hypertension prevalence among young adults identified by 
this study may well be a sign of rising hypertension rates in newer generations. This finding 
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highlights the urgent need for a major investment into public health approaches to reduce blood 
pressure at the population level if India is to curb the rise of its CVD epidemic. While 
hypertension was only weakly associated with household wealth and education, our findings on 
the important variation in prevalence between states, rural versus urban areas, sex, and age 
groups should be used to guide the planning and targeting of hypertension-focused primary care 
efforts.  
 
Given the sheer size of India’s population, the magnitude of its CVD epidemic,31,77 and the 
impact of CVD on household healthcare expenditures and economic growth,12,15,16 India’s 
success in addressing CVD risk factors will have an important bearing on the world’s ability to 
achieve the WHO’s Global NCD targets as well as the SDGs.20,33  
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Cardiovascular disease risk in India: a cross-sectional study 
of a nationally representative sample of 800,000 adults 
 
Abstract  
Background: Cardiovascular disease (CVD) is the leading cause of mortality in India. Yet, 
evidence on the population’s CVD risk is limited. To inform health system planning and 
effective targeting of interventions, this study aimed to determine how the prevalence of high 
CVD risk – and the factors that determine risk – varies among states in India, rural-urban 
location, and by individual-level socio-demographic characteristics.  
Methods: We used two large surveys carried out between 2012 and 2014, which included a 
nationally representative sample of 797,932 adults aged 30 to 74 years. The main outcome 
variable was ‘high CVD risk’ defined as a 10-year CVD risk !30%, as computed using the 
Framingham risk score. The prevalence of CVD risk factors and high CVD risk was examined 
by state, rural-urban residence, age, sex, household wealth, and education.  
Results: Overall, 14.6% (95% CI: 14.4 – 14.8) of females and 31.7% (95% CI: 31.4 – 32.0) of 
males were at high risk of CVD. High CVD risk was most prevalent in North, Northeast, and 
South India. While risk was positively associated with household wealth and living in an urban 
area, high CVD risk was nonetheless common in those aged 50-74 years in the poorest wealth 
quintile in rural areas (29.3% [95% CI: 28.3 - 30.3] among females and 63.3% [95% CI: 62.2 - 
64.3] among males). Smoking was more prevalent in poorer quintiles and rural areas, whereas 
body mass index, diabetes, and systolic blood pressure were positively associated with wealth 
and urban location. 
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Conclusions: Crude 10-year CVD risk in India was approximately twice as high as has been 
estimated for the population of the United States. High CVD risk was common in middle and old 
age across all population groups in India. We, however, identified substantial variation between 
states and socio-demographic groups that can facilitate effective targeting of CVD programs to 
those most in need. Major investments into targeted CVD prevention, screening, and treatment 
programs are urgently needed if India is to successfully stem its rising CVD epidemic and 
achieve the Sustainable Development Goals.   
 
Introduction 
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, including in low- and 
middle-income countries (LMICs).1 India is estimated to have contributed almost one fifth 
(18.9%) of the global CVD burden, as measured by disability-adjusted life years (DALYs), in 
2015.2 This proportion is likely to increase in the future for three main reasons. First, India is 
expected to make the greatest contribution to global population growth of any country until at 
least 2050.31 Second, India’s population is ageing and urbanising: the share of people over 60 
years of age is estimated to more than double from 8.9% to 19.4% between 2015 and 2050,31 and 
the percentage of Indians living in cities is projected to grow from 30.9% in 2010 to 50.3% in 
2050.32 Third, the rise in living standards and socio-cultural transitions in India are likely to lead 
to more obesogenic lifestyles.11 Studies among South Asian migrants in high-income ‘Western’ 
countries suggest that South Asians are more prone to developing CVD, and at an earlier age, 
when living in obesogenic environments than their local counterparts.87 In addition to its large 
burden of illness, CVD is also a major cause of impoverishing household healthcare expenditures 
in LMICs, and estimated to pose a great macroeconomic burden on societies.12,15,16  
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While the prevalence of important CVD risk factors - including both lifestyle factors (e.g., 
smoking and diet) and cardiometabolic factors (e.g., hypertension and diabetes) - has been 
studied in large population-based surveys in India,19,25,39,64,100,101 studies on predicted CVD risk 
in India have thus far been restricted to either healthcare facility-based samples or small 
population-based cohorts in specific locales.102-109 Understanding the predicted future incidence 
of CVD in India’s population, and how it varies among population groups, is critical for health 
system planning, and effective targeting of prevention, screening, and treatment, in order to 
mitigate the potentially crippling health and economic effects of CVD on India and her potential 
to achieve the Sustainable Development Goals (SDGs).33 
 
This study, which uses a nationally representative sample of 797,932 adults aged 30-74 years, 
aims to quantify the proportion of India’s adult population aged 30-74 years that is at high risk of 
CVD, and to determine how risk varies by state, rural versus urban location, and by individual-
level socio-demographic characteristics.   
 
 
Methods 
Data sources: 
We pooled data from two large household surveys in India, the District-Level Household 
Survey-4 (DLHS-4) and the second update of the Annual Health Survey (AHS), both of which 
were conducted between 2012 and 2014. These two surveys were combined because they i) are 
jointly representative of the entire population of India, ii) were conducted simultaneously, iii) are 
both representative at the district level, and iv) used the same questionnaire and methodology to 
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collect biomarker measurements. The states covered by each of the surveys are shown in 
eFigure1 (no areas in India were covered by both surveys).  
 
In both surveys, all non-pregnant household members aged 18 years and older were eligible for 
blood glucose, blood pressure (BP), height, and weight measurements. Participants’ blood 
glucose was measured using a capillary blood sample (from a finger prick) taken using a 
handheld blood glucose meter (SD CodeFree), which multiplied capillary blood glucose readings 
by 1.11 to display their plasma equivalent.57 Participants were instructed to fast for at least eight 
hours before the time of the measurement. BP was measured twice, with each measurement ten 
minutes apart, using an electronic upper arm BP monitor (Rossmax AW150). The sampling 
procedure of each survey is detailed in eMethods1.   
 
Ethics: 
This analysis of an existing dataset in the public domain received a determination of “Not 
Human Subjects Research” by the institutional review board of the Harvard T.H. Chan School of 
Public Health on 23 November 2016 (protocol number: IRB16-1915). 
 
Outcome variable: 
The main outcome variable in this analysis was a ‘high CVD risk’, which we defined as a 10-
year CVD risk greater or equal to 30%. This threshold was chosen because it is the cut-off used 
in the World Health Organisation’s (WHO) Global NCD Targets to decide who is eligible for 
drug therapy and counseling.20 We used the Framingham risk score (the version not requiring 
total cholesterol measurements),110 the most widely used CVD risk scoring system 
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internationally, to calculate CVD risk.21 Although very limited, extant evidence suggests that the 
Framingham score may underestimate CVD risk in South Asians, particularly among South 
Asian females.111 In secondary analyses, we also show results using CVD risk calculated with 
three other risk scores, which do not require blood lipid measurements, namely: Harvard-
NHANES,23 Globorisk,22 and the risk score developed by the WHO and International Society for 
Hypertension (WHO-ISH).24 While none of these scores have been validated in longitudinal 
studies specific to South Asian populations, the office-based version of the Harvard-NHANES 
score has been shown to highly correlate (Spearman’s rank correlation coefficient >0.9) in South 
Asian populations (Bangladesh, Bangalore [India], New Delhi and Chennai [India], and Karachi 
[Pakistan]) with well-established risk scores that require a blood lipid measurement (the 
[‘laboratory-based’] Framingham risk score, the Athero-Sclerotic Cardiovascular Disease risk 
calculator [ASCVD], and the Systematic Coronary Risk Evaluation [SCORE]).112     
 
All of the four risk scores predict the risk of a fatal or non-fatal CVD event, but each score 
defines a CVD event differently (eTable12). The Framingham risk score uses the broadest,21 and 
Globorisk22 and WHO-ISH24 the narrowest range of CVD events as outcome. The Globorisk 
project has calibrated its risk equation to 182 countries, including India, as described by Ueda et 
al.22 Similarly, the WHO has calibrated its risk score to each WHO sub-region.24 The 
Framingham and Harvard-NHANES risk scores were calibrated to India using the incidence rate 
(by five-year age group) of peripheral artery disease (Framingham only), ischaemic heart 
disease, and cerebrovascular disease in 2015 as estimated by the Global Burden of Disease 
project.2  
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The four risk scores predict CVD risk by sex using the following inputs: age, body mass index 
(BMI) (except WHO-ISH), presence of diabetes (except Globorisk), current smoking, systolic 
BP, and treatment for hypertension (except Globorisk and WHO-ISH). Diabetes was defined as 
having a high blood glucose reading or reporting to be on regular treatment for diabetes. High 
blood glucose was defined as a reading !126 mg/dl if reporting to have fasted, and !200 mg/dl if 
reporting not to have fasted. For systolic BP, we used the average of the two BP readings 
recorded.  
 
Statistical analysis:  
CVD risk was computed for each study participant aged 30 to 74 years. The sample was 
restricted to this age group because the CVD risk equations used in this study have been 
developed among adults of this age range only.21,23,113 Using sampling weights to account for the 
complex survey design (see eMethods4), we then calculated the mean proportion of participants 
with a high CVD risk at the national level, by state, and by individual-level socio-demographic 
characteristics. All prevalence estimates are unadjusted for individuals’ socio-demographic 
characteristics (other than age-standardisation). In addition, we used ordinary least squares 
regressions to regress the natural logarithm of the CVD risk score on socio-demographic 
characteristics and fixed effects for the primary sampling unit (PSU), i.e., a binary indicator for 
each PSU to adjust for unobserved differences between PSUs. The natural logarithm of CVD 
risk was used in these regression models to allow for a more intuitive interpretation of the 
regression coefficients as percentage changes in CVD risk. The regressions were run separately 
for males and females because each CVD risk score provides sex-specific risks. Two different 
regression models were fitted for each CVD risk score (except WHO-ISH because it only 
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provides risk categories rather than a continuous risk variable24) and sex: i) models that only 
included one socio-demographic characteristic, age group, and PSU-level fixed effects, and ii) 
models that included all socio-demographic characteristics and PSU-level fixed effects as 
explanatory variables. Standard errors were adjusted for clustering at the PSU level.  
 
The mean (for BMI and systolic BP) or the prevalence (for diabetes and smoking) of each CVD 
risk factor was plotted by state and socio-demographic characteristics, to help explain observed 
patterns in the CVD risk scores. We conducted a complete case analysis. The Global Burden of 
Disease Project’s 2013 population for India was used for age standardisation.114 Statistical 
analyses were run in R version 3.3.2 (2016, Vienna, Austria),62 the WHO-ISH score was 
calculated using the whoishRisk package,115 and all figures were created with the ggplot2 
package.63 
 
Results 
Sample characteristics: 
Socio-demographic information was available for a total of 1,094,754 adults aged 30-74 years, 
which includes individuals who were not present at the time of the household visit (as socio-
demographic information was collected for all household members from the household head). 
797,540 (72.9% [797,540/1,094,754]) survey participants who had all the values for the variables 
needed to calculate each CVD risk score (i.e., blood glucose, systolic BP, height and weight, age, 
sex, and smoking status) were included in the analysis. While mean BMI was similar between 
males and females (22.6 kg/m2 and 22.3 kg/m2, respectively), females were more likely to have a 
BMI <18.5kg/m2 and a BMI !25 kg/m2 than males (Table 3.1). 10.0% (42,066/42,0691) of 
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females and 10.7% (40,444/376,849) of males had diabetes. Smoking prevalence and mean 
systolic BP were higher among men than women (27.1% [102,182/376,849] versus 2.6% 
[10,992/420,691] and 129.1mmHg versus 126.7mmHg, respectively). 56.2% (236,555/420,691) 
of females and 34.0% (128,183/376,849) of males had not completed primary school and 
approximately one third of participants lived in urban areas. eTable13 shows that those who 
were excluded from the analysis (27.1% of participants) because they had a missing value for at 
least one of the variables needed to calculate predicted CVD risk, had a similar prevalence of 
CVD risk factors as those who were included in the analysis.   
  
Table 3.1. Sample characteristics 
Characteristic Females Males 
n 420691 376849 
   
Cardiovascular risk factors   
   
Age group    
30-34 years 72262/420691 (17.2%) 57874/376849 (15.4%) 
35-39 years 71458/420691 (17.0%) 56575/376849 (15.0%) 
40-44 years 64453/420691 (15.3%) 55851/376849 (14.8%) 
45-49 years 55589/420691 (13.2%) 50610/376849 (13.4%) 
50-54 years 49350/420691 (11.7%) 44312/376849 (11.8%) 
55-59 years 37064/420691 (8.8%) 36074/376849 (9.6%) 
60-64 years 31893/420691 (7.6%) 32639/376849 (8.7%) 
65-69 years 23553/420691 (5.6%) 25197/376849 (6.7%) 
70-74 years 15069/420691 (3.6%) 17717/376849 (4.7%) 
Missing  0/420691 (0.0%) 0/376849 (0.0%) 
   
Mean BMI in kg/m2 (SD)  22.6 (4.8) 22.3 (4.1) 
Missing  0/420691 (0.0%) 0/376849 (0.0%) 
BMI   
<18.5 kg/m2 72882/420691 (17.3%) 59100/376849 (15.7%) 
18.5-22.9 kg/m2 183441/420691 (43.6%) 176857/376849 (46.9%) 
23.0-24.9 kg/m2 63412/420691 (15.1%) 64810/376849 (17.2%) 
25.0-29.9 kg/m2 74037/420691 (17.6%) 61241/376849 (16.3%) 
!30.0 kg/m2 26919/420691 (6.4%) 14841/376849 (3.9%) 
   
Diabetes  42066/420691 (10.0%) 40444/376849 (10.7%) 
Missing  0/420691 (0.0%) 0/376849 (0.0%) 
   
Current smoking  10992/420691 (2.6%) 102182/376849 (27.1%) 
Missing  0/420691 (0.0%) 0/376849 (0.0%) 
   
Mean systolic BP in mmHg (SD) 126.7 (21.3) 129.1 (19.7) 
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Missing  0/420691 (0.0%) 0/376849 (0.0%) 
Systolic BP    
<120 mmHg 168890/420691 (40.1%) 118408/376849 (31.4%) 
120 – 129 mmHg 93055/420691 (22.1%) 92742/376849 (24.6%) 
130 – 139 mmHg 66204/420691 (15.7%) 75475/376849 (20.0%) 
140 – 179 mmHg 81570/420691 (19.4%) 82312/376849 (21.8%) 
!180 mmHg 10972/420691 (2.6%) 7912/376849 (2.1%) 
   
Current treatment for hypertension 9758/420691 (2.3%) 6501/376849 (1.7%) 
Missing  0/420691 (0.0%) 0/376849 (0.0%) 
   
Socio-demographic characteristics   
   
Educational attainment    
<Primary School 236555/419492 (56.4%) 128183/375652 (34.1%) 
Primary School 50585/419492 (12.1%) 51021/375652 (13.6%) 
Middle School 50218/419492 (12.0%) 61050/375652 (16.3%) 
Secondary School 40320/419492 (9.6%) 59369/375652 (15.8%) 
High School 19675/419492 (4.7%) 32860/375652 (8.7%) 
>High School 22139/419492 (5.3%) 43169/375652 (11.5%) 
Missing 1199/420691 (0.3%) 1197/376849 (0.3%) 
   
Urban area 136426/420691 (32.4%) 121112/376849 (32.2%) 
Missing 0/420691 (0.0%) 0/376849 (0.0%) 
   
Wealth quintile    
1 (poorest) 90885/420677 (21.6%) 79275/376839 (21.0%) 
2 83537/420677 (19.9%) 74815/376839 (19.9%) 
3 80524/420677 (19.1%) 72104/376839 (19.1%) 
4 81428/420677 (19.4%) 74609/376839 (19.8%) 
5 (richest) 84303/420677 (20.0%) 76036/376839 (20.2%) 
Missing  14/420691 (0.0%) 10/376849 (0.0%) 
Abbreviations: %=Percentage; BMI=Body Mass Index; kg=kilogram; m=meter; SD=standard deviation;  
BP=blood pressure; mmHg=millimeters of mercury. 
 
 
 
Cardiovascular disease risk at the national level: 
Overall, 14.6% (95% CI: 14.4 – 14.8) of females and 31.7% (31.4 – 32.0) of males were at high 
risk of CVD (eTable14). While this was the case for less than one percent of participants in the 
age groups 30-34 years and 35-39 years, 73.1% (72.0 – 74.1) of females and 96.9% (96.6 – 97.3) 
of males in the oldest age group (70-74 years) were at high risk. Among those older than 50 
years, 36.1% (35.6 - 36.5) of females and 67.6% (67.1 - 68.1) of males were at high risk of a 
CVD event in the next ten years. The Framingham risk score yielded similar risk estimates to 
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Harvard-NHANES, but substantially higher estimates than Globorisk and WHO-ISH 
(eTable15). As an alternative measure of need for treatment and counseling to reduce CVD risk, 
we are showing the crude proportion of participants who were either current smokers, had 
diabetes, had hypertension, or who were overweight in eTable16. 
 
Cardiovascular disease risk by state: 
The state-level prevalence (across all age groups) of a high CVD risk varied from 5.0% (4.5 – 
5.6) among females in Assam to 30.4% (28.8 – 32.0) among males in Kerala (Figure 3.1 and 
eTable17). Among both males and females, high CVD risk was most prevalent in South India 
(including Goa), the three most Northern states in the dataset (Himachal Pradesh, Punjab, and 
Uttarakandh), the Northeastern states (except Assam), and the Union Territory of Chandigarh. 
The variation in CVD risk between states was similar when using Harvard-NHANES, Globorisk, 
and WHO-ISH (eFigure15, eFigure16, and eFigure17). As shown in eFigure18, the age-
standardized proportion at a high CVD risk in a state/district was positively associated with the 
area’s standard of living (as measured by the state’s/district’s mean household wealth quintile).  
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Fig 3.1. Age-standardized prevalence of a high CVD risk, by state1,2,3,4 
1 High CVD risk was defined as a 10-year cardiovascular disease risk !30% as calculated with the Framingham risk 
score. 
2 The Union Territories of Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small 
area.  
3 Point estimates and 95% confidence intervals for each state are shown in eTable17. 
4 The Global Burden of Disease Project’s 2013 population for India was used for age standardisation.114  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; 
GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, 
Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, Meghalaya; MZ, Mizoram; 
NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; 
TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal. 
 
Figure 3.2 shows differences between states in the age-standardised mean (for BMI and systolic 
BP) or prevalence (for diabetes and smoking) for each of the cardiovascular risk factors that are 
included in the CVD risk score. Mean BMI was high in both Northern (Haryana, Himachal 
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Pradesh, Punjab, and Uttarakhand) and Southern states (Andhra Pradesh, Goa, Karnataka, 
Kerala, Tamil Nadu), ranging from 22.8 kg/m2 among males in Uttarakandh to 25.1 kg/m2 
among females in Punjab. Diabetes prevalence, however, was relatively low in the Northern 
states (ranging from 4.4% among males in Himachal Pradesh to 10.9% among females in 
Punjab). Mean systolic BP was highest in the Northern states (ranging from 123.7 mmHg among 
females in Haryana to 136.2 mmHg among males in Punjab) as well as in Nagaland and Sikkim 
(130.7 mmHg and 132.8 mmHg among females and 133.6 mmHg and 133.1 mmHg among 
males, respectively). Smoking was most prevalent among males in the Northeastern states of 
Arunachal Pradesh (46.4%), Manipur (60.3%), Meghalaya (59.7%), Mizoram (71.7%), and the 
Eastern state of West Bengal (49.5%). State-level point estimates and CIs for each risk factor are 
shown in eTable18. BMI, diabetes, and systolic BP were all positively associated with standard 
of living in a state/district (eFigure19-22).   
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Figure 3.2. Body mass index, diabetes, systolic blood pressure, and smoking prevalence by state1,2,3,4,5,6  
1 The prevalence of hypertension treatment was low throughout all states and is thus not shown.  
2 The Union Territories of Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small area.  
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3 Point estimates and 95% confidence intervals for each state are shown in eTable17.  
4 All outcome variables in this figure have been age-standardised using the Global Burden of Disease Project’s 2013 population for India.114  
5 ‘Smoking’ refers to smoking of any tobacco products but does not include chewing of tobacco.  
6 Diabetes was defined as a high capillary blood glucose measurement (!126mg/dl if fasted and !200mg/dl if non-fasted) or reporting to be on regular treatment 
for diabetes.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, 
Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, 
Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; 
UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal.!!
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Cardiovascular disease risk by individual-level socio-demographic characteristics:  
Stratifying the prevalence of high CVD risk by age group, sex, rural versus urban location, and 
wealth quintile shows that i) those living in urban areas generally had higher mean CVD risk 
than those living in rural areas, ii) irrespective of sex and location, having a high CVD risk was 
more common in the wealthiest than in the poorest quintile in all age groups (except the youngest 
age category), and iii) both the relative and absolute differences in the prevalence of high CVD 
risk between wealth quintiles were larger in rural than in urban areas (Figure 3.3). These 
patterns were generally similar when using Harvard-NHANES, Globorisk, or WHO-ISH instead 
of the Framingham risk score (eFigure23-25).    
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Figure 3.3. Percentage of population with a high (!30%) 10-year cardiovascular risk by 
household wealth quintile, age group, rural versus urban location, and sex.1 
1 This is the crude prevalence (disaggregated by household wealth quintile, age group, rural-urban residence, and 
sex) of a high (!30%) 10-year CVD risk as computed with the Framingham risk score. 
 
 
Table 3.2 shows the regression coefficients (which can be interpreted as approximations of the 
percentage change in CVD risk) when regressing the natural logarithm of the Framingham risk 
score on individuals’ socio-demographic characteristics. Household wealth quintile, education, 
and living in an urban area were positively associated with CVD risk among both sexes, but for 
all three variables, the coefficients for males were substantially smaller than those for females. 
The association between education and CVD risk was weak, once the regressions were adjusted 
for other socio-demographic characteristics. The regression results were similar when using 
Harvard-NHANES and Globorisk (eTable19 and eTable20). 
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Table 3.2. Ordinary least squares regressions of the natural logarithm of cardiovascular disease 
risk on socio-demographic covariates and PSU-level fixed effects1  
 Female (n=!420691) Male (n=376849) 
 Adjusted for age group only2 
Adjusted for all 
covariates3 
Adjusted for age group 
only2 
Adjusted for all 
covariates3 
 Coefficient
4 
(95% CI) P 
Coefficient4 
(95% CI) P 
Coefficient4 
(95% CI) P 
Coefficient4 
(95% CI) P 
Wealth quintile         
1 (poorest) Ref.  Ref.  Ref.  Ref.  
2 2.55 (2.06, 3.04) <0.0001 
2.23 (1.74, 
2.72) <0.0001 
1.06 (0.62, 
1.49) <0.0001 
0.97 (0.53, 
1.41) <0.0001 
3 5.18 (4.66, 5.70) <0.0001 
4.93 (4.40, 
5.45) <0.0001 
2.45 (1.98, 
2.91) <0.0001 
2.55 (2.08, 
3.02) <0.0001 
4 8.57 (8.04, 9.09) <0.0001 
8.18 (7.64, 
8.72) <0.0001 
4.43 (3.96, 
4.90) <0.0001 
4.53 (4.04, 
5.02) <0.0001 
5 (richest) 15.20 (14.67, 15.73) <0.0001 
14.66 (14.08, 
15.24) <0.0001 
9.12 (8.64, 
9.60) <0.0001 
9.12 (8.60, 
9.64) <0.0001 
Educational 
attainment         
<Primary 
School Ref.  Ref.  Ref.  Ref.  
Primary 
School 
6.55 (6.07, 
7.03) <0.0001 
4.20 (3.71, 
4.68) <0.0001 
1.96 (1.53, 
2.38) <0.0001 
0.96 (0.54, 
1.39) <0.0001 
Middle 
School 
7.33 (6.84, 
7.82) <0.0001 
3.90 (3.39, 
4.40) <0.0001 
3.16 (2.75, 
3.56) <0.0001 
1.49 (1.08, 
1.90) <0.0001 
Secondary 
School 
10.05 (9.51, 
10.59) <0.0001 
4.66 (4.09, 
5.22) <0.0001 
4.72 (4.30, 
5.14) <0.0001 
1.87 (1.43, 
2.30) <0.0001 
High School 8.94 (8.20, 9.67) <0.0001 
2.51 (1.74, 
3.27) <0.0001 
3.72 (3.21, 
4.24) <0.0001 
0.24 (-0.30, 
0.77) 0.39 
>High 
School 
7.96 (7.25, 
8.67) <0.0001 
-0.61 (-1.37, 
0.15) 0.12 
6.29 (5.81, 
6.77) <0.0001 
1.29 (0.77, 
1.82) 0.002 
Geography         
Rural Ref.  Ref.  Ref.  Ref.  
Urban 10.25 (9.66, 10.84) <0.0001 
10.90 (10.29, 
11.51) <0.0001 
8.15 (7.63, 
8.67) <0.0001 
8.68 (8.15, 
9.22) <0.0001 
Abbreviations: CI=Confidence Interval; PSU=primary sampling unit; Ref. = Reference category. 
1 Standard errors were adjusted for clustering at the household level.  
2 These models included one sociodemographic characteristic, age group, and a binary indicator variable for each 
PSU as explanatory variables.  
3 This model included all variables listed in the table, age group, and a binary indicator for each PSU as explanatory 
variables.   
4 Coefficients were multiplied by 100 so that they can be interpreted as an approximation of the percentage change 
in cardiovascular risk associated with a one unit change in the explanatory variable.    
 
 
 
Figure 3.4 shows that while mean BMI, diabetes, and mean systolic BP were all positively 
associated with household wealth and living in an urban area, the prevalence of diabetes and 
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mean systolic BP were nonetheless high in middle- and old-age among the poorest wealth 
quintiles and in rural areas. Smoking, on the other hand, was more common in poorer quintiles, 
in rural areas, and among males.  
 
Figure 3.4. Mean body mass index, diabetes and smoking prevalence, and mean systolic blood 
pressure by rural versus urban residence, sex, and household wealth quintile.  
1 These are crude (not age-standardised) estimates.   
2 ‘Smoking’ refers to smoking of any tobacco products but does not include chewing of tobacco.  
3 Diabetes was defined as a high capillary blood glucose measurement (!126mg/dl if fasted and !200mg/dl if non-
fasted) or reporting to be on regular treatment for diabetes.  
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Discussion 
By pooling and analyzing data on CVD risk that are nationally representative for India 
(accounting for more than a sixth of the world’s population31), we found that the predicted 10-
year CVD risk in India was high. In fact, it was roughly twice as high as the estimates for the 
United States (US) even though the US population is substantially older than that of India.10 In 
the (nationally representative) US National Health and Nutrition Examination Survey 
(NHANES) conducted in 2009-2010, the mean crude 10-year CVD risk (using the Framingham 
risk score) among those aged 30-74 years was 11.5% (95% CI: 10.7 - 12.3) among males and 
6.2% (95% CI: 5.8 - 6.6) among females.116 By comparison, in the same age range and using the 
same risk score, mean crude 10-year CVD risk in our study was 21.4% (21.3 - 21.6) among 
males and 12.7% (95% CI: 12.7 - 12.8) among females. Both systolic BP and smoking 
prevalence were higher in this sample than in NHANES. The study of NHANES, however, 
excluded participants with a previous or current CVD event, which were unable to do in this 
dataset due to lacking questionnaire data on CVD. The high predicted CVD risk in this study is 
particularly concerning given evidence from several studies that the Framingham risk score may 
underestimate risk in South Asian populations.111   
 
We found that having a high CVD risk is common in middle- and old-age across most states and 
population groups in India, including the rural poor. While age was the strongest determinant of 
CVD risk in this analysis, we identified important variation in risk among states (with CVD risk 
being highest in the Northern, Northeastern, and Southern states) and by individuals’ socio-
demographic characteristics. Regarding the latter, we found that i) CVD risk was higher in urban 
areas and among males; ii) while mean BMI was substantially higher among the wealthy than the 
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poor, diabetes and high systolic BP were common among the poor in middle and old age, and iii) 
smoking was most prevalent among poorer wealth quintiles and in rural areas. Thus, while a 
major investment in CVD and risk factor prevention, screening, and treatment is needed across 
India, this study provides important insights to effectively target health system resources for 
CVD management to those most in need.  
 
The risk estimates obtained with the Framingham and Harvard-NHANES score were 
substantially higher than those obtained using Globorisk and WHO-ISH. This observed 
difference in estimates was expected given that Globorisk and WHO-ISH predict the risk of 
(fatal or non-fatal) myocardial infarction or stroke, while Framingham and Harvard-NHANES 
include a broader set of outcomes. For its global NCD target that “at least 50% of eligible people 
receive drug therapy and counselling to prevent heart attacks and strokes” by 2020, the WHO 
defined eligibility as a 10-year CVD risk !30%.20 The large differences between risk scores 
observed in this study indicate that such a target is difficult to operationalise unless the risk score 
used to define eligibility is also specified. 
 
This study has several limitations. First, we had to rely on ‘office-based’ risk scores that used 
BMI instead of cholesterol measurements. However, in an analysis of nine cohorts from ten 
LMICs, Gaziano et al. have shown that the office-based version of the Harvard-NHANES score 
performed virtually as well in predicting CVD events as the laboratory-based versions of 
ASCVD, Framingham, and SCORE.112 Similarly, although Ueda et al. noted that the office-
based Globorisk score underestimated risk among those with diabetes, they found that it 
classified more than 80% of participants correctly into low and high CVD risk.22 Second, a 
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relatively high percentage (27.1%) of participants had a missing value for at least one variable 
needed to calculate their CVD risk. While we show that participants excluded because of a 
missing value had similar summary statistics for CVD risk factors as those included in the 
analysis, there is nonetheless potential for selection bias. Third, a one-time capillary blood 
glucose measurement is not recommended for the diagnosis of diabetes in clinical settings.79 
However, this screening method has been shown to have an acceptable sensitivity and specificity 
for defining diabetes in population-based research, and is hence the recommended method for 
monitoring diabetes prevalence in the WHO’s STEPwise Approach to Non-communicable 
Disease Risk-Factor Surveillance.80-82 Lastly, the Framingham risk score (and other CVD risk 
scores developed among Caucasian populations) may underestimate CVD risk, particularly 
among South Asian females.117 A related note of caution is that the CVD risk scores used here do 
not take into account consumption of smokeless tobacco, which is common in India and may 
increase CVD risk.118,119  
 
In conclusion, crude 10-year CVD risk in India is high and was common throughout socio-
demographic groups in middle and old age. We identified important variations in CVD risk and 
risk factor prevalence between states and population groups – information that will be essential 
for effective targeting of resources and interventions for prevention, screening, and treatment to 
those most in need. Given the detrimental effects of CVD on health,2 financial risk protection,12 
and economic growth,16 India’s performance in tackling its CVD epidemic will directly impact 
several SDGs (e.g., SDG 1: “End poverty in all its form everywhere” and SDG 3: “Ensure 
healthy lives and promote well-being for all at all ages”) and corresponding targets (SDG 3.4: 
“By 2030, reduce by one third premature mortality from NCDs” and SDG 3.8 on achieving 
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universal health coverage). Considering the size and growth of its population,31 the country’s 
performance in addressing its CVD epidemic will also have a decisive impact on the world’s 
ability to achieve the SDGs.33  
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Conclusion 
Main findings:  
The analyses presented in this dissertation reveal that: i) there is important variation in the 
prevalence of CVD risk factors by state, urban-rural residence, sex (except diabetes), and age; ii) 
relative wealth differences are substantial for diabetes but less so for hypertension and CVD risk; 
iii) differences in prevalence of each outcome by education are small once adjusted for age; iv) 
the poor have an important CVD risk factor prevalence, especially in urban areas, among males, 
and among older adults; v) absolute CVD risk differs greatly between risk scores highlighting 
that any goal or recommendation based on CVD risk must specify the risk score to be used; and 
vi) both diabetes and hypertension prevalence in a district are positively associated with the 
district’s standard of living (although for diabetes, this association is not present in the wealthiest 
quintile).    
 
Contributions of this dissertation to the literature:  
This dissertation makes several important contributions to the existing literature on CVD risk in 
India. First, the national prevalence estimates obtained from this study are free from any 
extrapolation or simulation as they are obtained from the first nationally representative analysis 
of these outcomes (diabetes, hypertension, and predicted CVD risk) in India. Second, this study 
is the first to provide empirical prevalence estimates on these outcomes for every state of India 
(with the exception of Gujarat, and Jammu and Kashmir). Third, unlike existing “national” 
studies (e.g., NCD RisC and the Global Burden of Disease), which use sophisticated modelling 
techniques to arrive at national prevalence estimates, this study was able to examine the 
association between the outcomes and individual-level socio-demographic characteristics (as 
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opposed to, for example, the Global Burden of Disease study’s socio-demographic index, which 
is an area-level measure of development). Fourth, unlike the INDIAB study,19 this dissertation 
employs PSU-level fixed effects in its regressions and thus examines the association of 
individual-level socio-demographic characteristics with the outcomes within areas. In a country 
as large and diverse as India, it seems statistically more appropriate to compare people within 
small areas rather than pooling them across the entire country and ignoring area-level effects on 
the outcomes. We, therefore, believe this is an important strength and contribution of this 
dissertation to the literature. Fifth, this dissertation is the first to use large-scale population-based 
data from India to calculate a predicted CVD risk.  
 
Comparison to existing prevalence estimates: 
This study provides new prevalence estimates for diabetes, hypertension, and high CVD risk for 
India. Table 4.1 lists existing prevalence estimates for diabetes and hypertension from studies 
that were conducted in more than one state of India and aimed to be representative either for the 
entire state, or all rural or urban areas in a state. The diabetes prevalence estimates in this study 
were lower than existing national estimates obtained from published studies that use modeling as 
the basis of their prevalence estimation.83,120,121 However, state-level prevalence estimates were 
similar to those reported in the largest sub-national study of diabetes to date (the ICMR-INDIAB 
study).19 It is important to note that we did not count as diabetic those who are on diabetes 
treatment and have achieved a normal blood glucose. Our prevalence estimates for diabetes are 
therefore likely to be an underestimate of true diabetes prevalence. With regards to blood 
pressure, this study’s hypertension prevalence estimate was lower than that estimated by NCD-
RisC.93 However, as detailed in Paper 2, we found a higher prevalence in younger age groups 
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than NCD-RisC had estimated. I did not identify any studies that report a predicted CVD risk in 
a population-based sample representative for at least one state of India.  
 
Policy implications:  
This dissertation has three main policy implications. First, by showing how CVD risk factors and 
composite risk varies among population groups in India, our analyses can inform targeting of 
relevant prevention, screening, and treatment programs. Specifically, our findings on the 
important variation of diabetes, hypertension, and predicted CVD risk between states and by 
urban-rural location can guide policy makers where geographically CVD risk reduction 
programs should be implemented. In addition, the variation in prevalence of diabetes, 
hypertension, and CVD risk by household wealth can inform policy makers and program 
managers on the type of households and neighborhoods that should be targeted with CVD-
related programs. Lastly, the variation in CVD risk by individual-level socio-demographic 
characteristics (e.g., age) can guide what patients at healthcare facilities and individuals within 
households (e.g., during household visits by community health workers) should be offered 
relevant screening services. Second, by providing a granular assessment of the current need for 
care for diabetes and hypertension, as well as the predicted risk of a CVD event (and thus future 
need for CVD care) in the coming ten years, this dissertation can inform the planning of relevant 
health system functions. Third, this thesis examines how prevalence of these conditions varies 
among socio-economic groups and can thus (albeit with the limitation that we do not have data 
on the total disease burden by socio-economic groups) contribute to discussions on the degree to 
which a policy focus on CVD in India might exacerbate current inequalities in health between 
socio-economic groups.  
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Limitations:  
An important limitation of this dissertation is the measurement of the outcome variables. 
Specifically, for both diabetes and hypertension, only participants who reported having 
experienced any symptoms lasting for more than one month in the last year were asked about 
diabetes and hypertension diagnosis and treatment. This limitation implies that the prevalence 
estimates obtained in this analysis (based on having a high blood glucose/pressure only in papers 
1 and 2) are likely lower than those from studies that defined these conditions based on having 
either a high blood glucose/pressure or reporting to be on treatment for the condition. In addition, 
since it is probable that wealthier individuals are more likely to be on antidiabetic and/or 
antihypertensive treatment than poorer participants, the wealth gradients observed in this 
dissertation are likely shallower than they would have been had full treatment information been 
available and included in the definition of the condition. However, defining these conditions 
based on having a high blood glucose/pressure only can be viewed as a measure of (unmet) need 
for control of the condition (as those who have achieved diabetes/hypertension control were not 
considered to be diabetic/hypertensive). A further limitation specific to the diabetes outcome is 
that diabetes was defined based on fasting blood glucose only. In a study of 96 population-based 
surveys, NCD-RisC has shown that defining diabetes based on fasting blood glucose only, 
compared to defining the condition based on a high fasting plasma glucose or two-hour oral 
glucose tolerance test, leads to a somewhat lower (by 2-6 percentage points) diabetes 
prevalence.122 A third limitation is that the only measures of socio-economic position in Indian 
society available in the AHS and DLHS-4 were data on household assets and characteristics 
(from which I created an asset index – referred to as ‘household wealth index’ in this 
dissertation) and educational attainment. Notably, there was no data on consumption expenditure 
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or household income. The household wealth index has been criticized for having only modest 
inter-observer and test–retest reliability.123 In addition, some have argued that data should not 
merely be collected on ownership of durable goods but also on their quality and nature.124 
Nonetheless, the asset index is a widely used indicator of household wealth having, for instance, 
been employed in virtually all Demographic and Health Surveys.125 There is no particular reason 
why the asset index would be less appropriate for India as compared to other LMICs given that 
asset indices are widely used in middle-income countries and even high-income countries, such 
as for the European Union’s 2020 poverty measure and the Dutch Life Situation Index.125-127 
Indeed, India was the country for which Filmer and Pritchett originally developed the asset index 
in their seminal study from 2001.58  
     
Future research: 
Future nationally representative studies of CVD risk factors in India should not only collect 
biomarker data but also include a rigorous set of questions on previous screening, awareness of 
diagnosis, reception of lifestyle advice, and current as well as past treatment for these conditions. 
Such data will provide a more comprehensive assessment of the unmet need for care of diabetes 
and hypertension, and thus be more informative to clinicians and policy makers. In addition, 
future studies may consider asking questions on consumption expenditure to allow for an 
alternative and arguably more accurate assessment of poverty. Specific to diabetes, future 
surveys should consider conducting a two-hour oral glucose tolerance test (OGTT) among at 
least a subsample of the participants as was done in INDIAB.19 With regards to predicted CVD 
risk, there is an urgent need for developing and validating CVD risk scores in South Asian cohort 
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studies given that it appears likely that a cohort in, for example, Framingham (Massachusetts, 
USA) can hardly be generalized to populations across the world.  
 
More generally, moving forward, India will need to improve its monitoring of NCDs to have 
access to reliable and timely information on the need for NCD prevention, screening, and 
treatment. Being able to monitor trends over time will require that conditions are assessed using 
the same method(s) across survey rounds. This point is of particular import to the monitoring of 
diabetes prevalence given that that the use of different biomarkers for diabetes has been shown to 
result in substantially different prevalence estimates.122 A simple and effective approach in this 
regard could be to add a comprehensive NCD module (including biomarker measurements) to 
the National Family Health Survey (NFHS) rounds, and to conduct these rounds more frequently 
(e.g., every five years). The fact that the latest round of the NFHS (the NFHS-4) is set to be the 
first to provide biomarker-based data on diabetes and measure BP is certainly a step in this 
direction.55 However, the quality of the data and survey instruments remains to be verified as the 
data have not yet been released into the public domain. Making such data available to the public 
in a timely manner - both for the purposes of transparency and to allow international and local 
researchers to gain insights from these large and expensive surveys - is crucial. Unfortunately, it 
took 55 months after completion of data collection for the AHS microdata to be made available 
in the public domain;55 and this was done without an individual identifier to allow merging of 
data across AHS datasets.  
 
Lastly, Indian policy makers will need to design and evaluate models to improve screening for 
diabetes and hypertension. Relatedly, those who are screened ‘positive’ will need to be 
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successfully linked to care and, those whose diagnosis is confirmed, retained in care long term. 
Among other examples, the global health community’s experience in this regard with HIV 
demonstrates that retaining patients along this chronic disease care continuum is a great 
challenge.128 Moving forward, India will therefore need to identify effective healthcare delivery 
models that can feasibly be scaled up to improve linkage to, and retention in care. 
Encouragingly, India’s public health community has already embarked on this challenge with 
several randomized trials of novel healthcare delivery models to improve care linkage, care 
retention, and/or medication adherence being currently underway or having been recently 
completed.129-134 In particular, it may be possible to leverage India’s large existing community 
health worker cadre – the Accredited Social Health Activists (or ‘ASHA’) – as well as the 
country’s rural child care centers (Anganwadis) and their staff to support primary care efforts for 
diabetes and hypertension. This is a promising possibility that the DISHA trial is currently 
investigating.132 Undoubtedly, however, the next hurdle will be to successfully translate the 
findings of these trials to policy. In addition to experimentation with new healthcare delivery 
models, the country’s public health community will also need to gather more evidence on 
primary prevention approaches for CVD. Currently, the effects of primary prevention policies in 
India, such as taxes on tobacco, palm oil, and sugar-sweetened beverages, have relied on 
modelling studies only.135-138 
 
Conclusion: 
While we identified important variation in the prevalence of diabetes, hypertension, and high 
CVD risk among states and by rural-urban location, prevalence levels in India are high across all 
geographic settings and socioeconomic groups in middle and old age. Major investments in 
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targeted CVD risk prevention, risk factor detection, and treatment programs are needed across 
the country if India is to avert catastrophic health, social, and economic consequences of these 
conditions and their sequelae. Given the size, growth, rapid urbanization, and aging of India’s 
population,31,32 as well as the high levels of impoverishing healthcare expenditures caused by 
NCDs,12 the country’s success in tackling its diabetes and hypertension epidemic will be crucial 
to achieving Sustainable Development Goals globally.  
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Table 4.1 Previously published diabetes and hypertension prevalence estimates for India. 
 
Study 
name/Organization 
Representativeness 
Year(s) of 
data 
collection 
Prevalence findings 
Socio-demographic 
variation in prevalence 
Reference 
 
Diabetes 
     
ICMR-INDIAB 15 states of India 2008-2015 
7.3% (7.0–7.5) 
[standardized to the India 
census 2011] 
Higher prevalence in 
urban areas, those with a 
higher socio-economic 
status (in rural areas), 
males, and older 
individuals. 
19 
IDF Diabetes Atlas 
Modelled estimates 
aiming for national 
representativeness 
Estimates 
for 2015 
9.3% (7.6 - 11.4) 
[standardized to the 
WHO reference 
Not reported 83 
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population] 
Global Burden of 
Disease Study 
Modelled estimates 
aiming for national 
representativeness 
Estimates 
for 2015 
6.5% (6.0-7.1) among the 
entire population 
(including children) 
Not reported 84 
NCD RisC 
Modelled estimates 
aiming for national 
representativeness 
Estimates 
for 2014 
9.1% (5.2 to 14.2) Not reported 120 
National Nutrition 
Monitoring Bureau’s 
Third Repeat Survey 
Rural areas in 10 states 2011-2012 
Men: 8.2% (7.7-8.7); 
Women: 6.8% (6.4-7.2) 
Higher among men, 
older individuals, and 
those without formal 
education; no association 
with occupation.  
38,39 
 
Hypertension 
     
NCD RisC 
Modelled estimates 
aiming for national 
Estimates 
for 2016 
26.5% (21.2 – 32.4) 
among males and 24.7% 
Not reported 93 
 ! 80 
representativeness (19.9 – 29.9) among 
females [age-
standardized to the WHO 
reference population] 
National Nutrition 
Monitoring Bureau’s 
Third Repeat Survey 
Rural areas in 10 states 2011-2012 
22.2% (21.7 – 22.8) 
among men and 21.6% 
(21.1 – 22.1) among 
women 
Higher among older 
individuals and those 
without formal education 
38,39 
SAGE 
Representative for 
adults aged !50 years in 
six Indian states  
2007-2008 
23% (no CI given) [age-
standardized using the 
United Nations 
Development Program’s 
world population 
pyramid] 
Higher among older 
individuals, in urban 
areas; no clear trends by 
wealth quintile or 
education; no difference 
by sex  
64 
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eMethods1. Methodology of the AHS and DLHS-4  
We pooled data from two large household surveys in India: The District-Level Household Survey-4 (DLHS-4) and 
the second update of the Annual Health Survey (AHS). eFigure1 shows the states and Union Territories covered by 
each survey. Both surveys are representative at the district level. They jointly cover all 29 states of India except 
Jammu and Kashmir (data were not collected due to violent conflicts) and Gujarat (data were not available in the 
public domain), and five of India’s seven Union Territories (data were not available for Dadra and Nagar Haveli, 
and Lakshadweep). The two states and two Union Territories not included in this analysis only accounted for 6% of 
India’s population in 2011 (the time of the last census).35 Both surveys administered a questionnaire to the 
household head to ascertain socio-demographic information for each household member (regardless of whether the 
individual was present or absent at the time of the interviewer’s visit), and measured blood glucose (BG) and blood 
pressure (BP) in each household member aged 18 years and older. All participants were asked to fast overnight until 
the time of the BG measurement in the morning. BG was measured once using the SD CodeFree handheld 
glucometer. BP was measured twice in the left upper arm (with the patient sitting) using an electronic BP monitor 
(Rossmax AW150). Data collectors were instructed to ensure a gap of at least three minutes between BP 
measurements. As part of the standard protocol, participants were asked to place their left arm on a flat surface 
(palm facing up) with the center of the upper arm being at approximately the same height as the heart, and instructed 
to refrain from talking during the measurement.  
 
Annual Health Survey: 
Data for the AHS were collected between 2012 and 2013 in all 284 districts of nine states of India, which were 
selected because they had the highest rate of infant and child mortality in the country in 2010.55 The two-stage 
cluster random sampling design of the AHS was self-weighting at the district level. In the first stage, villages in rural 
areas and census enumeration blocks in urban areas were selected through simple random sampling with probability 
proportional to population size (using projections from the 2001 India Census). In the second stage, households were 
selected through systematic random sampling (sampling the first household randomly, and then selecting every 
alternate household). The AHS dataset containing participants’ socio-demographic information was merged with the 
dataset containing BP measurements as outlined in eMethods2.  
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District-Level Household Survey-4: 
Data for the DLHS-4 were collected between 2012 and 2014 in all 336 districts of 18 states and five Union 
Territories (also referred to as ‘states’ in the manuscript) of India.55 In the first stage, census villages in rural areas 
were selected through probability proportional to population size (again, using projections from the 2001 India 
Census), and urban frame survey blocks in urban areas through simple random sampling. In the second stage, 
households were selected through systematic random sampling.90 
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eFigure1. States and Union Territories covered by each surveya 
!
a The Union Territories, Chandigarh, Daman and Diu, and Puducherry, which were all covered by the DLHS-4, are 
not visible in the map due to their small area.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; 
GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, 
Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, Meghalaya; MZ, Mizoram; 
NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; 
TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal
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eMethods2. Matching Annual Health Survey biomarker data to participants’ socio-
demographic data  
Annual Health Survey (AHS) data in the public domain does not have a unique identifier that allows for merging of 
the ‘laboratory dataset’, which contains BG and BP measurements, to the dataset that contains respondents’ full 
socio-demographic information. We thus merged these datasets using an indicator composed of the state, district, 
stratum (indicating rural versus urban location and village size), a household identifier that is unique within each 
primary sampling unit, and a household member serial number given during data entry as well as one assigned after 
data entry.  
 
607,227 out of 1,028,545 (59.0%) non-pregnant adults in the laboratory dataset were successfully matched to their 
corresponding socio-demographic information. As detailed in the tables below, participants who were not matched 
had similar characteristics as those who were matched. Participants were merged independently of whether their BG 
or BP measurement was missing.   
 
Across all nine AHS states: 
Variable Matched Not matched 
n=607,227 n=421,318 
Male (%) 50.7 48.4 
Age (mean ± SD) 40.8±15.9 38.9±17.0 
Diabetes (%) 7.0 6.3 
Plasma glucose in mg/dl (mean ± SD) 108.4±21.7 108.0±21.3 
Hypertension (%) 22.3 21.0 
Systolic BP (mean ± SD) 123.4±18.9 122.6±19.1 
Diastolic BP (mean ± SD) 77.9±12.5 77.3±12.3 
Urban (%) 19.4 18.0 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
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Assam: 
Variable Matched Not matched 
n=62,882 n=23,626 
Male (%) 51.3 44.5 
Age (mean ± SD) 40.3±14.9 37.1±16.1 
Diabetes (%) 7.5 7.3 
Plasma glucose in mg/dl (mean ± SD) 109.4±21.5 108.5±21.3 
Hypertension (%) 24.2 19.7 
Systolic BP (mean ± SD) 125.7±17.6 123.3±17.5 
Diastolic BP (mean ± SD) 79.5±11.8 77.9±11.5 
Urban (%) 16.8 19.8 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
 
 
Bihar: 
Variable Matched Not matched 
n=71,861 n=80,049 
Male (%) 49.6 53.5 
Age (mean ± SD) 40.8±15.9 38.3±16.9 
Diabetes (%) 6.9 5.3 
Plasma glucose in mg/dl (mean ± SD) 106.7±19.8 104.5±18.6 
Hypertension (%) 22.7 18.8 
Systolic BP (mean ± SD) 123.7±18.6 120.9±17.5 
Diastolic BP (mean ± SD) 77.9±12.8 77.2±11.6 
Urban (%) 9.6 8.3 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
 
 
Chhattisgarh: 
Variable Matched Not matched 
n=37,579 n=19,997 
Male (%) 52.6 48.4 
Age (mean ± SD) 39.9±14.9 38.8±16.1 
Diabetes (%) 8.8 9.2 
Plasma glucose in mg/dl (mean ± SD) 110.0±19.2 110.1±21.0 
Hypertension (%) 18.1 18.7 
Systolic BP (mean ± SD) 123.1±16.5 123.2±17.2 
Diastolic BP (mean ± SD) 77.7±11.9 77.5±12.2 
Urban (%) 19.1 22.2 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
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Jharkhand: 
Variable Matched Not matched 
n=35,721 n=18,875 
Male (%) 44.8 43.6 
Age (mean ± SD) 40.6±15.5 39.1±16.8 
Diabetes (%) 6.8 5.4 
Plasma glucose in mg/dl (mean ± SD) 105.4±24.8 103.9±21.7 
Hypertension (%) 25.0 24.3 
Systolic BP (mean ± SD) 123.0±20.0 122.7±19.9 
Diastolic BP (mean ± SD) 77.8±13.3 77.5±13.2 
Urban (%) 17.6 22.2 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
 
 
Madhya Pradesh: 
Variable Matched Not matched 
n=101,896 n=63,056 
Male (%) 54.4 51.1 
Age (mean ± SD) 40.0±15.8 38.9±16.8 
Diabetes (%) 6.2 5.4 
Plasma glucose in mg/dl (mean ± SD 107.3±20.0 107.3±19.0 
Hypertension (%) 21.7 21.2 
Systolic BP (mean ± SD) 124.6±18.1 124.3±17.8 
Diastolic BP (mean ± SD) 79.8±11.4 79.6±11.1 
Urban (%) 32.4 28.9 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
 
 
Odisha: 
Variable Matched Not matched 
n=92,000 n=21,570 
Male (%) 49.2 43.8 
Age (mean ± SD) 42.2±16.0 39.2±17.5 
Diabetes (%) 7.0 6.4 
Plasma glucose in mg/dl (mean ± SD) 107.6±24.0 106.3±23.2 
Hypertension (%) 20.2 18.6 
Systolic BP (mean ± SD) 120.7±19.8 119.6±19.8 
Diastolic BP (mean ± SD) 75.4±13.2 74.8±13.1 
Urban (%) 14.3 13.2 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
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Rajasthan: 
Variable Matched Not matched 
n=81,931 n=25,974 
Male (%) 49.6 44.6 
Age (mean ± SD) 41.0±16.1 37.9±17.5 
Diabetes (%) 6.9 6.2 
Plasma glucose in mg/dl (mean ± SD) 109.7±20.4 109.0±19.7 
Hypertension (%) 22.8 20.9 
Systolic BP (mean ± SD) 122.9±18.5 121.9±18.3 
Diastolic BP (mean ± SD) 78.7±11.9 78.2±11.8 
Urban (%) 17.7 17.1 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
 
 
Uttar Pradesh: 
Variable Matched Not matched 
n=103,384 n=148,213 
Male (%) 51.6 47.9 
Age (mean ± SD) 40.4±16.3 39.4±17.2 
Diabetes (%) 6.9 6.2 
Plasma glucose in mg/dl (mean ± SD) 110.4±22.0 110.2±22.3 
Hypertension (%) 21.8 22.0 
Systolic BP (mean ± SD) 123.1±20.0 122.9±20.6 
Diastolic BP (mean ± SD) 76.2±13.0 76.1±13.0 
Urban (%) 21.3 17.5 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
 
 
Uttarakhand: 
Variable Matched Not matched 
n=19,973 n=19,958 
Male (%) 47.0 42.6 
Age (mean ± SD) 42.7±16.6 40.1±17.3 
Diabetes (%) 8.0 7.3 
Plasma glucose in mg/dl (mean ± SD) 109.6±25.2 111.3±25.9 
Hypertension (%) 32.1 25.9 
Systolic BP (mean ± SD) 127.2±19.6 124.0±20.1 
Diastolic BP (mean ± SD) 81.5±11.8 79.2±12.3 
Urban (%) 22.0 21.3 
Abbreviations: BP=blood pressure; SD=standard deviation; mg=milligram; dl= deciliter. 
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eMethods3. Computation of the household wealth index 
While neither the AHS nor the DLHS-4 contained information on household income or expenditure, they both asked 
about household characteristics and ownership of durable assets, which allows for the creation of a household wealth 
index. We created a household wealth index through a Principal Component Analysis (PCA) using the methodology 
developed by Filmer and Pritchett.58 The advantage of a PCA is that the weights attributed to each asset or housing 
characteristic (henceforth assets) are not determined arbitrarily by the authors but instead are data-driven.  
 
As a first step, a binary indicator was generated for each asset. Data on the following assets were available in both 
surveys and coded as being equal to one if the household head reported owning or having access to the asset: 
improved water supply (private or public access to piped water, hand pump, tube well, borehole or protected dug 
well); improved sanitation facility (not shared (pour) flush toilet, Ventilated Improved Pit or pit latrine with slab), 
modern cooking fuel (liquefied petroleum gas, electricity, biogas), house structure (pucca), clean source of lighting 
(electricity, solar), house ownership, and land ownership. Furthermore, indicators for each of the following assets 
were set to one if the household head reported owning at least one item of the following durable goods: radio, 
television, phone, fridge, bike, scooter, car, computer, washing machine, and sewing machine.  
 
As a second step, the PCA was run separately for urban and rural areas on these binary indicator variables and the 
first (unrotated) principal component was extracted. The first principal component contains the largest part of the 
information on the variation in asset ownership and was used to predict the asset score of each household. The asset 
score has a mean of zero and standard deviation of one with lower asset scores indicating less wealth. To improve 
interpretability, the asset score was divided into quintiles (again, separately for rural and urban areas).   
 
Variables used to calculate the household wealth index: 
Asset Coded as 1 Coded as 0 
Improved water supply Piped water into dwelling, yard or 
plot; public tap or standpipe; hand 
pump; tube well or borehole; 
protected dug well 
Tanker, truck or cart with small 
tank; surface water;  
Improved sanitation facility If not shared: (Pour) flush 
connected to piped sewer system, 
septic tank or pit latrine; 
Ventilated Improved Pit; pit 
latrine with slab 
Any shared facility; pit latrine 
without slab; service latrine; open 
defecation 
Cooking fuel LPG; electricity; biogas Firewood; crop residue; cow dung 
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cake; coal, lignite or charcoal; 
kerosene 
House structure Pucca Semi-Pucca, Kuccha 
Source of lighting Electricity; solar Kerosene, other oils, none 
Ownership of house Owned Rented 
land Ownership of any land No land owned 
Radio 
Household owns at least one of 
this asset Household does not own this asset 
TV 
Phone 
Fridge 
Bike 
Scooter 
Car 
Computer 
Washing machine 
Sewing machine 
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eMethods4. Computation of sampling weights  
 
The AHS is self-weighting at the district level. For AHS respondents, we therefore computed weights that consisted 
of the proportion that is obtained when dividing the relative population size of a district (i.e., population size of the 
district divided by the population size across all nine AHS states) by the relative sample size of a district (i.e., 
sample size of the district divided by total AHS sample size across all nine states). For DLHS-4 respondents the 
same weight was computed as above for the AHS, which was then multiplied by the weights given in the DLHS-4 
dataset that adjust for the complex survey design (the DLHS-4 is not self-weighting). Lastly, the weights were 
adjusted for the fact that the AHS sample size is smaller relative to the population it represents than the DLHS-4 
sample size. These weights were used to calculate all crude prevalence estimates provided in the manuscript.  
 
To obtain age-standardized prevalence estimates, the weights for the crude prevalence estimates were multiplied by 
the proportion of adults in the respondent’s five-year age group in the WHO reference population.60 Code for the 
computation of these sampling weights can be obtained from the corresponding author. 
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eTable1. Sample characteristics stratified by whether the blood 
glucose or blood pressure measurement was missinga 
 
 Not missing Missing 
n 1,320,555 297,804 
   
Male, no. (%) 619,147 (46.9) 227,186 (76.3) 
Age group, no. (%)   
18-25 years 253,154 (19.2) 76,191 (25.6) 
26-35 years 320,018 (24.2) 70,311 (23.6) 
36-45 years 281,706 (21.3) 56,158 (18.9) 
46-55 years 212,465 (16.1) 42,385 (14.2)   
56-65 years 150,940 (11.4) 30,635 (10.3) 
>65 years 102,253 (7.7) 22,105 (7.4) 
   
Education, no. (%)   
<Primary School 504,829 (38.4) 91,186 (30.8) 
Primary School 163,953 (12.5) 34,474 (11.6) 
Middle School 203,128 (15.4) 46,764 (15.8) 
Secondary School 182,391 (13.9) 47,396 (16.0) 
High School 128,270 (9.8) 36,654 (12.4) 
>High School 132,544 (10.1) 39,459 (13.3) 
Household wealth quintile, no. (%)   
1 (poorest) 254,652 (20.2) 51,072 (17.8) 
2 248,101 (19.7) 55,014 (19.2) 
3 245,748 (19.5) 57,270 (20.0) 
4 253,905 (20.1) 60,619 (21.2) 
5 (richest) 259,491 (20.6) 62,408 (21.8) 
Currently married, no. (%) 988,456 (75.0) 198,873 (67.0) 
Urban area, no. (%) 429,330 (32.5) 106,233 (35.7) 
Abbreviations: no.=number; %=Percentage. 
a These numbers were not weighted using sampling weights.  
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eTable2. National diabetes and hypertension prevalence by age 
group and sexa,b!
!
 Diabetes Hypertension 
 Female, % (95% CI) Male, % (95% CI) Female, % (95% CI) Male, % (95% CI) 
Age group     
18-25 years 2.6 (2.4 - 2.7) 2.4 (2.2 - 2.5) 9.2 (8.9 - 9.6) 14.6 (14.2 - 15.0) 
26-35 years 4.0 (3.8 - 4.2) 4.6 (4.4 - 4.8) 14.2 (13.8 - 14.6) 21.0 (20.6 - 21.4) 
36-45 years 7.0 (6.8 - 7.3) 7.5 (7.3 - 7.8) 23.0 (22.6 - 23.4) 27.7 (27.2 - 28.2) 
46-55 years 11.2 (10.9 - 11.5) 11.3 (10.9 - 11.6) 32.7 (32.2 - 33.2) 33.7 (33.1 - 34.3) 
56-65 years 13.2 (12.8 - 13.6) 13.5 (13.1 - 14.0) 41.2 (40.6 - 41.9) 39.0 (38.3 - 39.6) 
>65 years 13.9 (13.4 - 14.4) 14.0 (13.5 - 14.5) 48.6 (47.9 - 49.3) 43.4 (42.7 - 44.2) 
Total population     
Crude 7.3 (7.1 - 7.4) 7.8 (7.6 - 8.0) 23.6 (23.3 - 23.8) 27.4 (27.0 - 27.7) 
Age-standardized2 6.1 (6.0 - 6.3) 6.5 (6.4 - 6.7) 20.0 (19.7 - 20.3) 24.5 (24.2 - 24.9) 
a The diabetes prevalence shown in this table assumes all AHS participants were fasted at the time of the blood 
glucose measurement. eTable3 shows national diabetes prevalence assuming all AHS participants were unfasted.  
b Age-standardization was to the World Health Organization’s reference population.60   
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eTable3. National diabetes prevalence assuming all AHS 
respondents were unfasteda!
 
 Diabetes 
Age group Female Percent (95% CI) 
Male 
Percent (95% CI) 
18-25 years 2.1 (2.0 - 2.3) 1.8 (1.7 - 1.9) 
26-35 years 3.4 (3.2 - 3.5) 3.7 (3.5 - 3.8) 
36-45 years 5.8 (5.5 – 6.0) 6.0 (5.8 - 6.2) 
46-55 years 9.1 (8.8 - 9.5) 8.9 (8.6 - 9.2) 
56-65 years 10.5 (10.2 - 10.9) 10.6 (10.2 - 10.9) 
>65 years 10.6 (10.2 - 11.1) 10.3 (9.8 - 10.7) 
Total (crude) 5.9 (5.7 - 6.1) 6.1 (5.9 - 6.2) 
Total (age-standardized1) 5.0 (4.8 - 5.1) 5.1 (5.0 - 5.3) 
a Age-standardization was to the World Health Organization’s reference population.60   
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eFigure2. Hypertension prevalence by five-year age group for India 
and WHO/NCD-RisC regionsa,b,c 
a Data for ‘South Asia’, ‘Central & Eastern Europe’, ‘High-income Western’, and ‘World’ were extracted from Zhou 
et al.139 
b WHO/NCD-RisC estimates are for 2015. 
c The countries included in each world region are listed below.  
 
South Asia: Afghanistan, Bangladesh, Bhutan, India, Nepal, Pakistan 
 
Central and Eastern Europe 
Central Europe: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Czech 
Republic, Hungary, Macedonia (TFYR), Montenegro, Poland, Romania, Serbia, 
Slovakia, Slovenia 
Eastern Europe: Belarus, Estonia, Latvia, Lithuania, Moldova, Russian Federation, Ukraine 
 
High-income Western countries  
High-income English-speaking countries: Australia, Canada, Ireland, New 
Zealand, United Kingdom, United States of America 
North-Western Europe: Austria, Belgium, Denmark, Finland, Germany, Greenland, Iceland, Luxembourg, 
Netherlands, Norway, Sweden, Switzerland  
South-Western Europe: Andorra, Cyprus, France, Greece, Israel, Italy, Malta, 
Portugal, Spain 
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eFigure3. Prevalence of diabetes by rural versus urban residence, sex, and household 
wealth quintile assuming all AHS respondents were unfasted 
!
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eFigure4. Prevalence of diabetes and hypertension by rural versus urban residence, sex, 
and education 
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eFigure5. Prevalence of diabetes by rural versus urban residence, sex, and education 
assuming all AHS respondents were unfasted 
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eTable4. Regression results for diabetes assuming all AHS 
participants were unfasteda,b  
 Diabetes 
Characteristic 
Rural Urban 
Difference in probabilityb  
(95% CI) P 
Difference in probabilityb 
(95% CI) P 
Age group     
18-25 years Ref.  Ref.  
26-35 years 1.28 (1.15 - 1.42) <0.001 2.54 (2.30 - 2.77) <0.001 
36-45 years 3.14 (2.97 - 3.31) <0.001 6.66 (6.34 - 6.98) <0.001 
46-55 years 5.35 (5.13 - 5.58) <0.001 11.12 (10.71 - 11.53) <0.001 
56-65 years 6.81 (6.55 - 7.08) <0.001 14.45 (13.95 - 14.95) <0.001 
>65 years 7.50 (7.19 - 7.81) <0.001 15.17 (14.58 - 15.75) <0.001 
Wealth quintile     
1 (poorest) Ref.  Ref.  
2 0.11 (-0.01 - 0.23) <0.067 0.84 (0.54 - 1.14) <0.001 
3 0.24 (0.08 - 0.40) <0.003 1.88 (1.53 - 2.22) <0.001 
4 0.72 (0.53 - 0.90) <0.001 2.67 (2.29 - 3.04) <0.001 
5 (richest) 2.32 (2.08 - 2.56) <0.001 3.32 (2.90 - 3.74) <0.001 
Education      
<Primary School Ref.  Ref.  
Primary School 0.49 (0.34 - 0.65) <0.001 0.67 (0.31 - 1.03) <0.001 
Middle School 0.37 (0.22 - 0.52) <0.001 0.54 (0.21 - 0.87) 0.001 
Secondary School 0.18 (0.00 - 0.37) 0.050 0.41 (0.08 - 0.75) 0.016 
High School -0.76 (-0.96 - -0.56) 0.001 -0.49 (-0.84 - -0.14) 0.006 
>High School -1.11 (-1.36 - -0.85) 0.001 -1.38 (-1.74 - -1.02) <0.001 
Currently married  -0.26 (-0.40 - -0.13) <0.001 0.21 (-0.04 - 0.46) 0.197 
Male  0.25 (0.16 - 0.35) <0.001 0.56 (0.37 - 0.74) <0.001 
Abbreviations: Coeff.=Coefficient; CI=Confidence Interval; Ref.=Reference category.  
a These linear probability models included all socio-demographic variables listed in the table (age group, wealth 
quintile, education, marital status, and sex) and a binary indicator for each PSU (PSU-level fixed effects). Standard 
errors were adjusted for clustering at the PSU level.  
b These regressions coefficients should be interpreted as the average absolute difference (in percentage points) in the 
probability of having diabetes (compared to the reference category). 
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eTable5. Regression results for diabetes among those in whom 
fasting status could be ascertained (i.e., DLHS-4 participants only)a,b  
 
 Diabetes 
Characteristic 
Rural Urban 
Difference in probabilityb  
(95% CI) P 
Difference in probabilityb 
(95% CI) P 
Age group     
18-25 years Ref.  Ref.  
26-35 years 1.88 (1.69 - 2.06) <0.001 3.19 (2.93 - 3.45) <0.001 
36-45 years 5.22 (4.96 - 5.48) <0.001 8.53 (8.21 - 8.86) <0.001 
46-55 years 8.97 (8.62 - 9.31) <0.001 14.13 (13.65 - 14.61) <0.001 
56-65 years 11.55 (11.16 - 11.94) <0.001 18.32 (17.81 - 18.83) <0.001 
>65 years 13.08 (12.58 - 13.57) <0.001 19.84 (19.00 - 20.68) <0.001 
Wealth quintile     
1 (poorest) Ref.  Ref.  
2 0.76 (0.34 - 1.18) <0.001 1.61 (1.19 - 2.04) <0.001 
3 1.46 (1.02 - 1.91) <0.001 2.63 (2.16 - 3.09) <0.001 
4 2.68 (2.23 - 3.14) <0.001 2.60 (2.13 - 3.06) <0.001 
5 (richest) 3.44 (2.93 - 3.96) <0.001 1.74 (1.26 - 2.22) <0.001 
Education      
<Primary School Ref.  Ref.  
Primary School 0.86 (0.57 - 1.16) <0.001 1.06 (0.53 - 1.58) <0.001 
Middle School 0.86 (0.62 - 1.10) <0.001 1.13 (0.68 - 1.58) <0.001 
Secondary School 1.17 (0.86 - 1.49) <0.001 1.35 (0.88 - 1.83) <0.001 
High School 0.06 (-0.24 - 0.36) 0.694 0.22 (-0.33 - 0.77) 0.430 
>High School 1.04 (0.71 - 1.36) <0.001 0.50 (-0.10 - 1.10) 0.102 
Currently married  0.32 (0.11 - 0.53) 0.003 0.64 (0.32 - 0.96) <0.001 
Male  -0.06 (-0.22 - 0.10) 0.435 0.12 (-0.06 - 0.30) 0.183 
Abbreviations: Coeff.=Coefficient; CI=Confidence Interval; Ref.=Reference category.  
a These linear probability models included all socio-demographic variables listed in the table (age group, wealth 
quintile, education, marital status, and sex) and a binary indicator for each PSU (PSU-level fixed effects). Standard 
errors were adjusted for clustering at the PSU level.  
b These regressions coefficients should be interpreted as the average absolute difference (in percentage points) in the 
probability of having diabetes (compared to the reference category). 
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eFigure6. The predicted probability of diabetes by age group, rural-
urban location, and household wealth quintile assuming AHS 
participants were unfasteda 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
a Predicted probabilities were obtained from multivariable logistic regressions of diabetes on 
individuals’ socio-demographic characteristics (age group, household wealth quintile, education, 
marital status, sex, and rural-urban location), district-level fixed effects (i.e., a binary indicator 
for each district), and an interaction term between age group and household wealth quintile.  
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eFigure7. The predicted probability of diabetes by age group, rural-
urban location, and household wealth quintile among those in whom 
fasting status could be ascertained (i.e., DLHS-4 participants only)a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Predicted probabilities were obtained from multivariable logistic regressions of diabetes on 
individuals’ socio-demographic characteristics (age group, household wealth quintile, education, 
marital status, sex, and rural-urban location), district-level fixed effects (i.e., a binary indicator 
for each district), and an interaction term between age group and household wealth quintile.  
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eTable6. State-level age-standardized diabetes and hypertension prevalence estimates by 
sex  
 
State Sex 
Diabetes Hypertension 
Estimate Lower 95% CI 
Upper 
95% CI Estimate 
Lower 
95% CI 
Upper 
95% CI 
Andaman and Nicobar Female 7.96 6.49 9.72 26.34 23.35 29.57 
Andaman and Nicobar Male 8.57 6.69 10.92 37.16 34.18 40.25 
Andhra Pradesh Female 8.90 8.36 9.48 20.69 20.01 21.40 
Andhra Pradesh Male 9.43 8.86 10.03 28.26 27.34 29.20 
Arunachal Pradesh Female 4.50 3.47 5.81 21.42 19.84 23.10 
Arunachal Pradesh Male 4.33 3.33 5.61 27.69 26.39 29.04 
Assam Female 3.36 2.93 3.85 16.82 15.17 18.62 
Assam Male 3.92 3.38 4.55 21.26 19.47 23.16 
Bihar Female 2.39 2.02 2.82 20.82 19.37 22.34 
Bihar Male 3.06 2.64 3.53 20.24 19.00 21.53 
Chandigarh Female 9.75 7.79 12.14 31.30 28.14 34.65 
Chandigarh Male 10.56 8.75 12.69 41.75 38.21 45.37 
Chhattisgarh Female 3.62 3.08 4.25 13.50 12.19 14.93 
Chhattisgarh Male 5.30 4.49 6.24 17.12 15.69 18.64 
Daman and Diu Female 9.71 7.22 12.95 36.28 31.77 41.04 
Daman and Diu Male 6.72 4.32 10.32 43.53 38.33 48.87 
Goa Female 16.37 14.20 18.79 26.37 22.99 30.04 
Goa Male 17.90 15.37 20.74 32.90 29.09 36.95 
Haryana Female 5.52 5.20 5.85 20.33 19.74 20.93 
Haryana Male 5.53 5.20 5.87 28.10 27.38 28.82 
Himachal Pradesh Female 3.31 2.91 3.76 30.79 29.60 32.00 
Himachal Pradesh Male 3.26 2.83 3.76 38.53 37.07 40.02 
Jharkhand Female 3.08 2.59 3.66 18.81 17.48 20.23 
Jharkhand Male 3.85 3.28 4.52 24.72 22.80 26.75 
Karnataka Female 9.38 8.99 9.77 21.01 20.60 21.42 
Karnataka Male 10.17 9.74 10.61 25.45 24.89 26.02 
Kerala Female 11.76 10.79 12.82 32.98 31.28 34.72 
Kerala Male 14.43 13.15 15.81 41.35 39.25 43.47 
Madhya Pradesh Female 2.33 1.98 2.75 16.67 15.65 17.74 
Madhya Pradesh Male 2.75 2.25 3.34 19.87 18.64 21.15 
Maharashtra Female 5.13 4.83 5.44 21.76 21.18 22.35 
Maharashtra Male 5.58 5.26 5.93 28.17 27.42 28.92 
Manipur Female 7.39 6.72 8.14 17.59 16.52 18.72 
Manipur Male 7.94 7.23 8.70 25.69 24.27 27.16 
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Meghalaya Female 2.87 2.28 3.60 18.27 16.77 19.89 
Meghalaya Male 2.97 2.33 3.77 22.91 20.91 25.03 
Mizoram Female 3.45 3.01 3.95 14.82 13.97 15.72 
Mizoram Male 3.59 3.17 4.07 24.54 23.33 25.78 
Nagaland Female 5.58 5.03 6.18 31.78 30.15 33.44 
Nagaland Male 6.43 5.80 7.13 39.59 37.84 41.37 
NCT of Delhi Female 9.41 8.69 10.18 22.41 20.96 23.94 
NCT of Delhi Male 9.47 8.78 10.21 27.94 26.36 29.59 
Odisha Female 2.87 2.63 3.13 15.56 14.47 16.72 
Odisha Male 3.65 3.35 3.97 17.24 15.93 18.63 
Puducherry Female 15.50 14.38 16.68 17.62 16.58 18.71 
Puducherry Male 16.33 14.96 17.80 27.33 25.66 29.06 
Punjab Female 7.23 6.89 7.59 29.43 28.82 30.04 
Punjab Male 6.79 6.44 7.16 41.38 40.61 42.16 
Rajasthan Female 2.76 2.41 3.16 16.47 15.42 17.58 
Rajasthan Male 3.04 2.67 3.47 23.68 22.11 25.33 
Sikkim Female 5.21 4.42 6.14 30.44 28.71 32.23 
Sikkim Male 4.99 4.29 5.79 36.18 34.09 38.32 
Tamil Nadu Female 14.89 14.44 15.36 18.84 18.44 19.24 
Tamil Nadu Male 15.88 15.40 16.38 27.69 27.13 28.25 
Telangana Female 7.57 6.86 8.35 19.62 18.68 20.59 
Telangana Male 8.47 7.66 9.35 26.52 25.36 27.72 
Tripura Female 8.99 7.81 10.33 18.81 17.18 20.56 
Tripura Male 9.89 8.62 11.33 22.41 20.41 24.55 
Uttar Pradesh Female 3.16 2.84 3.52 18.17 17.11 19.28 
Uttar Pradesh Male 3.41 3.01 3.86 20.53 19.14 21.98 
Uttarakhand Female 3.86 2.78 5.34 22.28 19.92 24.83 
Uttarakhand Male 4.07 3.26 5.07 32.24 29.44 35.17 
West Bengal Female 9.33 8.74 9.96 21.03 20.29 21.78 
West Bengal Male 9.98 9.36 10.64 22.62 21.77 23.49 
 
Abbreviation: CI=Confidence interval.  
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eTable7. State-level age-standardized diabetes and hypertension prevalence estimates by 
rural versus urban location  
 
State 
Rural 
or 
urban 
Diabetes Hypertension 
Estimate Lower 95% CI 
Upper 
95% CI Estimate 
Lower 
95% CI 
Upper 
95% CI 
Andaman and Nicobar Rural 8.45 6.46 10.99 33.21 30.15 36.42 
Andaman and Nicobar Urban 7.88 5.86 10.51 28.17 23.53 33.32 
Andhra Pradesh Rural 7.97 7.40 8.58 23.04 22.26 23.85 
Andhra Pradesh Urban 12.12 11.29 13.01 26.86 25.70 28.05 
Arunachal Pradesh Rural 3.28 2.85 3.78 24.76 23.66 25.89 
Arunachal Pradesh Urban 6.43 4.38 9.34 23.61 20.91 26.55 
Assam Rural 3.42 2.94 3.96 18.31 16.83 19.89 
Assam Urban 4.86 3.56 6.59 22.47 19.01 26.35 
Bihar Rural 2.50 2.13 2.94 20.17 18.90 21.50 
Bihar Urban 4.16 3.05 5.65 23.99 21.26 26.96 
Chandigarh Rural 11.08 7.08 16.94 37.09 34.20 40.07 
Chandigarh Urban 9.86 8.14 11.91 36.30 32.80 39.95 
Chhattisgarh Rural 3.74 3.16 4.43 14.66 13.21 16.24 
Chhattisgarh Urban 6.87 5.32 8.84 17.72 15.39 20.31 
Daman and Diu Rural 9.40 6.73 12.97 36.04 32.24 40.02 
Daman and Diu Urban 2.25 1.17 4.29 62.71 54.71 70.07 
Goa Rural 17.39 15.11 19.93 31.68 28.56 34.98 
Goa Urban 16.83 13.81 20.35 27.76 22.81 33.33 
Haryana Rural 5.21 4.86 5.58 22.66 21.97 23.36 
Haryana Urban 6.08 5.63 6.56 26.32 25.40 27.27 
Himachal Pradesh Rural 3.28 2.91 3.70 33.75 32.68 34.84 
Himachal Pradesh Urban 3.35 2.49 4.50 35.52 31.06 40.25 
Jharkhand Rural 2.80 2.30 3.40 19.95 18.22 21.80 
Jharkhand Urban 5.55 4.56 6.74 26.18 24.50 27.93 
Karnataka Rural 8.46 8.03 8.92 20.73 20.27 21.19 
Karnataka Urban 11.68 11.08 12.31 26.46 25.83 27.09 
Kerala Rural 11.81 10.28 13.52 38.81 36.11 41.58 
Kerala Urban 14.21 12.86 15.69 34.04 31.77 36.39 
Madhya Pradesh Rural 2.02 1.70 2.41 17.39 16.30 18.54 
Madhya Pradesh Urban 3.54 2.62 4.77 20.19 18.16 22.39 
Maharashtra Rural 4.68 4.33 5.07 23.51 22.75 24.28 
Maharashtra Urban 6.17 5.73 6.64 26.14 25.20 27.11 
Manipur Rural 7.45 6.74 8.23 20.42 19.15 21.74 
Manipur Urban 8.01 6.94 9.23 22.99 20.94 25.18 
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Meghalaya Rural 2.75 2.14 3.52 19.25 17.56 21.08 
Meghalaya Urban 3.48 2.29 5.24 22.87 19.75 26.32 
Mizoram Rural 3.01 2.54 3.58 18.21 17.00 19.47 
Mizoram Urban 3.94 3.39 4.56 20.63 19.44 21.88 
Nagaland Rural 5.86 5.25 6.54 35.90 34.14 37.70 
Nagaland Urban 6.29 5.37 7.36 34.78 31.78 37.91 
NCT of Delhi Rural 9.86 8.51 11.40 23.62 20.34 27.26 
NCT of Delhi Urban 9.35 8.67 10.07 25.64 24.08 27.28 
Odisha Rural 2.94 2.71 3.18 15.70 14.46 17.02 
Odisha Urban 4.98 4.26 5.81 20.16 17.67 22.91 
Puducherry Rural 15.81 13.62 18.27 18.45 16.40 20.69 
Puducherry Urban 15.87 14.70 17.12 23.09 22.01 24.21 
Punjab Rural 6.75 6.36 7.17 35.46 34.71 36.23 
Punjab Urban 7.49 7.00 8.01 34.38 33.44 35.34 
Rajasthan Rural 2.43 2.09 2.83 18.32 17.31 19.37 
Rajasthan Urban 4.78 3.96 5.76 26.05 22.34 30.13 
Sikkim Rural 5.12 4.37 5.99 32.26 30.52 34.05 
Sikkim Urban 5.07 3.96 6.48 35.44 31.98 39.06 
Tamil Nadu Rural 13.28 12.75 13.83 21.26 20.74 21.78 
Tamil Nadu Urban 17.50 16.91 18.10 24.28 23.71 24.85 
Telangana Rural 7.41 6.47 8.48 21.43 20.28 22.61 
Telangana Urban 9.01 8.09 10.01 25.50 24.01 27.04 
Tripura Rural 9.20 7.90 10.68 18.35 16.64 20.19 
Tripura Urban 10.00 7.83 12.70 26.33 23.02 29.93 
Uttar Pradesh Rural 2.85 2.48 3.28 18.93 17.56 20.37 
Uttar Pradesh Urban 4.59 3.98 5.30 20.34 18.44 22.40 
Uttarakhand Rural 3.06 2.14 4.37 25.11 21.83 28.70 
Uttarakhand Urban 6.13 4.50 8.28 30.34 27.68 33.13 
West Bengal Rural 8.97 8.28 9.71 19.79 18.92 20.68 
West Bengal Urban 11.16 10.46 11.90 26.37 25.45 27.31 
 
Abbreviation: CI=Confidence interval.  
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eTable8. State-level crude diabetes and hypertension prevalence estimates by age group 
 
State Age (years) 
Diabetes Hypertension 
Estimate Lower 95% CI 
Upper 
95% CI Estimate 
Lower 
95% CI 
Upper 
95% CI 
Andaman and Nicobar 18-25 3.72 2.27 6.03 16.36 12.67 20.88 
Andaman and Nicobar 26-35 5.87 4.15 8.23 25.19 22.16 28.48 
Andaman and Nicobar 36-45 10.58 8.11 13.69 36.40 32.03 41.00 
Andaman and Nicobar 46-55 11.80 9.60 14.42 44.79 39.85 49.83 
Andaman and Nicobar 56-65 14.75 11.26 19.08 52.56 47.60 57.46 
Andaman and Nicobar >65 19.13 14.24 25.21 65.62 58.86 71.80 
Andhra Pradesh 18-25 2.80 2.37 3.32 10.43 9.71 11.20 
Andhra Pradesh 26-35 5.84 5.28 6.46 18.43 17.47 19.42 
Andhra Pradesh 36-45 11.81 10.95 12.72 27.73 26.59 28.89 
Andhra Pradesh 46-55 16.01 14.89 17.19 38.40 36.98 39.85 
Andhra Pradesh 56-65 19.55 18.25 20.92 47.28 45.65 48.91 
Andhra Pradesh >65 20.20 18.61 21.90 52.70 50.59 54.79 
Arunachal Pradesh 18-25 1.82 1.13 2.93 14.90 13.56 16.36 
Arunachal Pradesh 26-35 4.30 3.21 5.75 21.01 19.37 22.74 
Arunachal Pradesh 36-45 4.76 3.81 5.94 29.07 26.71 31.56 
Arunachal Pradesh 46-55 7.26 5.63 9.32 38.95 35.63 42.38 
Arunachal Pradesh 56-65 10.82 5.94 18.91 40.96 37.59 44.41 
Arunachal Pradesh >65 8.83 5.39 14.13 43.78 39.98 47.65 
Assam 18-25 1.05 0.70 1.57 7.63 6.70 8.67 
Assam 26-35 1.98 1.55 2.52 13.00 10.73 15.67 
Assam 36-45 4.31 3.58 5.19 20.95 19.32 22.68 
Assam 46-55 6.45 5.44 7.63 33.18 29.48 37.10 
Assam 56-65 9.18 7.85 10.70 39.04 35.45 42.75 
Assam >65 12.54 10.99 14.28 49.18 46.40 51.97 
Bihar 18-25 1.14 0.89 1.45 11.27 9.95 12.75 
Bihar 26-35 1.44 1.15 1.79 16.75 15.40 18.19 
Bihar 36-45 2.98 2.43 3.64 24.38 22.56 26.30 
Bihar 46-55 4.63 3.85 5.55 27.56 25.75 29.44 
Bihar 56-65 6.58 5.50 7.86 33.67 31.55 35.86 
Bihar >65 7.06 5.87 8.48 39.01 36.72 41.35 
Chandigarh 18-25 4.14 2.58 6.58 20.29 17.11 23.89 
Chandigarh 26-35 6.09 3.92 9.35 31.52 27.70 35.60 
Chandigarh 36-45 13.32 10.67 16.51 44.52 40.17 48.97 
Chandigarh 46-55 17.76 14.38 21.72 52.03 47.20 56.83 
Chandigarh 56-65 21.72 16.78 27.63 57.18 50.32 63.78 
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Chandigarh >65 21.91 15.28 30.40 61.94 51.86 71.09 
Chhattisgarh 18-25 2.07 1.60 2.68 7.77 6.67 9.03 
Chhattisgarh 26-35 2.84 2.27 3.53 10.34 9.28 11.52 
Chhattisgarh 36-45 4.90 4.02 5.95 17.65 15.99 19.44 
Chhattisgarh 46-55 7.81 6.48 9.37 24.83 22.42 27.41 
Chhattisgarh 56-65 11.53 9.43 14.03 33.10 29.80 36.57 
Chhattisgarh >65 10.95 8.96 13.33 38.20 35.10 41.40 
Daman and Diu 18-25 3.79 2.30 6.16 30.46 25.19 36.30 
Daman and Diu 26-35 7.33 3.64 14.23 33.10 28.49 38.06 
Daman and Diu 36-45 10.63 7.14 15.53 45.11 39.12 51.24 
Daman and Diu 46-55 16.59 11.39 23.53 51.61 44.41 58.74 
Daman and Diu 56-65 18.18 11.80 26.98 64.50 56.47 71.78 
Daman and Diu >65 17.26 9.49 29.35 57.15 47.62 66.17 
Goa 18-25 8.17 5.60 11.78 15.31 11.29 20.43 
Goa 26-35 12.77 10.35 15.65 22.68 18.75 27.16 
Goa 36-45 17.38 14.19 21.10 32.08 27.12 37.47 
Goa 46-55 25.10 21.31 29.30 40.33 36.01 44.81 
Goa 56-65 26.21 22.35 30.48 45.74 40.96 50.59 
Goa >65 41.02 35.72 46.53 51.06 45.42 56.66 
Haryana 18-25 2.84 2.55 3.16 15.49 14.75 16.25 
Haryana 26-35 4.40 4.02 4.80 20.43 19.67 21.20 
Haryana 36-45 6.37 5.92 6.86 27.97 27.08 28.88 
Haryana 46-55 9.32 8.67 10.01 34.50 33.44 35.58 
Haryana 56-65 11.15 10.41 11.93 40.44 39.23 41.67 
Haryana >65 11.78 10.83 12.79 47.68 46.22 49.15 
Himachal Pradesh 18-25 0.90 0.58 1.41 23.13 21.33 25.04 
Himachal Pradesh 26-35 1.74 1.32 2.28 27.59 26.04 29.19 
Himachal Pradesh 36-45 3.11 2.57 3.76 35.65 33.91 37.44 
Himachal Pradesh 46-55 5.71 4.87 6.67 42.40 40.41 44.41 
Himachal Pradesh 56-65 6.85 5.87 7.99 49.15 46.64 51.67 
Himachal Pradesh >65 8.45 7.10 10.04 52.81 49.92 55.68 
Jharkhand 18-25 0.55 0.33 0.90 10.82 9.27 12.58 
Jharkhand 26-35 1.63 1.21 2.19 15.33 13.72 17.09 
Jharkhand 36-45 4.14 3.43 4.99 24.34 22.62 26.15 
Jharkhand 46-55 7.47 6.33 8.80 34.43 32.20 36.73 
Jharkhand 56-65 9.82 8.09 11.86 43.79 40.98 46.63 
Jharkhand >65 9.82 8.15 11.80 49.53 46.59 52.49 
Karnataka 18-25 4.09 3.76 4.44 9.61 9.17 10.07 
Karnataka 26-35 6.50 6.12 6.90 16.94 16.39 17.51 
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Karnataka 36-45 11.93 11.36 12.53 27.87 27.18 28.58 
Karnataka 46-55 17.12 16.35 17.92 38.15 37.26 39.05 
Karnataka 56-65 19.76 18.83 20.73 46.10 45.05 47.15 
Karnataka >65 21.40 20.32 22.52 52.63 51.44 53.83 
Kerala 18-25 5.71 4.55 7.14 21.79 19.48 24.29 
Kerala 26-35 8.83 7.53 10.33 30.68 28.17 33.31 
Kerala 36-45 12.95 11.69 14.33 39.18 36.56 41.87 
Kerala 46-55 18.73 17.36 20.19 46.27 44.21 48.34 
Kerala 56-65 24.51 22.82 26.28 51.87 50.11 53.62 
Kerala >65 24.51 22.77 26.34 57.68 55.84 59.49 
Madhya Pradesh 18-25 0.92 0.69 1.22 11.01 9.74 12.42 
Madhya Pradesh 26-35 1.68 1.10 2.55 14.79 13.51 16.17 
Madhya Pradesh 36-45 2.67 2.31 3.08 19.54 18.30 20.84 
Madhya Pradesh 46-55 4.79 3.73 6.14 27.78 26.07 29.56 
Madhya Pradesh 56-65 6.59 5.59 7.76 35.28 33.44 37.17 
Madhya Pradesh >65 7.87 6.76 9.16 40.99 38.68 43.35 
Maharashtra 18-25 2.20 1.96 2.47 15.14 14.36 15.96 
Maharashtra 26-35 3.84 3.52 4.18 20.29 19.56 21.05 
Maharashtra 36-45 5.84 5.43 6.27 27.61 26.81 28.43 
Maharashtra 46-55 9.13 8.55 9.74 34.86 33.90 35.83 
Maharashtra 56-65 11.32 10.65 12.03 40.40 39.41 41.41 
Maharashtra >65 11.49 10.73 12.31 45.08 43.94 46.22 
Manipur 18-25 2.92 2.32 3.67 10.40 9.21 11.73 
Manipur 26-35 5.10 4.43 5.87 14.88 13.77 16.05 
Manipur 36-45 8.61 7.64 9.69 24.98 23.12 26.93 
Manipur 46-55 11.93 10.61 13.38 33.08 30.77 35.47 
Manipur 56-65 15.95 14.32 17.73 36.81 34.34 39.35 
Manipur >65 20.04 17.91 22.37 42.52 39.55 45.56 
Meghalaya 18-25 1.65 1.15 2.35 12.91 11.36 14.64 
Meghalaya 26-35 1.86 1.32 2.61 16.21 14.50 18.08 
Meghalaya 36-45 3.01 2.22 4.07 24.12 21.49 26.96 
Meghalaya 46-55 6.68 5.24 8.49 31.28 28.67 34.01 
Meghalaya 56-65 6.82 5.22 8.87 38.30 34.00 42.79 
Meghalaya >65 7.49 5.27 10.55 49.94 44.70 55.18 
Mizoram 18-25 1.41 1.07 1.85 12.68 11.51 13.95 
Mizoram 26-35 2.39 1.98 2.87 17.94 16.74 19.21 
Mizoram 36-45 4.24 3.52 5.11 21.32 19.83 22.88 
Mizoram 46-55 6.32 5.38 7.41 27.15 25.37 29.01 
Mizoram 56-65 7.33 6.08 8.80 30.37 28.05 32.79 
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Mizoram >65 12.51 10.58 14.74 38.19 35.55 40.90 
Nagaland 18-25 2.78 2.15 3.59 16.04 14.39 17.83 
Nagaland 26-35 4.33 3.63 5.16 26.54 24.74 28.41 
Nagaland 36-45 6.63 5.79 7.59 39.93 37.78 42.12 
Nagaland 46-55 8.37 7.37 9.48 48.43 46.24 50.63 
Nagaland 56-65 9.63 8.40 11.02 56.45 53.98 58.89 
Nagaland >65 11.48 9.99 13.16 62.25 59.73 64.71 
NCT of Delhi 18-25 3.81 3.26 4.45 17.15 15.36 19.11 
NCT of Delhi 26-35 7.33 6.54 8.21 22.35 20.66 24.12 
NCT of Delhi 36-45 13.23 12.06 14.50 29.59 27.76 31.48 
NCT of Delhi 46-55 16.32 14.86 17.89 35.87 33.76 38.04 
NCT of Delhi 56-65 19.44 17.40 21.67 42.00 39.49 44.56 
NCT of Delhi >65 23.70 20.26 27.52 47.32 43.37 51.31 
Odisha 18-25 0.54 0.39 0.76 6.51 5.60 7.55 
Odisha 26-35 1.36 1.16 1.61 10.46 9.34 11.69 
Odisha 36-45 3.25 2.91 3.63 17.16 15.74 18.67 
Odisha 46-55 6.70 6.04 7.42 25.67 23.94 27.49 
Odisha 56-65 8.40 7.58 9.30 34.47 32.63 36.36 
Odisha >65 8.83 8.00 9.73 42.25 40.44 44.09 
Puducherry 18-25 4.17 3.33 5.20 8.38 7.11 9.86 
Puducherry 26-35 10.98 9.66 12.45 13.41 11.98 14.98 
Puducherry 36-45 19.03 17.25 20.94 24.94 23.06 26.92 
Puducherry 46-55 25.62 23.49 27.86 33.26 31.28 35.31 
Puducherry 56-65 32.05 29.35 34.88 45.76 43.05 48.50 
Puducherry >65 32.87 29.65 36.25 53.32 49.78 56.82 
Punjab 18-25 2.62 2.36 2.90 19.80 19.04 20.57 
Punjab 26-35 4.73 4.36 5.13 29.13 28.32 29.96 
Punjab 36-45 8.18 7.68 8.71 42.00 41.06 42.95 
Punjab 46-55 13.01 12.30 13.75 52.64 51.61 53.66 
Punjab 56-65 16.40 15.55 17.29 59.68 58.57 60.77 
Punjab >65 17.80 16.73 18.93 64.64 63.34 65.91 
Rajasthan 18-25 1.19 0.93 1.53 10.15 9.02 11.39 
Rajasthan 26-35 1.66 1.33 2.07 14.83 13.78 15.94 
Rajasthan 36-45 3.09 2.63 3.63 21.96 20.36 23.64 
Rajasthan 46-55 5.17 4.51 5.92 30.52 28.78 32.33 
Rajasthan 56-65 7.36 6.41 8.42 40.32 37.90 42.80 
Rajasthan >65 8.55 7.45 9.80 47.25 44.91 49.60 
Sikkim 18-25 2.62 1.87 3.65 17.13 15.17 19.28 
Sikkim 26-35 3.10 2.47 3.89 29.13 26.70 31.69 
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Sikkim 36-45 6.43 5.20 7.94 39.39 36.73 42.12 
Sikkim 46-55 9.11 7.51 11.01 54.28 50.54 57.98 
Sikkim 56-65 12.76 10.52 15.40 52.34 48.15 56.50 
Sikkim >65 10.83 8.44 13.79 56.32 52.01 60.54 
Tamil Nadu 18-25 5.20 4.78 5.65 9.58 9.09 10.10 
Tamil Nadu 26-35 10.59 10.09 11.12 16.53 15.97 17.10 
Tamil Nadu 36-45 18.14 17.49 18.79 25.19 24.53 25.88 
Tamil Nadu 46-55 25.41 24.59 26.25 35.22 34.40 36.05 
Tamil Nadu 56-65 29.48 28.50 30.48 43.89 42.89 44.89 
Tamil Nadu >65 29.60 28.43 30.80 49.64 48.40 50.87 
Telangana 18-25 3.83 2.97 4.92 12.87 11.67 14.17 
Telangana 26-35 5.91 5.12 6.80 19.31 18.22 20.45 
Telangana 36-45 9.64 8.69 10.67 28.15 26.62 29.72 
Telangana 46-55 14.39 13.02 15.88 33.76 31.88 35.70 
Telangana 56-65 15.22 13.76 16.80 39.58 37.50 41.71 
Telangana >65 17.55 15.56 19.73 44.65 41.60 47.74 
Tripura 18-25 4.24 3.27 5.48 11.57 9.89 13.49 
Tripura 26-35 6.69 5.42 8.25 17.42 15.43 19.62 
Tripura 36-45 11.52 9.71 13.60 23.38 21.09 25.84 
Tripura 46-55 16.46 14.15 19.07 30.23 27.24 33.40 
Tripura 56-65 19.27 16.46 22.43 36.11 31.94 40.50 
Tripura >65 24.51 20.70 28.77 46.95 43.11 50.83 
Uttar Pradesh 18-25 1.21 0.94 1.56 11.88 10.63 13.25 
Uttar Pradesh 26-35 1.91 1.60 2.27 15.11 13.79 16.53 
Uttar Pradesh 36-45 3.55 3.09 4.07 22.20 20.79 23.69 
Uttar Pradesh 46-55 6.73 5.97 7.58 27.53 25.91 29.21 
Uttar Pradesh 56-65 7.26 6.43 8.20 32.38 30.50 34.32 
Uttar Pradesh >65 7.84 6.97 8.81 37.63 35.57 39.73 
Uttarakhand 18-25 1.11 0.44 2.78 13.01 10.42 16.14 
Uttarakhand 26-35 1.47 0.84 2.56 20.60 17.84 23.67 
Uttarakhand 36-45 4.72 3.51 6.30 29.24 26.30 32.36 
Uttarakhand 46-55 6.43 4.93 8.35 40.29 36.21 44.51 
Uttarakhand 56-65 12.19 9.76 15.13 48.48 43.98 53.01 
Uttarakhand >65 10.91 8.37 14.10 54.20 49.81 58.52 
West Bengal 18-25 4.70 4.17 5.29 9.58 8.87 10.33 
West Bengal 26-35 7.58 6.92 8.30 16.24 15.34 17.17 
West Bengal 36-45 11.11 10.35 11.91 25.54 24.43 26.68 
West Bengal 46-55 15.47 14.36 16.65 34.76 33.45 36.10 
West Bengal 56-65 17.06 15.87 18.31 42.98 41.35 44.62 
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West Bengal >65 20.26 18.72 21.88 51.22 49.23 53.20 
!! 115 
eTable9. State-level age-standardized diabetes prevalence estimates by sex assuming all 
AHS respondents were unfasted  
 
State Sex 
Diabetes 
Estimate Lower 95% CI 
Upper 
95% CI 
Assam Female 0.47 0.35 0.63 
Assam Male 0.50 0.36 0.68 
Bihar Female 0.25 0.19 0.34 
Bihar Male 0.38 0.28 0.50 
Chhattisgarh Female 0.21 0.14 0.31 
Chhattisgarh Male 0.47 0.33 0.65 
Jharkhand Female 0.82 0.62 1.07 
Jharkhand Male 1.16 0.90 1.50 
Madhya Pradesh Female 0.34 0.28 0.42 
Madhya Pradesh Male 0.47 0.36 0.63 
Odisha Female 0.70 0.61 0.80 
Odisha Male 0.87 0.74 1.01 
Rajasthan Female 0.40 0.33 0.48 
Rajasthan Male 0.37 0.30 0.45 
Uttar Pradesh Female 0.69 0.59 0.80 
Uttar Pradesh Male 0.65 0.54 0.78 
Uttarakhand Female 1.03 0.74 1.43 
Uttarakhand Male 0.96 0.68 1.35 
 
Abbreviation: CI=Confidence interval. 
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eTable10. State-level age-standardized diabetes prevalence estimates by rural versus urban 
location assuming all AHS respondents were unfasted  
!
 
State Rural or urban 
Diabetes 
Estimate Lower 95% CI Upper 95% CI 
Assam Rural 0.42 0.31 0.57 
Assam Urban 0.86 0.52 1.44 
Bihar Rural 0.27 0.21 0.36 
Bihar Urban 0.58 0.35 0.96 
Chhattisgarh Rural 0.26 0.17 0.40 
Chhattisgarh Urban 0.62 0.45 0.86 
Jharkhand Rural 0.67 0.52 0.87 
Jharkhand Urban 1.99 1.40 2.84 
Madhya Pradesh Rural 0.26 0.21 0.33 
Madhya Pradesh Urban 0.69 0.51 0.92 
Odisha Rural 0.65 0.57 0.73 
Odisha Urban 1.57 1.24 1.98 
Rajasthan Rural 0.28 0.23 0.34 
Rajasthan Urban 0.80 0.63 1.00 
Uttar Pradesh Rural 0.48 0.41 0.57 
Uttar Pradesh Urban 1.24 1.02 1.50 
Uttarakhand Rural 0.76 0.53 1.09 
Uttarakhand Urban 1.57 1.02 2.43 
 
Abbreviation: CI=Confidence interval!
!
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eTable11. State-level crude diabetes prevalence estimates by age group assuming all AHS 
respondents were unfasted 
 
State Age (years) 
Diabetes 
Estimate Lower 95% CI Upper 95% CI 
Assam 18-25 0.05 0.02 0.12 
Assam 26-35 0.17 0.07 0.40 
Assam 36-45 0.61 0.42 0.88 
Assam 46-55 0.87 0.62 1.22 
Assam 56-65 1.67 1.27 2.20 
Assam >65 1.73 1.20 2.48 
Bihar 18-25 0.03 0.01 0.13 
Bihar 26-35 0.08 0.04 0.15 
Bihar 36-45 0.35 0.25 0.51 
Bihar 46-55 0.69 0.48 0.99 
Bihar 56-65 1.02 0.74 1.41 
Bihar >65 1.04 0.73 1.50 
Chhattisgarh 18-25 0.09 0.03 0.26 
Chhattisgarh 26-35 0.13 0.07 0.26 
Chhattisgarh 36-45 0.23 0.13 0.40 
Chhattisgarh 46-55 0.95 0.61 1.47 
Chhattisgarh 56-65 1.28 0.77 2.12 
Chhattisgarh >65 0.94 0.54 1.64 
Jharkhand 18-25 0.06 0.02 0.25 
Jharkhand 26-35 0.40 0.21 0.74 
Jharkhand 36-45 1.06 0.75 1.50 
Jharkhand 46-55 2.44 1.80 3.31 
Jharkhand 56-65 3.18 2.34 4.30 
Jharkhand >65 2.44 1.73 3.45 
Madhya Pradesh 18-25 0.12 0.07 0.21 
Madhya Pradesh 26-35 0.16 0.11 0.23 
Madhya Pradesh 36-45 0.46 0.35 0.62 
Madhya Pradesh 46-55 0.78 0.60 1.03 
Madhya Pradesh 56-65 1.59 0.91 2.75 
Madhya Pradesh >65 0.89 0.65 1.22 
Odisha 18-25 0.09 0.04 0.19 
Odisha 26-35 0.25 0.18 0.35 
Odisha 36-45 0.94 0.77 1.17 
Odisha 46-55 1.82 1.53 2.16 
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Odisha 56-65 1.82 1.52 2.17 
Odisha >65 1.38 1.09 1.74 
Rajasthan 18-25 0.03 0.01 0.09 
Rajasthan 26-35 0.14 0.08 0.24 
Rajasthan 36-45 0.36 0.26 0.50 
Rajasthan 46-55 1.05 0.80 1.37 
Rajasthan 56-65 1.17 0.91 1.50 
Rajasthan >65 1.53 1.09 2.14 
Uttar Pradesh 18-25 0.08 0.04 0.14 
Uttar Pradesh 26-35 0.18 0.12 0.26 
Uttar Pradesh 36-45 0.82 0.64 1.04 
Uttar Pradesh 46-55 1.75 1.43 2.14 
Uttar Pradesh 56-65 1.96 1.57 2.43 
Uttar Pradesh >65 1.29 1.00 1.67 
Uttarakhand 18-25 0.25 0.04 1.38 
Uttarakhand 26-35 0.16 0.05 0.52 
Uttarakhand 36-45 1.09 0.65 1.82 
Uttarakhand 46-55 1.70 1.08 2.66 
Uttarakhand 56-65 3.98 2.78 5.69 
Uttarakhand >65 2.91 1.99 4.25 
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eFigure8. Association of the state- and district-level age-
standardized prevalence of diabetes with mean household wealth 
quintilea,b 
 
 
a p-values refer to the statistical significance of the linear (ordinary least squares) regression line (shown in grey).  
b States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
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Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal. 
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eFigure9. Predicted probability of diabetes from a multilevel linear 
probability model1!!!
!
!
1 These predicted probabilities were obtained from a multilevel linear probability model with age (group-mean 
centered and normalized), sex, rural-urban location, household wealth quintile, and education as level 1 variables, 
and district-level mean household wealth quintile (grand-mean centered) as level 2 variable. The model included a 
random intercept at the level of the district and random slopes for household wealth quintile.    
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eFigure10. Association of the state- and district-level age-
standardized prevalence of hypertension with mean household 
wealth quintilea,b 
 
 
a p-values refer to the statistical significance of the linear (ordinary least squares) regression line (shown in grey).  
b States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
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Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal.  
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eFigure11. Predicted probability of hypertension from a multilevel linear 
probability model1   
!
!
1 These predicted probabilities were obtained from a multilevel linear probability model with age (group-mean 
centered and normalized), sex, rural-urban location, household wealth quintile, and education as level 1 variables, 
and district-level mean household wealth quintile (grand-mean centered) as level 2 variable. The model included a 
random intercept at the level of the district and random slopes for household wealth quintile.    
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eFigure12. Comparison of age-standardized national diabetes prevalence 
reported in different studiesa,b 
 
 
 
Abbreviations: NCD-RisC = NCD Risk Factor Collaboration; IDF = International Diabetes 
Federation!!
a The NCD-RisC estimate is for 2014 and the IDF estimate for 2015.83,120 
b The horizontal bar is a 95% confidence interval (AHS & DLHS-4) or a 95% uncertainty 
interval (NCD-RisC and IDF). 
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eMethods5. Matching AHS biomarker data to participants’ sociodemographic 
data  
 
AHS data in the public domain does not have a unique identifier that allows for merging of the ‘laboratory dataset’, 
which contains height, weight, blood pressure, and blood glucose measurements, to the dataset that contains 
respondents’ full sociodemographic and treatment information. We thus merged these datasets using an indicator 
composed of the state, district, stratum (indicating rural versus urban location and village size), a household 
identifier that is unique within each PSU, and a household member serial number given during data entry as well as 
one assigned after data entry.  
 
415,728 out of 661,141 (62.9%) non-pregnant adults aged 30 to 74 years in the laboratory dataset were successfully 
matched to their corresponding sociodemographic and treatment information. As detailed in the tables below, 
participants who were not matched had similar characteristics as those who were matched.   
 
Across all nine AHS states: 
Variable Matched Not matched 
n= 415,728 n=245,413 
Male (%) 49.8 49.0 
Age (mean ± SD) 46.5±11.7 47.1±12.3 
Glucose (mean ± SD) 99.0±21.3 99.2±21.6 
Diabetes (%) 4.6 4.6 
Systolic BP (mean ± SD) 125.4±19.3 125.6±19.9 
BMI (mean ± SD) 21.2±3.7 21.2±3.7 
Urban (%) 19.3 18.3 
Abbreviations: SD=standard deviation 
 
 
Assam: 
Variable Matched Not matched 
n=44,479 n=13,132 
Male (%) 51.3 47.1 
Age (mean ± SD) 45.4±11.2 45.6±12.0 
Glucose (mean ± SD) 99.8±21.0 99.8±21.2 
Diabetes (%) 5.2 5.4 
Systolic BP (mean ± SD) 128.1±18.0 127.2±18.4 
BMI (mean ± SD) 21.5±3.3 21.1±3.5 
Urban (%) 17.1 23.1 
Abbreviations: SD=standard deviation 
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Bihar: 
Variable Matched Not matched 
n=49,213  n=45,723  
Male (%) 48.4 53.5 
Age (mean ± SD) 46.4±11.8 46.6±12.3 
Glucose (mean ± SD) 97.0±18.9 95.2±18.4 
Diabetes (%) 3.9 3.4 
Systolic BP (mean ± SD) 125.4±19.0 123.8±18.3 
BMI (mean ± SD) 20.7±3.1 20.9±3.1 
Urban (%) 9.9 8.3 
Abbreviations: SD=standard deviation 
 
 
Chhattisgarh: 
Variable Matched Not matched 
n=26,035 n= 12,185 
Male (%) 51.0 49.2 
Age (mean ± SD) 45.8±11.3 46.5±12.0 
Glucose (mean ± SD) 100.5±18.2 101.2±21.1 
Diabetes (%) 5.5 6.6 
Systolic BP (mean ± SD) 125.2±17.1 126.1±17.8 
BMI (mean ± SD) 21.2±3.3 21.3±3.4 
Urban (%) 19.4 23.2 
Abbreviations: SD=standard deviation 
 
 
Jharkhand: 
Variable Matched Not matched 
n=24,645 n=11,255  
Male (%) 44.5 45.0 
Age (mean ± SD) 46.3±11.7 47.3±12.3 
Glucose (mean ± SD) 96.9±24.9 96.6±22.5 
Diabetes (%) 5.1 4.7 
Systolic BP (mean ± SD) 125.6±20.7 126.7±21.0 
BMI (mean ± SD) 21.2±4.1 21.2±3.9 
Urban (%) 17.5 22.7 
Abbreviations: SD=standard deviation 
 
 
Madhya Pradesh: 
Variable Matched Not matched 
n=67,506 n=37,172  
Male (%) 53.2 52.1 
Age (mean ± SD) 46.0±11.7 46.7±12.2 
Glucose (mean ± SD) 97.9±19.2 98.0±18.6 
Diabetes (%) 3.7 3.5 
Systolic BP (mean ± SD) 126.3±18.2 126.7±17.9 
BMI (mean ± SD) 21.2±3.2 21.2±3.3 
Urban (%) 32.6 29.2 
Abbreviations: SD=standard deviation 
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Odisha: 
Variable Matched Not matched 
n=65,511 n=12,034  
Male (%) 49.2 45.6 
Age (mean ± SD) 47.0±11.8 47.9±12.3 
Glucose (mean ± SD) 98.7±23.5 99.0±24.5 
Diabetes (%) 5.0 5.2 
Systolic BP (mean ± SD) 122.7±20.2 123.4±20.7 
BMI (mean ± SD) 21.2±4.0 21.3±4.1 
Urban (%) 14.0 13.8 
Abbreviations: SD=standard deviation 
 
 
Rajasthan: 
Variable Matched Not matched 
n=55,928 n=13,682  
Male (%) 47.8 46.3 
Age (mean ± SD) 46.6±11.7 47.3±12.5 
Glucose (mean ± SD) 100.1±20.1 100.2±19.9 
Diabetes (%) 4.4 4.3 
Systolic BP (mean ± SD) 124.8±19.0 125.4±19.5 
BMI (mean ± SD) 21.4±4.0 21.4±4.1 
Urban (%) 17.6 17.7 
Abbreviations: SD=standard deviation 
 
 
Uttar Pradesh: 
Variable Matched Not matched 
n=68,497 n=88,121  
Male (%) 50.7 47.9 
Age (mean ± SD) 47.0±11.9 47.6±12.5 
Glucose (mean ± SD) 100.9±22.0 101.1±22.9 
Diabetes (%) 4.8 4.9 
Systolic BP (mean ± SD) 124.9±20.6 125.8±21.4 
BMI (mean ± SD) 21.2±3.9 21.0±3.9 
Urban (%) 20.7 17.3 
Abbreviations: SD=standard deviation 
 
 
Uttarakhand: 
Variable Matched Not matched 
n=13,914 n=12,109  
Male (%) 46.3 42.2 
Age (mean ± SD) 48.0±12.1 47.7±12.3 
Glucose (mean ± SD) 100.1±24.4 103.2±26.8 
Diabetes (%) 5.6 5.6 
Systolic BP (mean ± SD) 129.6±19.7 127.2±20.9 
BMI (mean ± SD) 22.9±4.0 22.7±4.3 
Urban (%) 21.7 21.2 
Abbreviations: SD=standard deviation 
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eTable12. Outcomes predicted by each cardiovascular risk score 
 Framingham21  Harvard-NHANES23 Globorisk22 WHO-ISH24 
Fatal 
outcomes 
•! Any coronary disease 
•! Stroke 
•! Any coronary disease 
•! Stroke 
•! Myocardial 
infarction 
•! Stroke 
•! Sudden cardiac 
death 
•! Myocardial 
infarction 
•! Stroke 
Non-
fatal 
outcomes 
•! Angina pectoris 
•! Coronary 
insufficiency 
•! Heart failure 
•! Myocardial 
infarction 
•! Peripheral artery 
disease 
•! Stroke 
•! Transient ischemic 
attack 
•! Congestive heart 
failure 
•! Coronary 
revascularization 
•! Myocardial infarction 
•! Stroke 
•! Myocardial 
infarction 
•! Stroke 
•! Myocardial 
infarction 
•! Stroke 
 
 
  
!! 130 
eFigure13. Histogram of Body Mass Index  
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eFigure14. Histogram of systolic blood pressure  
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eTable13. Characteristics of adults excluded from the analysis  
 
In total, 27.1% (296,822/1,094,754) of participants were excluded from the analysis because they had a missing 
value for at least one of the cardiovascular disease risk factors needed to compute a predicted cardiovascular risk 
(age, sex, Body Mass Index, blood glucose, smoking status, systolic blood pressure, and treatment for hypertension). 
The table below compares (by sex) the sampling characteristics of those who were excluded from the analysis with 
those who were included. 
 
Characteristic 
Female Male 
Included Excluded Included Excluded 
n 420,852 108,937 377,080 187,885 
     
Cardiovascular risk factors     
     
Age group (%)     
30-34 years 17.2 18.3 15.3 18.6 
35-39 years 17.0 16.5 15.0 16.5 
40-44 years 15.3 14.0 14.8 15.1 
45-49 years 13.2 11.6 13.4 12.9 
50-54 years 11.7 11.6 11.8 11.0 
55-59 years 8.8 8.9 9.6 8.6 
60-64 years 7.6 8.2 8.7 7.7 
65-69 years 5.6 6.3 6.7 5.5 
70-74 years 3.6 4.7 4.7 4.0 
     
Mean BMI in kg/m2 (SD)  22.6 (4.8) 22.5 (4.8) 22.3 (4.1) 22.1 (4.1) 
 
BMI (%)     
<18.5 kg/m2 17.3 17.6 15.7 16.8 
18.5-22.9 kg/m2 43.6 44.6 46.9 47.1 
23.0-24.9 kg/m2 15.1 15.0 17.2 17.2 
25.0-29.9 kg/m2 17.6 16.8 16.3 15.3 
!30.0 kg/m2 6.4 5.9 3.9 3.5 
     
Diabetes (%) 10.0 10.0 10.8 12.9 
     
Current smoking (%) 2.6 2.6 27.1 27.9 
     
Mean systolic BP in mmHg (SD) 126.7 (21.3) 126.4 (21.3) 129.1 (19.7) 128.6 (19.5) 
 
Systolic BP (%)     
<120 mmHg 40.1 40.1 31.4 31.6 
120 – 129 mmHg 22.1 22.4 24.6 24.9 
130 – 139 mmHg 15.7 15.9 20.0 21.1 
140 – 179 mmHg 19.4 19.2 21.9 20.6 
!180 mmHg 2.6 2.4 2.1 1.8 
     
Current treatment for hypertension 2.3 2.1 1.7 1.4 
     
Socio-demographic characteristics     
     
Educational attainment (%)     
!! 133 
<Primary School 56.4 57.1 34.1 30.6 
Primary School 12.1 11.2 13.6 12.3 
Middle School 12.0 11.5 16.2 16.2 
Secondary School 9.6 8.9 15.8 16.9 
High School 4.7 4.9 8.8 9.9 
>High School 5.3 6.3 11.5 14.0 
     
Urban area (%) 32.4 32.6 32.2 36.8 
     
Wealth quintile (%)     
1 (poorest) 21.6 17.4 21.0 15.2 
2 19.9 18.8 19.8 17.9 
3 19.1 20.0 19.1 20.4 
4 19.4 21.5 19.8 22.2 
5 (richest) 20.0 22.3 20.2 24.3 
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eTable14. Prevalence of high 10-year cardiovascular risk and mean risk, by age group 
 
 Percentage at high risk1 Mean risk 
Age 
Female 
(95% CI) 
Male 
(95% CI) 
Female 
(95% CI) 
Male 
(95% CI) 
30-34 years 0.0 (0.0, 0.0) 0.1 (0.0, 0.1) 3.9 (3.9, 3.9) 6.1 (6.1, 6.2) 
35-39 years 0.2 (0.2, 0.2) 0.8 (0.7, 0.9) 6.3 (6.3, 6.3) 10.1 (10.0, 10.2) 
40-44 years 1.5 (1.4, 1.6) 4.7 (4.4, 5.0) 9.7 (9.6, 9.7) 15.1 (15.0, 15.2) 
45-49 years 6.2 (5.9, 6.6) 18.1 (17.6, 18.7) 14.2 (14.1, 14.3) 21.6 (21.5, 21.8) 
50-54 years 14.8 (14.2, 15.3) 38.0 (37.1, 38.8) 19.5 (19.3, 19.7) 28.9 (28.7, 29.1) 
55-59 years 26.9 (26.2, 27.7) 60.3 (59.4, 61.1) 25.4 (25.1, 25.6) 37.1 (36.8, 37.4) 
60-64 years 43.7 (42.8, 44.6) 80.0 (79.3, 80.7) 32.2 (31.8, 32.5) 44.8 (44.5, 45.1) 
65-69 years 59.4 (58.5, 60.4) 91.5 (90.9, 92.0) 38.0 (37.7, 38.4) 51.9 (51.5, 52.2) 
70-74 years 73.1 (72.0, 74.1) 96.9 (96.6, 97.3) 44.3 (43.8, 44.7) 58.7 (58.3, 59.1) 
     
30-74 years 14.6 (14.4, 14.8) 31.7 (31.4, 32.0) 12.7 (12.7, 12.8) 21.4 (21.3, 21.6) 
50-74 years 36.1 (35.6, 36.5) 67.6 (67.1, 68.1) 28.7 (28.6, 28.9) 41.4 (41.2, 41.6) 
Abbreviation: CI=confidence interval. 
1 Defined as a 10-year cardiovascular risk !30% as computed with the Framingham risk score. 
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eTable15. Prevalence of a high 10-year cardiovascular risk (risk !30%) and mean risk as 
calculated by Harvard-NHANES and Globorisk 
 Harvard-NHANES Globorisk1 WHO-ISH2 
 Female 
(95% CI) 
Male 
(95% CI) 
Female 
(95% CI) 
Male 
(95% CI) 
Female 
(95% CI) 
Male 
(95% CI) 
 
% at high risk 
30-34 years 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) - - 0.0 (0.0, 0.1) 0.1 (0.1, 0.2) 
35-39 years 0.0 (0.0, 0.0) 0.1 (0.1, 0.1) - - 0.1 (0.1, 0.1) 0.2 (0.2, 0.3) 
40-44 years 0.0 (0.0, 0.1) 1.1 (1.0, 1.2) 0.0 (0.0, 0.0) 0.5 (0.4, 0.6) 0.2 (0.2, 0.3) 0.4 (0.3, 0.5) 
45-49 years 0.8 (0.7, 0.9) 6.9 (6.6, 7.3) 0.1 (0.1, 0.2) 1.7 (1.5, 1.9) 0.4 (0.3, 0.5) 0.8 (0.7, 0.9) 
50-54 years 5.4 (5.0, 5.8) 23.3 (22.7, 24.0) 0.7 (0.6, 0.8) 3.0 (2.8, 3.2) 3.0 (2.7, 3.2) 2.4 (2.2, 2.6) 
55-59 years 15.3 (14.8, 
15.9) 
47.7 (46.9, 
48.6) 1.9 (1.7, 2.1) 4.6 (4.2, 4.9) 4.2 (3.9, 4.5) 3.5 (3.2, 3.8) 
60-64 years 33.8 (33.0, 
34.7) 
73.8 (73.1, 
74.5) 4.4 (4.1, 4.7) 5.8 (5.4, 6.2) 8.6 (8.2, 9.1) 8.4 (8.0, 8.9) 
65-69 years 58.5 (57.5, 
59.5) 
91.2 (90.7, 
91.8) 6.9 (6.5, 7.4) 7.0 (6.6, 7.4) 9.5 (9.0, 10.0) 9.5 (9.0, 10.0) 
70-74 years 82.6 (81.7, 
83.5) 
98.0 (97.7, 
98.2) 
13.2 (12.4, 
13.9) 
11.0 (10.3, 
11.8) 
15.7 (14.9, 
16.5) 
11.0 (10.2, 
11.7) 
30-74 years 11.1 (10.9, 
11.2) 
26.1 (25.9, 
26.4) - - 2.6 (2.5, 2.7) 2.8 (2.7, 2.9) 
50-74 years 29.2 (28.8, 
29.6) 
59.4 (58.9, 
59.9) 3.9 (3.7, 4.0) 5.5 (5.3, 5.7) 6.7 (6.5, 6.8) 6.1 (5.9, 6.3) 
 
Mean risk 
(%) 
    
  
30-34 years 2.0 (2.0, 2.0) 4.0 (4.0, 4.0) - - - - 
35-39 years 3.7 (3.7, 3.7) 7.1 (7.0, 7.1) - - - - 
40-44 years 6.3 (6.2, 6.3) 11.3 (11.2, 11.3) 3.7 (3.7, 3.7) 7.9 (7.8, 7.9) - - 
45-49 years 10.1 (10.1, 
10.2) 
17.1 (17.0, 
17.2) 5.5 (5.5, 5.6) 
11.0 (10.9, 
11.1) - - 
50-54 years 15.2 (15.1, 
15.4) 
24.1 (24.0, 
24.3) 8.2 (8.2, 8.3) 
13.5 (13.3, 
13.6) - - 
55-59 years 21.2 (21.0, 
21.3) 
32.6 (32.3, 
32.8) 
11.5 (11.4, 
11.6) 
15.3 (15.2, 
15.5) - - 
60-64 years 28.5 (28.3, 
28.8) 
40.9 (40.7, 
41.2) 
14.9 (14.8, 
15.0) 
17.0 (16.8, 
17.1) - - 
65-69 years 35.8 (35.5, 
36.1) 
49.0 (48.7, 
49.4) 
17.2 (17.1, 
17.4) 
18.4 (18.3, 
18.5) - - 
70-74 years 43.5 (43.2, 
43.9) 
57.2 (56.8, 
57.5) 
21.1 (20.9, 
21.3) 
20.9 (20.7, 
21.1) - - 
30-74 years 15.9 (15.8, 
16.0) 
25.0 (24.9, 
25.1) - - - - 
50-74 years 25.3 (25.1, 
25.4) 
37.6 (37.4, 
37.7) 
13.0 (12.9, 
13.1) 
16.3 (16.2, 
16.4) - - 
Abbreviation: CI=confidence interval. 
1 The Globorisk score predicts cardiovascular risk for adults aged 40-74 years only. 
2 WHO-ISH computes a risk category rather than a continuous risk score. It was, therefore, not possible to estimate 
mean risk for WHO-ISH.  
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eTable16. Proportion of participants who were overweight, current smokers, 
hypertensive, or had diabetes  
!
The table below shows the proportion of participants who were either current smokers, had 
diabetes, hypertension, or who were overweight. Diabetes was defined as having a high blood 
glucose reading or reporting to be on regular treatment for diabetes. Hypertension was defined as 
a systolic blood pressure !140mmHg, a diastolic blood pressure !90mmHg, or reporting to be on 
regular treatment for hypertension. Overweight was defined as a Body Mass Index !25kg/m2. 
The proportions shown were weighted using sampling weights (but not age-standardized).  
 
Age 
Female 
(95% CI) 
Male 
(95% CI) 
30-34 years 32.26 (31.60 - 32.93) 49.31 (48.58 - 50.04) 
35-39 years 38.22 (37.56 - 38.88) 55.79 (55.06 - 56.53) 
40-44 years 43.66 (42.95 - 44.38) 59.74 (58.97 - 60.52) 
45-49 years 49.15 (48.43 - 49.87) 63.73 (62.99 - 64.47) 
50-54 years 54.14 (53.32 - 54.96) 66.15(65.29 – 67.00) 
55-59 years 56.00 (55.13 - 56.87) 68.37 (67.57 - 69.18) 
60-64 years 60.90 (59.98 - 61.81) 70.04 (69.26 - 70.82) 
65-69 years 61.48 (60.48 - 62.49) 69.63 (68.72 - 70.53) 
70-74 years 63.39 (62.20 - 64.56) 70.00 (68.99 - 71.01) 
   
30-74 years 53.0 (52.5 - 53.5) 67.2 (66.8 - 67.7) 
50-74 years 46.84 (46.36 - 47.33) 61.82 (61.36 - 62.27) 
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eFigure15. Age-standardized prevalence of a 10-year cardiovascular risk 
!30% as estimated by the Harvard-NHANES score, by state1!
1 The Union Territories, Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small 
area.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; 
GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, 
Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, Meghalaya; MZ, Mizoram; 
NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; 
TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal. 
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eFigure16. Age-standardized prevalence of a 10-year cardiovascular risk 
!30% as estimated by Globorisk, by state1 
1 The Union Territories, Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small 
area.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; 
GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, 
Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, Meghalaya; MZ, Mizoram; 
NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; 
TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal. 
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eFigure17. Age-standardized prevalence of a 10-year cardiovascular risk 
!30% as estimated by WHO-ISH, by state1!
1 The Union Territories, Chandigarh, Daman and Diu, and Puducherry are not visible in the map due to their small 
area.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CT, Chhattisgarh; DL, Delhi; 
GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, Jammu & Kashmir; JH, Jharkhand; KA, 
Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, Manipur; ML, Meghalaya; MZ, Mizoram; 
NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; RJ, Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; 
TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand (Uttaranchal); WB, West Bengal. 
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eFigure18. Association between an area’s standard of living and high 
cardiovascular disease risk1,2,3,4,5   
 
 
 
1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 The proportion of people in a state/district that is at high CVD risk has been age-standardised to the Global Burden 
of Disease project’s 2013 population structure for India.114   
3 P-values refer to the statistical significance of the linear (ordinary least squares) regression line (shown in grey).  
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal.
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eTable17. Prevalence of a high (!30%) 10-year cardiovascular risk, by state and sex 
State Sex 
Framingham1 Harvard-NHANES1 Globorisk1 
Estimate Lower CI Upper CI Estimate Lower CI Upper CI Estimate Lower CI Upper CI 
Andaman and Nicobar Female 12.4 10.6 14.4 5.8 4.7 6.9 3.4 2.3 4.7 
Andaman and Nicobar Male 22.8 20.7 25.0 16.6 14.6 18.7 5.0 3.6 6.7 
Andhra Pradesh Female 12.7 12.1 13.3 8.5 8.0 8.9 2.4 2.1 2.7 
Andhra Pradesh Male 24.2 23.3 25.1 18.4 17.7 19.1 5.3 4.8 5.8 
Arunachal Pradesh Female 6.4 5.7 7.1 3.5 2.8 4.2 1.9 1.2 2.7 
Arunachal Pradesh Male 20.1 18.9 21.4 13.1 12.1 14.2 2.7 2.2 3.2 
Assam Female 5.0 4.5 5.6 3.1 2.8 3.5 0.4 0.3 0.5 
Assam Male 17.2 15.9 18.6 12.5 11.5 13.5 1.5 1.3 1.9 
Bihar Female 5.2 4.7 5.6 3.3 3.0 3.5 0.6 0.5 0.7 
Bihar Male 16.6 15.6 17.6 12.6 11.8 13.4 1.3 1.0 1.5 
Chandigarh Female 9.9 8.3 11.5 5.8 4.8 6.9 0.7 0.4 1.2 
Chandigarh Male 21.7 18.8 24.8 14.9 12.5 17.4 2.6 1.7 3.8 
Chhattisgarh Female 5.5 4.7 6.3 3.4 2.9 4.0 1.2 0.8 1.7 
Chhattisgarh Male 14.4 13.2 15.6 10.5 9.5 11.7 1.4 1.0 1.9 
Daman and Diu Female 10.6 8.4 12.9 6.1 4.4 8.1 1.7 0.8 2.9 
Daman and Diu Male 17.8 12.9 23.4 11.3 7.9 15.4 3.7 1.3 7.3 
Goa Female 15.5 13.7 17.3 10.6 9.3 11.9 1.8 1.2 2.4 
Goa Male 25.8 23.2 28.5 19.9 17.6 22.3 2.9 1.7 4.5 
Haryana Female 8.3 8.0 8.7 6.1 5.8 6.4 1.3 1.1 1.5 
Haryana Male 21.4 20.8 22.0 15.7 15.2 16.2 2.8 2.5 3.1 
Himachal Pradesh Female 9.2 8.4 10.0 5.7 5.1 6.2 1.9 1.6 2.3 
Himachal Pradesh Male 29.3 27.7 30.9 21.0 19.7 22.3 4.8 4.0 5.7 
Jharkhand Female 6.2 5.5 6.9 3.5 3.1 4.0 0.8 0.6 1.0 
Jharkhand Male 15.4 14.2 16.6 11.7 10.7 12.7 2.1 1.6 2.6 
Karnataka Female 11.8 11.4 12.1 7.4 7.1 7.6 2.0 1.9 2.2 
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Karnataka Male 20.8 20.4 21.3 15.7 15.3 16.1 4.1 3.8 4.4 
Kerala Female 14.3 13.6 14.9 9.9 9.4 10.5 2.1 1.9 2.5 
Kerala Male 30.4 28.8 32.0 22.4 21.2 23.6 5.1 4.4 5.8 
Madhya Pradesh Female 5.3 4.6 6.2 3.6 3.1 4.1 0.5 0.3 0.6 
Madhya Pradesh Male 15.7 15.0 16.5 11.1 10.6 11.7 1.1 0.8 1.4 
Maharashtra Female 8.2 7.9 8.5 5.8 5.5 6.0 1.2 1.1 1.3 
Maharashtra Male 16.2 15.8 16.6 12.5 12.2 12.9 2.1 1.9 2.3 
Manipur Female 9.1 8.5 9.8 6.3 5.8 6.8 1.7 1.4 2.1 
Manipur Male 28.4 27.3 29.6 19.5 18.6 20.4 3.1 2.7 3.7 
Meghalaya Female 6.3 5.5 7.1 3.4 2.9 4.0 1.4 1.0 1.8 
Meghalaya Male 21.7 20.1 23.4 14.4 13.1 15.8 5.1 4.0 6.2 
Mizoram Female 6.5 6.0 7.1 4.4 4.1 4.8 2.2 1.7 2.6 
Mizoram Male 23.1 22.1 24.0 15.0 14.2 15.7 3.2 2.7 3.7 
Nagaland Female 10.7 9.7 11.7 5.5 4.9 6.1 2.8 2.2 3.3 
Nagaland Male 30.2 28.5 31.9 21.4 20.0 22.9 6.9 6.0 7.8 
NCT of Delhi Female 8.5 7.7 9.3 4.7 4.2 5.3 0.9 0.6 1.3 
NCT of Delhi Male 17.4 16.4 18.6 12.1 11.3 13.0 2.3 1.8 2.8 
Odisha Female 6.3 5.9 6.7 4.0 3.7 4.3 0.7 0.6 0.8 
Odisha Male 16.9 16.1 17.7 13.1 12.5 13.7 1.8 1.6 2.1 
Puducherry Female 14.5 13.6 15.5 9.9 9.1 10.7 1.9 1.5 2.4 
Puducherry Male 22.1 20.5 23.8 18.1 16.7 19.5 3.8 3.0 4.6 
Punjab Female 12.9 12.5 13.3 8.6 8.3 8.9 2.5 2.3 2.7 
Punjab Male 22.7 22.2 23.3 16.9 16.4 17.3 4.8 4.4 5.1 
Rajasthan Female 6.3 5.8 6.8 4.4 4.0 4.8 1.1 0.9 1.2 
Rajasthan Male 17.9 16.8 19.1 13.0 12.2 13.9 1.8 1.5 2.2 
Sikkim Female 12.3 11.2 13.4 6.6 5.9 7.4 4.6 3.7 5.6 
Sikkim Male 20.0 18.7 21.4 13.9 12.7 15.1 6.5 5.2 7.8 
Tamil Nadu Female 13.3 12.9 13.7 8.4 8.1 8.7 1.8 1.6 1.9 
Tamil Nadu Male 22.7 22.2 23.2 17.7 17.3 18.1 3.8 3.5 4.0 
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Telangana Female 8.4 7.8 9.1 5.6 5.1 6.1 1.2 0.9 1.5 
Telangana Male 20.3 19.4 21.3 15.1 14.3 15.9 3.4 2.9 3.9 
Tripura Female 9.2 7.9 10.5 5.1 4.3 5.9 1.7 1.0 2.4 
Tripura Male 21.4 19.3 23.5 15.2 13.6 16.9 3.0 2.2 3.9 
Uttar Pradesh Female 7.2 6.7 7.7 4.6 4.3 5.0 1.1 0.9 1.3 
Uttar Pradesh Male 19.9 19.0 20.8 14.4 13.8 15.1 2.2 1.8 2.6 
Uttarakhand Female 10.2 8.9 11.6 7.7 6.7 8.8 1.7 1.3 2.3 
Uttarakhand Male 25.9 23.3 28.5 20.6 18.4 23.0 4.3 3.4 5.4 
West Bengal Female 10.1 9.6 10.6 5.7 5.3 6.0 1.8 1.5 2.0 
West Bengal Male 25.2 24.4 26.1 18.7 18.0 19.4 4.2 3.8 4.6 
Abbreviations: CI=95% confidence interval 
1 Harvard-NHANES and Framingham estimates are for those aged 30 to 74 years, while Globorisk estimates are for those aged 40 to 74 years.  
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eTable18. Prevalence of cardiovascular risk factors, by state and sex 
State Sex 
Mean BMI (kg/m2) Diabetes prevalence (%) Mean systolic BP (mmHg) Smoking prevalence (%) 
Estimate Lower CI 
Upper 
CI Estimate 
Lower 
CI 
Upper 
CI Estimate 
Lower 
CI 
Upper 
CI Estimate 
Lower 
CI 
Upper 
CI 
Andaman and 
Nicobar Female 23.8 23.4 24.2 11.1 9.0 13.4 128.8 126.9 130.8 2.7 1.7 3.9 
Andaman and 
Nicobar Male 23.7 23.4 24.1 12.1 9.9 14.4 132.0 130.3 133.7 24.6 21.1 28.3 
Andhra Pradesh Female 23.5 23.4 23.7 13.0 12.2 13.9 125.5 125.0 126.0 3.4 2.7 4.2 
Andhra Pradesh Male 23.5 23.4 23.7 14.3 13.4 15.2 128.8 128.3 129.3 30.2 28.6 31.9 
Arunachal 
Pradesh Female 23.0 22.8 23.2 6.4 5.1 8.0 125.2 124.1 126.4 8.5 7.3 9.7 
Arunachal 
Pradesh Male 22.7 22.6 22.9 6.2 4.7 7.8 127.0 126.1 127.9 46.4 43.9 48.9 
Assam Female 21.5 21.2 21.7 5.0 4.3 5.7 123.7 122.7 124.7 1.3 1.1 1.5 
Assam Male 21.5 21.3 21.8 6.1 5.2 7.0 128.1 127.2 128.9 29.4 26.3 32.6 
Bihar Female 21.0 20.8 21.2 3.2 2.7 3.7 123.6 122.6 124.6 2.7 2.1 3.3 
Bihar Male 20.6 20.5 20.8 4.3 3.7 5.0 125.2 124.5 125.9 22.5 20.4 24.7 
Chandigarh Female 24.5 24.1 24.8 15.0 12.2 18.0 129.1 127.6 130.7 0.3 0.1 0.6 
Chandigarh Male 23.9 23.5 24.2 14.6 12.2 17.2 133.8 132.5 135.0 18.7 13.2 24.9 
Chhattisgarh Female 21.2 21.0 21.4 5.0 4.2 5.8 123.4 122.3 124.5 0.4 0.3 0.6 
Chhattisgarh Male 21.6 21.4 21.8 7.2 6.0 8.5 127.0 126.1 127.8 15.1 13.0 17.3 
Daman and Diu Female 23.5 22.7 24.3 14.8 10.2 20.1 130.2 127.9 132.4 0.1 0.0 0.3 
Daman and Diu Male 24.1 23.4 24.7 10.5 6.3 15.6 132.3 130.2 134.5 9.9 6.2 14.4 
Goa Female 24.4 24.0 24.8 21.9 19.4 24.4 128.4 126.9 129.8 2.2 1.2 3.4 
Goa Male 24.0 23.7 24.3 24.8 22.0 27.7 131.4 129.6 133.2 9.3 7.1 11.8 
Haryana Female 23.3 23.2 23.4 8.1 7.6 8.6 123.7 123.3 124.0 2.2 1.9 2.5 
Haryana Male 23.0 22.9 23.1 8.3 7.8 8.9 127.6 127.3 128.0 35.3 34.0 36.6 
Himachal 
Pradesh Female 23.0 22.8 23.2 4.8 4.1 5.5 130.3 129.6 131.0 2.5 1.9 3.1 
Himachal 
Pradesh Male 23.0 22.9 23.2 4.4 3.8 5.1 132.7 132.0 133.5 41.7 39.1 44.3 
Jharkhand Female 21.2 20.9 21.5 4.5 3.8 5.3 122.3 121.5 123.2 0.7 0.4 1.0 
Jharkhand Male 21.6 21.4 21.8 5.9 5.0 6.9 126.6 125.6 127.6 9.9 8.2 11.7 
Karnataka Female 22.8 22.7 22.9 12.9 12.4 13.4 126.8 126.5 127.1 0.9 0.8 1.0 
Karnataka Male 22.9 22.8 22.9 13.8 13.2 14.4 128.6 128.3 128.9 21.4 20.5 22.2 
Kerala Female 24.4 24.2 24.6 15.1 14.0 16.1 129.6 128.7 130.5 0.8 0.6 1.1 
Kerala Male 23.9 23.7 24.2 18.3 16.9 19.8 132.3 131.2 133.4 30.4 28.2 32.7 
Madhya Pradesh Female 21.3 21.2 21.5 3.5 2.9 4.1 123.9 122.8 125.1 0.9 0.4 1.7 
Madhya Pradesh Male 21.1 20.9 21.2 4.0 3.5 4.5 126.2 125.5 126.9 25.4 23.8 27.0 
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Maharashtra Female 22.3 22.2 22.4 7.4 7.0 7.8 123.7 123.4 123.9 0.5 0.4 0.6 
Maharashtra Male 22.7 22.6 22.8 8.3 7.8 8.7 126.2 126.0 126.5 9.4 8.8 10.0 
Manipur Female 22.9 22.8 23.1 9.6 8.7 10.5 123.5 122.9 124.1 12.6 10.8 14.5 
Manipur Male 22.6 22.4 22.7 10.2 9.3 11.2 128.1 127.5 128.7 60.3 57.9 62.7 
Meghalaya Female 21.8 21.6 22.0 3.8 3.0 4.7 125.2 124.3 126.1 5.8 4.7 7.1 
Meghalaya Male 22.1 21.9 22.3 4.3 3.3 5.4 127.7 126.5 128.9 59.7 56.2 63.3 
Mizoram Female 22.1 21.9 22.2 4.6 4.0 5.3 119.1 118.5 119.6 26.1 24.5 27.6 
Mizoram Male 22.3 22.1 22.4 4.8 4.2 5.5 125.7 125.2 126.3 71.7 70.1 73.2 
Nagaland Female 22.2 22.0 22.4 7.1 6.1 8.1 130.7 129.8 131.7 1.4 1.0 1.9 
Nagaland Male 22.3 22.1 22.5 7.5 6.6 8.5 133.6 132.6 134.5 42.1 39.6 44.6 
NCT of Delhi Female 24.0 23.7 24.2 15.3 14.0 16.7 124.8 124.2 125.4 1.8 1.3 2.4 
NCT of Delhi Male 23.7 23.6 23.9 14.4 13.3 15.6 127.1 126.6 127.7 27.8 25.6 30.0 
Odisha Female 21.4 21.2 21.6 4.2 3.9 4.7 120.0 119.2 120.9 0.9 0.7 1.1 
Odisha Male 21.4 21.2 21.6 5.6 5.1 6.2 121.7 120.7 122.6 19.6 18.1 21.1 
Puducherry Female 25.1 24.8 25.4 20.7 19.1 22.3 123.9 123.3 124.6 0.3 0.1 0.5 
Puducherry Male 24.2 23.9 24.4 22.2 20.5 24.1 128.2 127.3 129.1 14.0 12.1 16.0 
Punjab Female 25.1 25.0 25.1 10.9 10.4 11.3 131.2 130.9 131.5 0.3 0.2 0.4 
Punjab Male 24.3 24.2 24.4 10.4 9.9 10.9 136.2 135.9 136.6 15.9 15.0 16.8 
Rajasthan Female 21.5 21.3 21.7 3.7 3.3 4.2 121.4 120.8 122.1 2.2 1.6 2.8 
Rajasthan Male 21.3 21.1 21.5 4.5 3.9 5.0 126.1 125.4 126.7 23.6 20.9 26.5 
Sikkim Female 24.5 24.2 24.8 7.5 6.4 8.6 132.8 131.5 134.0 6.0 4.9 7.2 
Sikkim Male 23.6 23.3 23.8 7.4 6.4 8.6 133.1 132.0 134.2 23.6 21.2 26.1 
Tamil Nadu Female 24.0 23.9 24.2 20.1 19.5 20.7 124.3 124.0 124.6 0.5 0.4 0.5 
Tamil Nadu Male 23.3 23.2 23.3 21.2 20.6 21.8 128.3 128.1 128.6 19.4 18.6 20.2 
Telangana Female 22.4 22.2 22.7 9.9 9.0 10.9 122.3 121.6 122.9 2.9 2.2 3.6 
Telangana Male 22.9 22.7 23.1 11.3 10.3 12.4 125.2 124.5 125.9 34.7 32.5 37.0 
Tripura Female 21.8 21.6 22.1 14.8 12.8 17.0 125.7 124.5 126.9 5.6 3.9 7.6 
Tripura Male 21.8 21.5 22.0 15.7 13.4 18.2 127.1 125.8 128.4 39.3 34.8 43.9 
Uttar Pradesh Female 21.7 21.5 21.8 4.7 4.2 5.2 122.9 122.1 123.6 2.5 2.1 2.9 
Uttar Pradesh Male 20.8 20.6 21.0 5.2 4.6 5.8 125.0 124.1 125.9 32.9 31.0 34.7 
Uttarakhand Female 23.4 22.9 23.8 6.3 4.7 8.0 125.8 124.5 127.2 1.6 1.1 2.3 
Uttarakhand Male 22.8 22.5 23.1 6.9 5.4 8.6 131.7 130.3 133.2 26.6 22.6 30.9 
West Bengal Female 21.7 21.6 21.8 11.6 10.9 12.4 127.0 126.4 127.5 3.3 2.8 3.9 
West Bengal Male 21.7 21.6 21.8 12.8 12.0 13.6 126.9 126.4 127.5 49.5 48.0 51.0 
Abbreviations: CI=95% confidence interval 
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eFigure19. Association between mean Body Mass Index and household wealth 
quintile at the state and district level1,2,3,4,5!!!
 
 
 
1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Mean Body Mass Index has been age-standardised to the Global Burden of Disease project’s 2013 population 
structure for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
<0.0001.  
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal.
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1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Mean Body Mass Index has been age-standardised to the Global Burden of Disease project’s 2013 population 
structure for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
<0.0001.   
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
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eFigure20. Association between diabetes prevalence and household wealth 
quintile at the state and district level1,2,3,4,5  !
 
 
1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Diabetes prevalence has been age-standardised to the Global Burden of Disease project’s 2013 population structure 
for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
<0.0001 
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal.
TS
KA
TR
WB
TN
SK
MHNL
KL
AP
AR
HR
GA
PB
HP
MN
MZ
DL
ML
PY
CH
AN
DD
JH
OD RJUPMP
CT UKAS
BR
0
5
10
15
20
25
30
1 2 3 4 5
Mean household wealth quintile
Di
ab
et
es
 p
re
va
le
nc
e 
(%
)
Central
East
North
Northeast
South
West
!! 149 
 
 
1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Diabetes prevalence has been age-standardised to the Global Burden of Disease project’s 2013 population structure 
for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
<0.0001.  
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
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eFigure21. Association between smoking prevalence and household wealth 
quintile at the state and district level1,2,3,4,5  !
 
 
 
1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Smoking prevalence has been age-standardised to the Global Burden of Disease project’s 2013 population 
structure for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
0.84. 
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal.
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1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Smoking prevalence has been age-standardised to the Global Burden of Disease project’s 2013 population 
structure for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
0.81. 
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
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eFigure22. Association between mean systolic blood pressure and household 
wealth quintile at the state and district level1,2,3,4,5  !
 
 
1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Mean systolic blood pressure has been age-standardised to the Global Burden of Disease project’s 2013 population 
structure for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
0.002. 
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
Abbreviations: AP, Andhra Pradesh; AR, Arunachal Pradesh; AS, Assam; BR, Bihar; CH, Chandigarh; CT, 
Chhattisgarh; DD, Daman and Diu; DL, Delhi; GA, Goa; GJ, Gujarat; HR, Haryana; HP, Himachal Pradesh; JK, 
Jammu & Kashmir; JH, Jharkhand; KA, Karnataka; KL, Kerala; MP, Madhya Pradesh; MH, Maharashtra; MN, 
Manipur; ML, Meghalaya; MZ, Mizoram; NL, Nagaland; OD, Odisha (Orissa); PB, Punjab; PY, Puducherry; RJ, 
Rajasthan; SK, Sikkim; TN, Tamil Nadu; TS, Telangana State; TR, Tripura; UP, Uttar Pradesh; UK, Uttarakhand 
(Uttaranchal); WB, West Bengal.
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1 Standard of living was measured by the mean household wealth quintile in a state/district, whereby household 
wealth quintile was computed at the national level (and not separately for rural and urban areas).  
2 Mean systolic blood pressure has been age-standardised to the Global Burden of Disease project’s 2013 population 
structure for India.114   
3 The p-value for the statistical significance of the linear (ordinary least squares) regression line (shown in grey) was 
<0.0001. 
4 States and districts were divided into regions as per their allocation to Zonal Councils by the Government of 
India.92   
5 The sample in each state and district has been restricted to those aged 30 to 74 years.  
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eFigure23. Percentage of population with a high (!30%) 10-year Harvard-
NHANES score by household wealth quintile, age group, rural versus urban 
location, and sex. 
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eFigure24. Percentage of population with a high (!30%) 10-year Globorisk 
score by household wealth quintile, age group, rural versus urban location, 
and sex.1!
 
 
1 Globorisk estimates cardiovascular risk only for those aged 40 to 74 years.  
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eFigure25. Percentage of population with a high (!30%) 10-year WHO-ISH 
score by household wealth quintile, age group, rural versus urban location, 
and sex. 
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eTable19. Ordinary least squares regressions of the natural logarithm of the 
Harvard-NHANES risk score on sociodemographic covariates and PSU-level 
fixed effects1 
 
 Female (n=420,691) Male (n=376,849) 
 Adjusted for age group only2 
Adjusted for all 
covariates3 
Adjusted for age group 
only2 
Adjusted for all 
covariates3 
 Coefficient
4 
(95% CI) P 
Coefficient4 
(95% CI) P 
Coefficient4 
(95% CI)! P!
Coefficient4 
(95% CI)! P!
Wealth quintile     ! ! ! !
1 (poorest) Ref.  Ref.  Ref.! ! Ref.! !
2 3.16 (2.78, 3.55) <0.001 
2.77 (2.39, 
3.15) <0.001 
1.30 (0.90, 
1.71)! <0.001!
1.13 (0.72, 
1.54)! <0.001!
3 6.22 (5.81, 6.62) <0.001 
5.86 (5.45, 
6.27) <0.001 
2.88 (2.45, 
3.31)! <0.001!
2.84 (2.40, 
3.27)! <0.001!
4 10.21 (9.80, 10.62) <0.001 
9.63 (9.20, 
10.05) <0.001 
5.02 (4.58, 
5.46)! <0.001!
4.90 (4.44, 
5.35)! <0.001!
5 (richest) 17.54 (17.12, 17.96) <0.001 
16.55 (16.10, 
17.00) <0.001 
9.61 (9.16, 
10.05)! <0.001!
9.26 (8.78, 
9.75)! <0.001!
Educational 
attainment     ! ! ! !
<Primary 
School Ref.  Ref.  Ref.! ! Ref.! !
Primary 
School 
7.00 (6.62, 
7.37) <0.001 
4.31 (3.93, 
4.69) <0.001 
2.29 (1.89, 
2.69)! <0.001!
1.26 (0.87, 
1.66)! <0.001!
Middle 
School 
8.45 (8.06, 
8.83) <0.001 
4.53 (4.14, 
4.92) <0.001 
3.58 (3.20, 
3.96)! <0.001!
1.87 (1.48, 
2.25)! <0.001!
Secondary 
School 
11.53 (11.11, 
11.96) <0.001 
5.41 (4.97, 
5.85) <0.001 
5.42 (5.03, 
5.80)! <0.001!
2.51 (2.10, 
2.91)! <0.001!
High School 11.01 (10.43, 11.59) <0.001 
3.70 (3.11, 
4.29) <0.001 
4.45 (3.97, 
4.93)! <0.001!
0.89 (0.39, 
1.39)! <0.001!
>High School 11.15 (10.59, 11.71) <0.001 
1.44 (0.84, 
2.03) <0.001 
7.23 (6.78, 
7.67)! <0.001!
2.15 (1.66, 
2.63)! <0.001!
Geography     ! ! ! !
Rural Ref.  Ref.  Ref.! ! Ref.! !
Urban 12.35 (11.89, 12.81) <0.001 
12.78 (12.30, 
13.26) <0.001 
8.65 (8.16, 
9.13)! <0.001!
9.02 (8.52, 
9.51) <0.001!
Abbreviations: CI=Confidence Interval; Ref. = Reference category. 
1 Standard errors were adjusted for clustering at the household level.  
2 These models included one sociodemographic characteristic, age group, and a binary indicator variable for each 
primary sampling unit (PSU) as explanatory variables.  
3 This model included all variables listed in the table, age group, and a binary indicator for each PSU as explanatory 
variables.   
4 Coefficients were multiplied by 100 so that they can be interpreted more easily as an approximation of the 
percentage change in cardiovascular risk associated with a one unit change in the explanatory variable.    
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eTable20. Ordinary least squares regressions of the natural logarithm of the 
Globorisk score on sociodemographic covariates and PSU-level fixed effects1 
 
 Female (n=276,467) Male (n=261,954) 
 Adjusted for age group only2 
Adjusted for all 
covariates3 
Adjusted for age group 
only2 
Adjusted for all 
covariates3 
 Coefficient
4 
(95% CI) P 
Coefficient4 
(95% CI) P 
Coefficient4 
(95% CI)! P!
Coefficient4 
(95% CI)! P!
Wealth quintile     ! ! ! !
1 (poorest) Ref.  Ref.  Ref.! ! Ref.! !
2 2.01 (1.44 - 2.57) <0.001 
1.61 (1.05 - 
2.18) <0.001 
1.58 (1.00 – 
2.15)! <0.001!
1.37 (0.79 - 
1.94)! <0.001!
3 4.30 (3.71 - 4.90) <0.001 
3.75 (3.15 - 
4.35) <0.001 
3.01 (2.40 – 
3.61)! <0.001!
2.79 (2.18 - 
3.41! <0.001!
4 7.18 (6.57 - 7.78) <0.001 
6.25 (5.63 – 
6.87) <0.001 
5.03 (4.41 – 
5.64)! <0.001!
4.68 (4.04 - 
5.32)! <0.001!
5 (richest) 14.25 (13.64 - 14.86) <0.001 
12.62 (11.97 – 
13.27) <0.001 
10.56 (9.94 – 
11.18)! <0.001!
9.89 (9.22 – 
10.57)! <0.001!
Educational 
attainment     ! ! ! !
<Primary 
School Ref.  Ref.  Ref.! ! Ref.! !
Primary 
School 
6.55 (6.00 - 
7.10) <0.001 
4.28 (3.72 - 
4.84) <0.001 
2.25 (1.71 – 
2.79)! <0.001!
1.23 (0.69 - 
1.78)! <0.001!
Middle 
School 
7.83 (7.23 – 
8.42) <0.001 
4.63 (4.02 - 
5.24) <0.001 
3.45 (2.92 - 
3.99)! <0.001!
1.78 (1.24 – 
2.32)! <0.001!
Secondary 
School 
10.76 (10.09 - 
11.43) <0.001 
5.77 (5.06 - 
6.47) <0.001 
5.79 (5.25 - 
6.33)! <0.001!
2.84 (2.28 - 
3.41)! <0.001!
High School 10.73 (9.73 - 11.73) <0.001 
5.11 (4.09 – 
6.14) <0.001 
3.94 (3.24 – 
4.65)! <0.001!
0.47 (-0.27 - 
1.20)! 0.216!
>High School 10.29 (9.35 – 11.23) <0.001 
2.95 (1.97 - 
3.94) <0.001 
7.00 (6.37 – 
7.64)! <0.001!
2.12 (1.42 - 
2.81)! <0.001!
Geography     ! ! ! !
Rural Ref.  Ref.  Ref.! ! Ref.! !
Urban 9.40 (8.73 – 10.08) <0.001 
8.84 (8.14 – 
9.54) <0.001 
5.93 (5.25 – 
6.61)! <0.001!
6.10 (5.40 – 
6.80)! <0.001!
Abbreviations: CI=Confidence Interval; Ref. = Reference category. 
1 Standard errors were adjusted for clustering at the household level.  
2 These models included one sociodemographic characteristic, age group, and a binary indicator variable for each 
primary sampling unit (PSU) as explanatory variables.  
3 This model included all variables listed in the table, age group, and a binary indicator for each PSU as explanatory 
variables.   
4 Coefficients were multiplied by 100 so that they can be interpreted more easily as an approximation of the 
percentage change in cardiovascular risk associated with a one unit change in the explanatory variable.    
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